SVB Financial (SIVBQ) 10-K24 Feb 232022 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($)	12 Months Ended
Cover Page - USD ($)	Dec. 31, 2022	Jan. 31, 2023	Jun. 30, 2022
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Entity File Number	001-39154
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Registrant Name	SVB FINANCIAL GROUP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-1962278
Entity Central Index Key	0000719739
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Amendment Flag	false
Entity Common Stock, Shares Outstanding		59,200,925
Entity Address, Address Line One	3003 Tasman Drive
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1191
City Area Code	408
Local Phone Number	654-7400
Entity Public Float			$ 23,336,532,366
ICFR Auditor Attestation Flag	true
Documents Incorporated by Reference	Definitive proxy statement for the Company's 2022 Annual Meeting of Stockholders to be filed within 120 days of the end of the fiscal year ended December 31, 2021
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	SIVB
Security Exchange Name	NASDAQ
Series A Preferred Stock
Entity Information [Line Items]
Title of 12(b) Security	Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A
Trading Symbol	SIVBP
Security Exchange Name	NASDAQ

Audit Information

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2022
Auditor Information [Abstract]
Auditor Name	KPMG LLP
Auditor Firm ID	185
Auditor Location	San Francisco, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 13,803	$ 14,586
Available-for-sale securities, at fair value (cost of $28,602 and $27,370, respectively, including $530 and $61 pledged as collateral, respectively)	26,069	27,221
Held-to-maturity securities, at amortized cost and net of allowance for credit losses of $6 and $7 (fair value of $76,169 and $97,227, respectively)	91,321	98,195
Non-marketable and other equity securities	2,664	2,543
Total investment securities	120,054	127,959
Loans, amortized cost	74,250	66,276
Allowance for credit losses: loans	(636)	(422)
Net loans	73,614	65,854
Premises and equipment, net of accumulated depreciation and amortization	394	270
Goodwill	375	375
Other intangible assets, net	136	160
Lease right-of-use assets	335	313
Accrued interest receivable and other assets	3,082	1,791
Total assets	211,793	211,308
Liabilities:
Noninterest-bearing demand deposits	80,753	125,851
Interest-bearing deposits	92,356	63,352
Total deposits	173,109	189,203
Short-term borrowings	13,565	71
Lease liabilities	413	388
Other liabilities	3,041	2,467
Long-term debt	5,370	2,570
Total liabilities	195,498	194,699
Commitments and contingencies (Note 21 and Note 26)
SVBFG stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 383,500 and 383,500 shares issued and outstanding, respectively	3,646	3,646
Common stock, $0.001 par value, 150,000,000 shares authorized; 59,171,883 and 58,748,469 shares issued and outstanding, respectively	0	0
Additional paid-in capital	5,318	5,157
Retained earnings	8,951	7,442
Accumulated other comprehensive income (loss)	(1,911)	(9)
Total SVBFG stockholders’ equity	16,004	16,236
Noncontrolling interests	291	373
Total equity	16,295	16,609
Total liabilities and total equity	$ 211,793	$ 211,308

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Amortized Cost	$ 28,602	$ 27,370
Available-for-sale securities at fair value, pledged as collateral	530	61
Allowance for credit loss	6	7
Held-to-maturities, fair value	$ 76,169	$ 97,227
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	383,500	383,500
Preferred stock, shares outstanding	383,500	383,500
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares, issued	59,171,883	58,748,469
Common stock, shares outstanding	59,171,883	58,748,469

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Interest income:
Loans	$ 3,208	$ 1,966	$ 1,520
Investment securities:
Taxable	2,113	1,199	635
Non-taxable	140	106	61
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities	212	18	26
Total interest income	5,673	3,289	2,242
Interest expense:
Deposits	862	62	60
Borrowings	326	48	25
Total interest expense	1,188	110	85
Net interest income	4,485	3,179	2,157
Provision for credit losses	420	123	220
Net interest income after provision for credit losses	4,065	3,056	1,937
Noninterest income:
Gains (losses) on investment securities, net	(285)	761	421
Gains on equity warrant assets, net	148	560	237
Client investment fees	386	75	132
Wealth management and trust fees	83	44	0
Foreign exchange fees	285	262	179
Credit card fees	150	131	98
Deposit service charges	126	112	90
Lending related fees	94	76	57
Letters of credit and standby letters of credit fees	57	51	47
Investment banking revenue	420	459	414
Commissions	98	79	67
Other	166	128	98
Total noninterest income	1,728	2,738	1,840
Noninterest expense:
Compensation and benefits	2,293	2,015	1,318
Professional services	480	392	247
Premises and equipment	269	178	127
Net occupancy	101	83	101
Business development and travel	85	24	24
FDIC and state assessments	75	48	28
Merger-related charges	50	129	0
Other	268	201	190
Total noninterest expense	3,621	3,070	2,035
Income before income tax expense	2,172	2,724	1,742
Income tax expense	563	651	448
Net income before noncontrolling interests and dividends	1,609	2,073	1,294
Net loss (income) attributable to noncontrolling interests	63	(240)	(86)
Preferred stock dividends	(163)	(63)	(17)
Net income available to common stockholders	$ 1,509	$ 1,770	$ 1,191
Earnings per common share—basic (usd per share)	$ 25.58	$ 31.74	$ 23.05
Earnings per common share—diluted (usd per share)	$ 25.35	$ 31.25	$ 22.87

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income before noncontrolling interests	$ 1,609	$ 2,073	$ 1,294
Change in foreign currency cumulative translation gains and losses:
Foreign currency translation gains (losses), net of hedges	(54)	(2)	16
Related tax benefit (expense)	15	0	(5)
Change in unrealized gains and losses on AFS securities:
Unrealized holding gains (losses)	(2,503)	(644)	606
Related tax benefit (expense)	686	179	(168)
Reclassification adjustment for (gains) losses included in net income	(21)	(31)	(61)
Related tax expense (benefit)	6	9	17
Cumulative-effect adjustment for unrealized losses on securities transferred from AFS to HTM	0	(132)	0
Related tax benefit	0	37	0
Amortization of unrealized holding (gains) losses on securities transferred from AFS to HTM	13	(1)	2
Related tax expense (benefit)	(4)	0	(1)
Change in unrealized gains and losses on cash flow hedges:
Unrealized gains (losses)	0	0	232
Related tax (expense) benefit	0	0	(64)
Reclassification adjustment for gains included in net income	(56)	(63)	(50)
Related tax expense	16	17	14
Other comprehensive income (loss), net of tax	(1,902)	(632)	538
Comprehensive income (loss)	(293)	1,441	1,832
Comprehensive (income) loss attributable to noncontrolling interests	63	(240)	(86)
Comprehensive income (loss) attributable to SVBFG	$ (230)	$ 1,201	$ 1,746

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions		Total	Noncumulative Preferred Stock	Cumulative adjustment for adoption of amendment	Preferred Stock	Preferred Stock Noncumulative Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative adjustment for adoption of amendment	Accumulated Other Comprehensive Income (Loss)	Total SVBFG Stockholders’ Equity	Total SVBFG Stockholders’ Equity Noncumulative Preferred Stock	Total SVBFG Stockholders’ Equity Cumulative adjustment for adoption of amendment	Noncontrolling Interests
Balance, beginning of period, net of tax at Dec. 31, 2019		$ 6,622			$ 340		$ 0	$ 1,470	$ 4,576		$ 85	$ 6,471			$ 151
Balance, beginning of period, net of tax (Accounting Standards Update 2017-08) at Dec. 31, 2019	[1]			$ (35)						$ (35)				$ (35)
Balance (in shares) at Dec. 31, 2019							51,655,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under share-based and employee benefit plans, net (in shares)							477,079
Common stock issued under share-based and employee benefit plans, net		31					$ 0	31				31
Net income		1,294							1,208			1,208			86
Capital calls and distributions, net		(24)													(24)
Other comprehensive income (loss), net of tax		538									538	538
Share-based compensation, net		84						84				84
Common stock repurchases (in shares)							(244,223)
Common stock repurchases		(60)					$ 0		(60)			(60)
Dividends on preferred stock		(17)							(17)			(17)
Balance, end of period, net of tax at Dec. 31, 2020		8,433			340		$ 0	1,585	5,672		623	8,220			213
Balance (in shares) at Dec. 31, 2020							51,888,463
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under share-based and employee benefit plans, net (in shares)							445,025
Common stock issued under share-based and employee benefit plans, net		11					$ 0	11				11
Issuance of stock (in shares)							4,527,000
Issuance of stock		2,363	$ 3,306			$ 3,306		2,363				2,363	$ 3,306
Issuance of common stock for the acquisition of Boston Private (in shares)							1,887,981
Issuance of common stock for the acquisition of Boston Private		1,060					$ 0	1,060				1,060
Net income		2,073							1,833			1,833			240
Capital calls and distributions, net		(80)													(80)
Other comprehensive income (loss), net of tax		(632)									(632)	(632)
Share-based compensation, net		138						138				138
Dividends on preferred stock		(63)							(63)			(63)
Balance, end of period, net of tax at Dec. 31, 2021		16,609			3,646		$ 0	5,157	7,442		(9)	16,236			373
Balance (in shares) at Dec. 31, 2021							58,748,469
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under share-based and employee benefit plans, net (in shares)							423,414
Common stock issued under share-based and employee benefit plans, net		(22)					$ 0	(22)				(22)
Net income		1,609							1,672			1,672			(63)
Capital calls and distributions, net		(19)													(19)
Other comprehensive income (loss), net of tax		(1,902)									(1,902)	(1,902)
Share-based compensation, net		183						183				183
Dividends on preferred stock		(163)							(163)			(163)
Balance, end of period, net of tax at Dec. 31, 2022		$ 16,295			$ 3,646		$ 0	$ 5,318	$ 8,951		$ (1,911)	$ 16,004			$ 291
Balance (in shares) at Dec. 31, 2022							59,171,883

[1]See Note 2- "Summary of Significant Accounting Policies" for additional details.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income before noncontrolling interests	$ 1,609	$ 2,073	$ 1,294
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	420	123	220
Changes in fair values of equity warrant assets, net of proceeds from exercises	(60)	(26)	(2)
Changes in fair values of derivatives, net	193	52	(82)
Gains (losses) on investment securities, net	285	(761)	(421)
Distributions of earnings from non-marketable and other equity securities	57	201	86
Depreciation and amortization	222	151	101
Amortization of premiums and discounts on investment securities, net	388	451	75
Amortization of share-based compensation	183	136	84
Amortization of deferred loan fees	(259)	(269)	(174)
Deferred income tax (benefit) expense	591	(8)	7
Excess tax benefit from exercise of stock options and vesting of restricted shares	(18)	(40)	(6)
Losses from the write-off of premises and equipment and right-of-use assets	2	39	30
Changes in other assets and liabilities:
Accrued interest receivable and payable, net	(45)	(185)	(26)
Accounts receivable and payable, net	6	17	19
Income tax receivable and payable, net	(179)	(122)	98
Accrued compensation	(48)	332	191
Proceeds from termination of interest rate swaps	0	0	228
Other, net	(483)	(296)	(310)
Net cash provided by operating activities	2,864	1,868	1,412
Cash flows from investing activities:
Purchases of AFS securities	(12,724)	(12,147)	(23,208)
Proceeds from sales of AFS securities	9,495	1,591	2,654
Proceeds from maturities and paydowns of AFS securities	1,452	4,768	4,184
Purchases of HTM securities	(4,961)	(85,519)	(6,778)
Proceeds from maturities and paydowns of HTM securities	11,469	13,428	4,036
Purchases of non-marketable and other equity securities	(381)	(365)	(201)
Proceeds from sales and distributions of capital of non-marketable and other equity securities	106	666	148
Net increase in loans	(7,879)	(13,726)	(11,927)
Purchases of premises and equipment	(215)	(113)	(87)
Business acquisitions, net	0	1,081	(27)
Net cash used for investing activities	(3,638)	(90,336)	(31,206)
Cash flows from financing activities:
Net increase (decrease) in deposits	(16,094)	78,238	40,224
Net increase (decrease) in short-term borrowings	13,494	21	6
Proceeds from issuance of long-term debt	2,795	1,636	495
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests	(19)	(80)	(23)
Net proceeds from the issuance of preferred stock	0	3,306	0
Payment of preferred stock dividends	(163)	(63)	(17)
Common stock repurchase	0	0	(60)
Proceeds from issuance of common stock, net	(22)	2,374	31
Net cash provided (used for) by financing activities	(9)	85,432	40,656
Net increase (decrease) in cash and cash equivalents	(783)	(3,036)	10,862
Cash and cash equivalents at beginning of period	14,586	17,622	6,760
Cash and cash equivalents at end of period	13,803	14,586	17,622
Cash paid during the period for:
Interest	981	93	84
Income taxes, net of refunds	96	739	299
Noncash items during the period:
Changes in unrealized gains and losses on AFS securities, net of tax	(1,832)	(488)	394
Distributions of stock from investments	2	72	12
Transfers from AFS securities to HTM	$ 0	$ 8,953	$ 0

Nature of Business

Nature of Business	12 Months Ended
Nature of Business	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Nature of Business SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our consolidated financial statements, when we refer to "SVB",“SVB Financial Group,” “SVBFG”, the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company entity, SVB Financial Group (not including subsidiaries). We offer commercial banking products and services through our principal subsidiary, the Bank, which is a California-chartered bank founded in 1983 and a member of the Federal Reserve System. Through its subsidiaries, the Bank also offers asset management, private wealth management and other investment services. In addition, through SVB Financial's other subsidiaries and divisions, we offer investment banking and non-banking products and services, such as funds management and M&A advisory services. We primarily focus on serving corporate clients in the following industries: technology, life science/healthcare, private equity/venture capital and premium wine. Our corporate clients range widely in terms of size and stage of maturity. Additionally, we focus on cultivating strong relationships with firms within the venture capital and private equity community worldwide, many of which are also our clients and may invest in our corporate clients. Headquartered in Santa Clara, California, we operate in centers of innovation in the United States and around the world.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments and 5) income taxes. Principles of Consolidation and Presentation Our consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. We consolidate entities in which we have a controlling financial interest. Before we determine whether we have a controlling financial interest, we must evaluate whether the entity is a voting interest entity or a variable interest entity ("VIE"). VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support and, as a group, lack one of the following characteristics: (i) the power to direct the activities that most significantly impact the entity’s economic performance, (ii) the obligation to absorb the expected losses of the entity or (iii) the right to receive the expected returns of the entity. We hold a controlling financial interest in a VIE when we are the primary beneficiary. A primary beneficiary is the party that has both: (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses or receive benefits of a VIE that could potentially be significant to a VIE. Generally, the parties that make management and investment decisions, or parties that can unilaterally remove such decision-makers are deemed to have the power to direct the activities of a VIE. When assessing whether we have the obligation to absorb losses or the right to receive benefits from the VIE, we consider all of our economic interests in the VIE, including any fees and other compensation received for providing investment and management services if that compensation is not customary and commensurate with the services provided. Voting interest entities are entities that (i) have sufficient equity to finance their activities and (ii) provide the equity investors power to make significant decisions relating to the entity’s operations. For such entities, we have a controlling financial interest if we hold a majority of voting rights. All significant intercompany accounts and transactions with consolidated entities have been eliminated. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, cash balances due from banks, interest-earning deposits, Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities. For the consolidated statements of cash flows, we consider cash equivalents to be investments that are readily convertible to known amounts of cash, so near to their maturity that they present an insignificant risk of change in fair value due to changes in market interest rates, and purchased in conjunction with our cash management activities. Investment Securities Available-for-Sale Securities and the Allowance for Credit Losses on Available-for-Sale Securities Our AFS securities portfolio is a fixed income investment portfolio that is managed to earn an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification and meeting our asset and liability management objectives. The accretion of discounts and amortization of premiums over the contractual terms of the underlying securities are included in interest income. We apply the retrospective method of amortization for discounts and premiums to prepayable AFS securities. When the estimated remaining lives of securities changes, the related premium or discount is adjusted with a corresponding cumulative charge or benefit to interest income. Sales of AFS securities use the specific identification method. AFS securities are recorded at fair value. Unrealized gains and losses on AFS securities, net of applicable taxes, are reported in AOCI, a separate component of SVBFG's stockholders' equity. Impairment losses on AFS securities are recognized through earnings when we intend to sell an AFS security, or it is more likely than not that we will be required to sell the security before recovery of its amortized cost. Additionally, we evaluate whether a credit loss exists for securities that we intend to hold. We consider all factors in determining whether a credit loss exists, including the period over which the debt security is expected to recover. A credit impairment is recognized through a valuation allowance against the security with an offset through earnings. The allowance is limited to the amount that its fair value is less than the amortized cost basis. Held-to-Maturity Securities and the Allowance for Credit Losses on Held-to-Maturity Securities Debt securities purchased with the positive intent and ability to hold to its maturity are classified as HTM securities and are recorded at amortized cost, net of any ACL. We apply the retrospective method of amortization for discounts and premiums to prepayable HTM securities. When the estimated remaining lives of securities changes, the related premium or discount is adjusted with a corresponding cumulative charge or benefit to interest income. We measure ECL on HTM securities on a collective basis by major security type and standard credit rating. Certain securities in our HTM securities portfolio are either explicitly or implicitly guaranteed by the U.S. government, are highly rated by major rating agencies and have a long history of no credit losses. With respect to these securities, we consider the risk of credit loss to be zero and, therefore, we do not record an ECL. The estimate of ECL on our HTM securities that are not guaranteed by the U.S. government considers historical credit loss information and severity of loss in the event of default and leverages external data adjusted for current conditions. A reasonable and supportable forecast period of one year is applied, with immediate reversion to long-term average historical loss rates when remaining contractual lives of securities exceed one year. We do not estimate ECL on AIR from HTM securities as AIR is reversed or written off when the full collection of the AIR related to a security becomes doubtful. AIR from HTM securities totaled $211 million at December 31, 2022, and $225 million at December 31, 2021, and is excluded from the amortized cost disclosures within our HTM security disclosures in Note 9—“Investment Securities” as it is included and reported separately within "Accrued interest receivable and other assets" in our consolidated balance sheets. ECL on HTM securities that do not share common risk characteristics with our collective portfolio are individually measured based on net realizable value, or the difference between the discounted value of the expected future cash flows and the recorded amortized cost basis of the security. Transfers of investment securities into the HTM category from the AFS category are made at fair value at the date of transfer. The net unrealized gains, net of tax, are retained in other comprehensive income, and the carrying value of the HTM securities are amortized over the life of the securities in a manner consistent with the amortization of a premium or discount. Non-Marketable and Other Equity Securities Non-marketable and other equity securities include investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised and investments in qualified affordable housing projects. A majority of these investments are managed through our SVB Capital funds business in funds of funds and direct venture funds. Our accounting for investments in non-marketable and other equity securities depends on several factors, including the level of ownership, power to control and the legal structure of the subsidiary making the investment. As further described below, we base our accounting for such securities on: (i) fair value accounting, (ii) measurement alternative for other investments without a readily determinable fair value, (iii) equity method accounting and (iv) the proportional amortization method, which is used only for qualified affordable housing projects. Fair Value Accounting Our consolidated managed funds qualify as investment companies and therefore report their investments at estimated fair value, with unrealized gains and losses reflected as gains on investment securities, net, a component of noninterest income. The portion of any investment gains or losses attributable to other limited partners is reflected as net income attributable to NCI and adjusts our net income to reflect its percentage ownership. Our consolidated managed funds of funds make investments in venture capital and private equity funds. A summary of our ownership interests in such funds as of December 31, 2022, is presented in the following table: Limited partnership Company Direct and Indirect Ownership in Limited Partnership Managed funds of funds Strategic Investors Fund, LP 12.6 % Capital Preferred Return Fund, LP 20.0 Growth Partners, LP 33.0 Redwood Evergreen Fund, LP 100.0 Our direct investments in public portfolio companies are valued based on quoted market prices less a discount if the securities are subject to certain security-specific sale restrictions. Gains or losses resulting from changes in the net asset value are recorded as gains on investment securities, net, a component of noninterest income. Other Investments without a Readily Determinable Fair Value Our direct investments in private companies do not have a readily determinable fair value. We measure these investments at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments from the same issuer. Such changes are recognized through earnings. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have certain security-specific sale restrictions or other features that indicate a discount to fair value is warranted. Our investments in unconsolidated funds where we do not have the ability to exercise significant influence over their operating and financial policies are valued using the net asset value as obtained from the general partners of the fund investments, because the funds do not have a readily determinable fair value. The general partners of these funds prepare their financial statements using guidance consistent with fair value accounting. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period. Gains or losses resulting from changes in the net asset value are recorded as gains on investment securities, net, a component of noninterest income. Equity Method Our equity method non-marketable securities consist of investments in venture capital and private equity funds, privately-held companies, debt funds, renewable energy investments and joint ventures. Our equity method non-marketable securities and related accounting policies are described as follows: • Equity securities and investments in limited partnerships, such as preferred or common stock in privately-held companies in which we have the ability to exercise significant influence over the investees' operating and financial policies through voting interests, board involvement or other influence are accounted for under the equity method and • The Bank's joint venture bank in China (SPD-SVB), for which we have 50 percent ownership, is accounted for under the equity method. We recognize our proportionate share of the results of operations of these equity method investees in our results of operations, based on the most current financial information available from the investee. We may use the hypothetical liquidation at book value method for investments that involve complex equity structures where liquidation rights are not proportional to the underlying percentage ownership interests. We review our investments accounted for under the equity method at least quarterly for possible other-than-temporary impairment. Our review typically includes an analysis of facts and circumstances for each investment, the expectations of the investment's future cash flows and capital needs, variability of its business and the company's exit strategy. For our fund investments, we use the net asset value per share as provided by the general partners of the fund investments. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period. We reduce our investment value when we consider declines in value to be other-than-temporary and recognize the estimated loss as a loss on investment securities, a component of noninterest income. Proportional Amortization Method In order to fulfill our responsibilities under the CRA, we invest as a limited partner in low income housing partnerships that operate qualified affordable housing projects and generate tax benefits, including federal low income housing tax credits, for investors. The partnerships are deemed to be VIEs because they do not have sufficient equity investment at risk and are structured with non-substantive voting rights. We are not the primary beneficiary of the VIEs and do not consolidate them. Our investments in low income housing partnerships are recorded in non-marketable and other equity securities within our investment securities portfolio on the consolidated balance sheet. As a practical expedient, we amortize the investment in proportion to the allocated tax benefits under the proportional amortization method of accounting and present such benefits net of investment amortization in income tax expense. Loans Loans are reported at amortized cost which consists of the principal amount outstanding, net of unearned loan fees. Unearned loan fees reflect unamortized deferred loan origination and commitment fees net of unamortized deferred loan origination costs. In addition to cash loan fees, we often obtain equity warrant assets that give us an option to purchase a position in a client company's stock in consideration for providing credit facilities. The grant date fair values of these equity warrant assets are deemed to be loan fees and are deferred as unearned income and recognized as an adjustment of loan yield through loan interest income. The net amount of unearned loan fees is amortized into loan interest income over the contractual terms of the underlying loans and commitments using the constant effective yield method, adjusted for actual loan prepayment experience, or the straight-line method, as applicable. Allowance for Credit Losses The allowance for credit losses for loans considers credit risk and is adjusted by a provision for ECL charged to expense and reduced by the charge-off of loan amounts, net of recoveries. Our allowance for credit losses is an estimate of expected losses inherent with the Company's existing loans at the balance sheet date. Determining the appropriateness of the allowance is complex and requires judgment by management about the effect of matters that are inherently uncertain. Loan Portfolio Segments and Classes of Financing Receivables The process to estimate the ECL on loans involves procedures to appropriately consider the unique characteristics of our loan portfolio. Our eight portfolio segments are determined by using the following risk dimensions: (i) underwriting methodology, (ii) industry niche and (iii) life stage. The eight portfolio segments are further disaggregated into eleven classes of financing receivables and represents the level at which credit risk is monitored. Credit quality is assessed and monitored by evaluating various attributes, and the results of those evaluations are utilized in underwriting new loans and in our process to estimate ECL. For further information refer to Note 9—“Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments.” The following provides additional information regarding our portfolio segments and classes of financing receivables: • Global Fund Banking (segment and class) – The vast majority of our GFB portfolio segment consists of capital call lines of credit, the repayment of which is dependent on the payment of capital calls by the underlying limited partner investors in funds managed by certain private equity and venture capital firms. • Investor Dependent (segment) – Loans are made primarily to technology and life science/healthcare companies. These borrowers typically have modest or negative cash flows and rarely have an established record of profitable operations. Repayment of these loans may be dependent upon receipt by borrowers of additional equity financing from venture capital firms or other investors, or in some cases, a successful sale to a third party or an IPO. This portfolio segment is further disaggregated into two classes of financing receivables: ◦ Early-Stage (class) – Loans to pre-revenue, development-stage companies and companies that are in the early phases of commercialization, with revenues of up to $5 million. ◦ Growth Stage (class) – Loans to growth-stage enterprises. Within growth-stage enterprises, we consider companies with revenues between $5 million and $15 million, or pre-revenue clinical-stage biotechnology companies, to be Mid Stage, and companies with revenues in excess of $15 million to be Later Stage. • Cash Flow Dependent and Innovation C&I (segment) – Loans are made primarily to technology and life science/healthcare companies that are not Investor Dependent, for example repayment is not dependent on additional equity financing, a successful sale or an IPO. This portfolio segment consists of two classes of financing receivables: ◦ Cash Flow Dependent – SLBO (class) – Loans are typically used to assist a select group of private equity sponsors with the acquisition of businesses, are larger in size and repayment is generally dependent upon the cash flows of the combined entities. Acquired companies are typically established, later-stage businesses of scale and characterized by reasonable levels of leverage with loan structures that include meaningful financial covenants. The sponsor’s equity contribution is often 50 percent or more of the acquisition price. ◦ Innovation C&I (class) – Other C&I loans in innovation sectors such as technology and life science/healthcare industries. These loans are dependent on either the borrower’s cash flows or balance sheet for repayment. Cash flow dependent loans require the borrower to maintain cash flow from operations that is sufficient to service all debt. Borrowers must demonstrate normalized cash flow in excess of all fixed charges associated with operating the business. Balance sheet dependent loans include asset-backed loans and are structured to require constant current asset coverage (e.g., cash, cash equivalents, accounts receivable and, to a much lesser extent, inventory) in an amount that exceeds the outstanding debt. The repayment of these arrangements is dependent on the financial condition, and payment ability, of third parties with whom our clients do business. • Private Bank (segment and class) – Loans to our Private Bank clients who are primarily private equity/venture capital professionals and executives in the innovation companies as well as high net worth clients acquired from Boston Private. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, personal capital call lines of credit, lines of credit against liquid assets and other secured and unsecured lending products. In addition, we provide owner occupied commercial mortgages to Private Bank clients and real estate secured loans to eligible employees through our EHOP. • CRE (segment and class) – Generally acquisition financing loans for commercial properties such as office buildings, retail properties, apartment buildings and industrial/warehouse space. • Other C&I (segment and class) – Loans that include working capital and revolving lines of credit, as well as term loans for equipment and fixed assets. These loans are primarily to clients that are not in the technology and life sciences/healthcare industries. Additionally, this portfolio segment contains commercial tax-exempt loans to not-for-profit private schools, colleges, public charter schools and other not-for-profit organizations. • Premium Wine and Other (segment) – This portfolio segment consists of two classes of financing receivables: ◦ Premium Wine (class) – Loans to wine producers, vineyards and wine industry or hospitality businesses across the Western United States. A large portion of these loans are secured by real estate collateral such as vineyards and wineries. ◦ Other (class) – Primarily construction and land loans for financing new developments as well as financing for improvements to existing buildings. These also include our community development loans made as part of our responsibilities under the CRA. • PPP (segment and class) – Combined loans issued through the PPP. These loans represent clients across all portfolio segments and are guaranteed by the SBA. We maintain a systematic process for the evaluation of individual loans and portfolio segments for inherent risk of estimated credit losses for loans. At the time of approval, each loan in our portfolio is assigned a credit risk rating. Credit risk ratings are assigned on a scale of 1 to 10, with 1 representing loans with a low risk of nonpayment, 9 representing loans with the highest risk of nonpayment and 10 representing loans which have been charged-off. The credit risk ratings for each loan are monitored and updated on an ongoing basis. This credit risk rating process includes, but is not limited to, consideration of such factors as payment status, the financial condition and operating performance of the borrower, borrower compliance with loan covenants, underlying collateral values and performance trends, the degree of access to additional capital, the presence of credit enhancements such as third party guarantees (where applicable), the degree to which the borrower is sensitive to external factors and the depth and experience of the borrower's management team. Our policies require a committee of senior management to review, at least quarterly, credit relationships with a credit risk rating of 5 through 9 that exceed specific dollar values Expected Credit Loss Measurement The methodology for estimating the amount of ECL reported in the ACL is the sum of two main components: (i) ECL assessed on a collective basis for pools of loans that share similar risk characteristics which includes a qualitative adjustment based on management’s assessment of the risks that may lead to a future loan loss experience different from our historical loan loss experience and (ii) ECL assessed for individual loans that do not share similar risk characteristics with other loans. We do not estimate ECL on AIR on loans as AIR is reversed or written off against interest income when the full collection of the AIR related to a loan becomes doubtful, which is when loans are placed on nonaccrual status. AIR on loans totaled $402 million at December 31, 2022, and $171 million at December 31, 2021, and is excluded from the amortized cost disclosures in Note 10—“Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments”, as it is included and reported separately within "Accrued interest receivable and other assets" in our consolidated balance sheets. While the evaluation process of our ACL on loans uses historical and other objective information, the classification of loans and the estimate of the ACL for loans rely on the judgment and experience of our management. A committee comprised of senior management evaluates the appropriateness of the ACL for loans, which includes review of loan portfolio segmentation, quantitative models, internal and external data inputs, economic forecasts, credit risk ratings and qualitative adjustments. Loans That Share Similar Risk Characteristics with Other Loans We derive an estimated ECL assumption from a non-discounted cash flow approach based on our portfolio segments discussed above. This approach incorporates a calculation of three predictive metrics: (i) PD, (ii) LGD and (iii) EAD, over the estimated life of the exposure. PD and LGD assumptions are developed based on quantitative models and inherent risk of credit loss, both of which involve significant judgment. Renewals and extensions within our control are not considered in the estimated contractual term of a loan. The quantitative models are based on historical credit loss experience, adjusted for probability-weighted economic scenarios. These scenarios are used to support a reasonable and supportable forecast period of approximately three years for all portfolio segments. To the extent the remaining contractual lives of loans in the portfolio extend beyond the reasonable and supportable period, we revert to historical averages using a method that will gradually trend towards the mean historical loss over the remaining contractual lives of loans, adjusted for prepayments. The macroeconomic scenarios and their weighting are reviewed on a quarterly basis. We also apply a qualitative factor adjustment to the results obtained through our quantitative ECL models to consider model imprecision, emerging risk assessments, trends and other subjective factors that may not be adequately represented in quantitative ECL models. These adjustments to historical loss information are for asset-specific risk characteristics, and also reflect our assessment of the extent that current conditions and reasonable and supportable forecasts differ from conditions that existed during the period over which historical information was evaluated. These adjustments are aggregated to become our qualitative allocation. Based on our qualitative assessment estimate of changing risks in the lending environment, the qualitative allocation may vary significantly from period to period and may include, but is not limited to, consideration of the following factors: • Changes in lending policies and procedures, including changes in underwriting standards and collection, charge-off and recovery practices not considered elsewhere in estimating credit losses; • Changes in international, national, regional and local economic and business conditions and developments that affect the collectability of the portfolio, including the condition of various market segments; • Changes in the nature and volume of the portfolio and in the terms of loans; • Changes in the experience, ability and depth of lending management and other relevant staff; • Changes in the volume and severity of past due loans, the volume of nonaccrual loans and the volume and severity of adversely classified or graded loans; • Changes in the quality of our loan review system; • Changes in the value of underlying collateral for collateral-dependent loans; • The existence and effect of any concentrations of credit, and changes in the level of such concentrations; • The effect of other external factors such as competition and legal and regulatory requirements on the level of estimated credit losses in our existing portfolio; and • The effect of limitations of available data, model imprecision and recent macro-economic factors that may not be reflected in the forecast information. Loans That Do Not Share Similar Risk Characteristics We monitor our loan pools to ensure all assets therein continue to share similar risk characteristics with other financial assets inside the pool. Changes in credit risk, borrower circumstances or the recognition of write-offs may indicate that a loan's risk profile has changed, and the asset should be removed from its current pool. For a loan that does not share risk characteristics with other loans, ECL is measured based on the net realizable value, that is, the difference between the discounted value of the expected future cash flows and the amortized cost basis of the loan. When a loan is collateral-dependent and the repayment is expected to be provided substantially through the operation or sale of the collateral, the ECL is measured as the difference between the amortized cost basis of the loan and the fair value of the collateral. The fair value of the collateral will be determined by the most recent appraisal, as adjusted to reflect a reasonable marketing period for the sale of the asset(s) and an estimate of reasonable selling expenses. Collateral-dependent loans will have independent appraisals completed at least annually. Allowance for Credit Losses: Unfunded Credit Commitments We maintain a separate ACL for unfunded credit commitments, which is included in other liabilities, and the related ECL in our provision for credit losses. We estimate the amount of expected losses by using historical trends to calculate a probability of an unfunded credit commitment being funded and derive historical lifetime expected loss factors for each portfolio segment similar to our funded loan ECL. The collectively assessed ECL for unfunded credit commitments also includes the same qualitative allocations applied for our funded loan ECL. For unfunded credit commitments related to loans that do not share similar risk characteristics with other loans, where applicable, a separate estimate of ECL will be included in our total ACL on unfunded credit commitments. Loan commitments that are determined to be unconditionally cancellable by the Company do not require an ACL on unfunded credit commitments. Uncollectible Loans and Write-offs Our charge-off policy applies to all loans, regardless of portfolio segment. Commercial loans are considered for a full or partial charge-off in the event that principal or interest is over 180 days past due and the loan lacks sufficient collateral and it is not in the process of collection. Consumer loans are considered for a full or partial charge-off in the event that principal or interest is over 120 days past due and the loan lacks sufficient collateral and it is not in the process of collection. We also consider writing off loans in the event of any of the following circumstances: 1) the loan, or a portion of the loan is deemed uncollectible due to: (i) the borrower's inability to make recurring payments, (ii) material changes in the borrower's financial condition, or (iii) the expected sale of all or a portion of the borrower's business is insufficient to repay the loan in full, or 2) the loan has been identifi

Business Combination

Business Combination	12 Months Ended
Business Combination	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Business Combination	Business Combination Boston Private On July 1, 2021, we acquired, by merger, 100 percent of the voting equity interests of Boston Private Financial Holdings, Inc., the parent company of Boston Private Bank & Trust Company. The acquisition of Boston Private accelerates SVB’s private banking and wealth management offering, strengthening SVB’s overall platform and ability to fully meet the financial needs of its clients. The acquisition was accounted for as a business combination and accordingly, the results of Boston Private's operations have been included in the Company's consolidated financial statements from the date of acquisition. We acquired Boston Private for $1.2 billion comprised of $2.10 in cash and 0.0228 shares of SVB common stock for each Boston Private share. For the transaction, we issued approximately 1.9 million shares of SVB common stock and registered an additional 99,000 shares of SVB common stock issuable upon the exercise, vesting or settlement of converted legacy Boston Private equity awards. The following table summarizes the allocation of the purchase price to the net assets of Boston Private as of July 1, 2021: (Dollars in millions) July 1, 2021 Cash paid $ 174 Share-based consideration 1,050 Replacement equity awards 10 Total purchase consideration $ 1,234 Fair value of net assets acquired 1,033 Goodwill $ 201 The following table summarizes the estimated fair value of assets acquired and liabilities assumed upon the finalization of the purchase: (Dollars in million) July 1, 2021 Assets acquired: Cash and cash equivalents $ 1,290 Investment securities 1,429 Loans 7,217 Premises and equipment 39 Intangible assets 104 Right-of-use assets 107 Other assets 284 Total assets acquired 10,470 Liabilities assumed: Deposits 8,983 Borrowings 132 Lease liabilities 103 Other liabilities 219 Total liabilities assumed 9,437 Fair value of net assets acquired $ 1,033 The Company recognized identifiable intangible assets of $104 million and goodwill of $201 million as a result of the acquisition. Intangible assets of $104 million are subject to amortization over their estimated useful lives. The goodwill recorded includes expected revenue-generating synergies driven by the broadening of our product suite and strength of the combined platform, providing our teams with expanded capabilities, technology and scalability to meet the increasing needs of our private banking clients. Goodwill amounts have been allocated to the SVB Private reporting segment and will not be deductible for tax purposes. The following table summarizes the fair value and estimated useful lives of the other intangible assets at the date of acquisition: (Dollars in millions) Estimated Fair Value Weighted Average Estimated Useful Life - in Years Other intangible assets: Customer relationships $ 85 20 Other 19 6 Total other intangible assets $ 104 Of the $7.2 billion net loans acquired, $1.4 billion exhibited credit deterioration on the date of purchase. The following table provides a summary of these PCD loans at acquisition: (Dollars in millions) July 1, 2021 Par value of PCD loans $ 1,368 PCD ACL at acquisition (22) Non-credit premium on PCD loans 43 Purchase price of PCD loans $ 1,389 Due to the various conversions of Boston Private systems since the date of acquisition, as well as other streamlining and continuing integration of Boston Private's operating activities into those of the Company, reporting for revenue and net income of the former Boston Private operations for the period subsequent to the acquisition is impracticable. Supplementary pro forma financial information related to the acquisition is not included because the impact to the Company's consolidated statements of income is not material. Direct expenses related to the acquisition of Boston Private were expensed as incurred and were $22 million for twelve months ended December 31, 2021. All expenses were included in merger-related charges, a component of noninterest expense, with the exception of $6 million attributable to the three months ended March 31, 2021, which were recorded in professional services. MoffettNathanson LLC On December 10, 2021, we acquired 100 percent of the voting equity interests of MoffettNathanson LLC, a New York-based independent sell-side research firm known for its coverage of high-growth, disruptive companies in the Media, Communications and Technology sectors. The acquisition enables SVB’s investment banking business, SVB Securities, to expand its research coverage to include companies in both the healthcare and technology industries. The acquisition was accounted for as a business combination and accordingly, the results of MoffettNathanson LLC operations have been included in the Company's consolidated financial statements from the date of acquisition.

Stockholders' Equity and EPS

Stockholders' Equity and EPS	12 Months Ended
Stockholders' Equity and EPS	Dec. 31, 2022
Equity and Earnings Per Share [Abstract]
Stockholders' Equity and EPS	Stockholders' Equity and EPS Accumulated Other Comprehensive Income The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income for 2022, 2021 and 2020 : Year ended December 31, (Dollars in millions) Income Statement Location 2022 2021 2020 Reclassification adjustment for (gains) losses on AFS securities included in net income Gains (losses) on investment securities, net $ (21) $ (31) $ (61) Related tax expense (benefit) Income tax expense 6 9 17 Reclassification adjustment for (gains) losses on cash flow hedges included in net income Net interest income (56) (63) (50) Related tax expense (benefit) Income tax expense 16 17 14 Total reclassification adjustment for (gains) losses included in net income, net of tax $ (55) $ (68) $ (80) The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for 2022, 2021 and 2020. Refer to Note 16—“Derivative Financial Instruments” for additional information regarding the termination of our cash flow hedges during the quarter ended March 31, 2020. Over the next 12 months, we expect that approximately $41 million in AOCI at December 31, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income. Year ended December 31, (Dollars in millions) 2022 2021 2020 Balance, beginning of period, net of tax $ 83 $ 130 $ (2) Net (decrease) increase in fair value, net of tax — (1) 168 Net realized (gain) loss reclassified to net income, net of tax (40) (46) (36) Balance, end of period, net of tax $ 43 $ 83 $ 130 EPS Basic EPS is the amount of earnings available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issuable for stock options and restricted stock unit awards outstanding under our 2006 Equity Incentive Plan and our ESPP. Potentially dilutive common shares are excluded from the computation of dilutive EPS in periods in which the effect would be antidilutive. The following is a reconciliation of basic EPS to diluted EPS for 2022, 2021 and 2020: Year ended December 31, (Dollars in millions except per share amounts, shares in thousands) 2022 2021 2020 Numerator: Net income available to common stockholders $ 1,509 $ 1,770 $ 1,191 Denominator: Weighted average common shares outstanding—basic 58,987 55,763 51,685 Weighted average effect of dilutive securities: Stock options and ESPP 168 283 151 Restricted stock units 361 592 248 Weighted average common shares outstanding—diluted 59,516 56,638 52,084 Earnings per common share: Basic $ 25.58 $ 31.74 $ 23.05 Diluted $ 25.35 $ 31.25 $ 22.87 The following table summarizes the weighted average common shares excluded from the diluted EPS calculation due to the antidilutive effect for 2022, 2021 and 2020: Year ended December 31, (Shares in thousands) 2022 2021 2020 Stock options 117 37 279 Restricted stock units 390 2 10 Total 507 39 289 Common Stock On March 22, 2021, to support the continued growth of our balance sheet, we issued and sold 2,000,000 shares of common stock at a price of $500.00 per share. We received net proceeds of $972 million after deducting underwriting discounts and commissions. On April 14, 2021, the Company issued and sold 300,000 additional shares of common stock under the full exercise of the underwriters' over-allotment option from our March 22, 2021 underwritten public offering. We received additional net proceeds of $146 million after deducting underwriting discounts and commissions. On July 1, 2021, the Company issued 1,887,981 shares of common stock for the acquisition of Boston Private at an exchange ratio of 0.0228 SIVB shares per Boston Private share. On August 12, 2021, the Company issued and sold 2,227,000 shares of common stock at a price of $564.00 per share. We received net proceeds of $1.2 billion after deducting underwriting discounts and commissions. Preferred Stock On December 9, 2019, the Company issued 5.25% Non-Cumulative Perpetual Series A Preferred Stock (''Series A Preferred Stock''). The public offering consisted of 14,000,000 depositary shares, each representing a 1/40th ownership interest in shares of the Series A preferred stock with $0.001 par value and liquidation preference of $1,000 per share, or $25 per depositary share. The Series A Preferred Stock is redeemable at the Company’s option, subject to all applicable regulatory approvals, on or after February 15, 2025. On February 2, 2021, the Company issued 4.10% Non-Cumulative Perpetual Series B Preferred Stock (''Series B Preferred Stock''). The public offering consisted of 750,000 depositary shares, each representing a 1/100th ownership interest in shares of Series B Preferred Stock with $0.001 par value and liquidation preferences of $100,000 per share, or $1,000 per depositary share. Dividends, if approved and declared by the Board of Directors, are payable quarterly, in arrears, at a rate per annum equal to (i) 4.10 percent from the original issue date to, but excluding, February 15, 2031 and (ii) for the February 15, 2031 dividend date and during each subsequent ten-year period, the ten-year treasury rate (calculated three On May 13, 2021, the Company issued 4.00% Non-Cumulative Perpetual Series C Preferred Stock (''Series C Preferred Stock''). The public offering consisted of 1,000,000 depositary shares, each representing a 1/100th ownership interest in shares of Series C Preferred Stock with $0.001 par value and liquidation preferences of $100,000 per share, or $1,000 per depositary share. Dividends, if approved and declared by the Board of Directors, are payable quarterly, in arrears, at a rate per annum equal to (i) 4.000 percent from the original issue date to, but excluding, May 15, 2026, and (ii) for the May 15, 2026 dividend date and during each subsequent five-year period, the five-year treasury rate (calculated three On October 28, 2021, the Company issued 4.25% and 4.70% Non-Cumulative Perpetual Series D Preferred Stock (''Series D Preferred Stock'') and Series E Preferred Stock ("Series E Preferred Stock"), respectively. The public offering for Series D Preferred Stock consisted of 1,000,000 depositary shares, each representing a 1/100th ownership interest in shares of Series D Preferred Stock with $0.001 par value and liquidation preferences of $100,000 per share, or $1,000 per depositary share. Series D Preferred Stock dividends, if approved and declared by the Board of Directors, are payable quarterly, in arrears, at a rate per annum equal to (i) 4.250 percent from the original issue date of the Series D Preferred Stock to, but excluding, November 15, 2026, and (ii) for the November 15, 2026 dividend date and during each subsequent five-year period, the five-year treasury rate (calculated three The public offering for Series E Preferred Stock consisted of 600,000 depositary shares, each representing a 1/100th ownership interest in shares of Series E Preferred Stock with $0.001 par value and liquidation preferences of $100,000 per share, or $1,000 per depositary share. Series E Preferred Stock dividends, if approved and declared by the Board of Directors, are payable quarterly, in arrears, at a rate per annum equal to (i) 4.700 percent from the original issue date of the Series E Preferred Stock to, but excluding, November 15, 2031, and (ii) for the November 15, 2031 dividend date and during each subsequent ten-year period, the ten-year treasury rate (calculated three The following table summarizes our preferred stock at December 31, 2022: Series Description Amount outstanding (in millions) Carrying value Shares issued and outstanding Par Value Ownership interest per depositary share Liquidation preference per depositary share 2022 dividends paid per depositary share Series A 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock $ 350 $ 340 350,000 $ 0.001 1/40th $ 25 $ 1.31 Series B 4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 750 739 7,500 0.001 1/100th 1,000 41.00 Series C 4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 985 10,000 0.001 1/100th 1,000 40.00 Series D 4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 989 10,000 0.001 1/100th 1,000 44.51 Series E 4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 600 593 6,000 0.001 1/100th 1,000 49.22

Share-Based Compensation

Share-Based Compensation	12 Months Ended
Share-Based Compensation	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Share-based compensation expense was recorded net of estimated forfeitures for 2022, 2021 and 2020, such that expense was recorded only for those share-based awards that are expected to vest. In 2022, 2021 and 2020, we recorded share-based compensation and related benefits as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Share-based compensation expense $ 183 $ 136 $ 84 Income tax benefit related to share-based compensation expense (39) (35) (20) Capitalized compensation costs 3 1 1 Equity Incentive Plans Our 2006 Equity Incentive Plan (the “2006 Incentive Plan”) was adopted in May 2006, and is amended from time to time. The 2006 Incentive Plan provides for the grant of various types of incentive awards, of which the following have been granted: (i) stock options, (ii) restricted stock awards, (iii) restricted stock units (subject to either time-and/or performance-based vesting) and (iv) other cash or stock settled equity awards. Eligible participants in the 2006 Incentive Plan include directors, employees and consultants. Subject to the provisions of Section 16 of the 2006 Incentive Plan, the maximum aggregate number of shares that may be awarded and sold thereunder is 12,028,505. Restricted stock awards/units are counted against the available-for-issuance limits of the 2006 Incentive Plan as two shares for every one share awarded. Further, if shares acquired under any such award are forfeited, repurchased by SVB Financial, used to satisfy the tax withholding obligations related to an award or otherwise canceled and would otherwise return to the 2006 Incentive Plan, two times the number of such shares will return to the 2006 Incentive Plan and will again become available for issuance. Under the terms of the 2006 Incentive Plan, and subject to certain exceptions, awards granted under the plan are subject to a minimum of at least one year of vesting. Generally in practice, restricted stock units vest annually over four years and require continued employment or other service through the vesting period. Performance-based restricted stock awards/units granted to executives generally vest upon meeting certain performance-based objectives over a three year period and, typically, additional time-based vesting follow the end of the performance period, and require continued employment or other service through the vesting date. Stock options typically vest annually over four years, from the grant date based on continued employment or other service, and expire no later than seven years after the grant date. A select number of awards granted to certain employees will continue to vest in accordance with the normal vesting schedule in the event that the employee retires (upon meeting certain age and service criteria) at least six months after the grant date and prior to the end of the vesting period, subject to certain conditions. For accounting purposes, the requisite service period for these awards is reduced on an individual basis, as necessary, to reflect the employee’s individual retirement eligibility date. The underlying BPFH shares of the legacy Boston Private stock options and restricted stock units were converted into shares of the Company in connection with the Boston Private acquisition on July 1, 2021. Information in this footnote includes the converted legacy Boston Private awards unless otherwise indicated. Upon acquisition, 28,724 options and 67,542 restricted stock units were assumed by the Company from legacy Boston Private plans. All awards assumed from the legacy Boston Private plans will be settled under the respective legacy plans. No future awards will be made under these plans. We maintain the 1999 ESPP under which participating employees may annually contribute up to 10 percent of their gross compensation (not to exceed $25,000) to purchase shares of our common stock at 85 percent of its fair market value at either the beginning or end of each six-month offering period, whichever price is less. To be eligible to participate in the ESPP, an employee must, among other requirements, be employed by the Company on both the date of offering and date of purchase, and be employed customarily for at least 20 hours per week and at least five months per calendar year. We issued 152,283 shares and received $44 million in cash under the ESPP in 2022. At December 31, 2022, a total of 907,303 shares of our common stock were still available for future issuance under the ESPP. Unrecognized Compensation Expense As of December 31, 2022, unrecognized share-based compensation expense was as follows: (Dollars in millions) Unrecognized Weighted Average Expected Recognition Period - in Years Stock options $ 13 2.39 years Restricted stock awards/units 235 2.68 years Total unrecognized share-based compensation expense $ 248 Valuation Assumptions The fair values of share-based awards for employee stock options and employee stock purchases made under our ESPP were estimated using the Black-Scholes option pricing model. The fair values of restricted stock units were based on our closing stock price on the date of grant. The following weighted average assumptions and fair values were used for our employee stock options and restricted stock units: Equity Incentive Plan Awards 2022 2021 2020 Weighted average expected term of options - in years 4.7 4.7 4.6 Weighted average expected volatility of the Company's underlying common stock 46.1 % 43.5 % 41.9 % Risk-free interest rate 3.06 0.85 0.37 Expected dividend yield — — — Weighted average grant date fair value - stock options $ 202.81 $ 224.63 $ 66.44 Weighted average grant date fair value - restricted stock units 463.10 554.32 199.51 The following weighted average assumptions and fair values were used for our ESPP: ESPP 2022 2021 2020 Expected term in years 0.5 0.5 0.5 Weighted average expected volatility of the Company's underlying common stock 43.5 % 36.2 % 51.9 % Risk-free interest rate 1.04 0.08 1.12 Expected dividend yield — — — Weighted average grant date fair value $ 156.24 $ 108.83 $ 69.54 The expected term is based on the implied term of the stock options using factors based on historical exercise behavior. The expected volatilities are based on a blended rate consisting of our historic volatility and our expected volatility over a five-year term which is an indicator of expected volatility and future stock price trends. For 2022, 2021 and 2020, expected volatilities for the ESPP were equal to the historical volatility for the previous six-month periods. The expected risk-free interest rates were based on the yields of U.S. Treasury securities, as reported by the FRB, with maturities equal to the expected terms of the employee stock options. Share-Based Payment Award Activity The table below provides stock option information for the year ended December 31, 2022: Options Weighted Weighted Average Remaining Contractual Life - in Years Aggregate Intrinsic Value of Outstanding at December 31, 2021 475,626 $ 260.77 Granted 77,888 477.80 Exercised (40,326) 184.75 Forfeited (23,546) 385.40 Outstanding at December 31, 2022 489,642 295.48 3.80 $ 11,968,937 Vested and expected to vest at December 31, 2022 480,972 293.91 3.77 11,851,281 Exercisable at December 31, 2022 300,872 238.23 2.84 9,528,647 The aggregate intrinsic value of outstanding options shown in the table above represents the pre-tax intrinsic value based on our closing stock price of $230.14 as of December 31, 2022. We expect to satisfy the exercise of stock options by issuing shares under the 2006 Incentive Plan or applicable legacy Boston Private equity plan. All future awards of stock options and restricted stock units will be issued from the 2006 Incentive Plan. At December 31, 2022 , 1,636,040 shares were available for future issuance. The table below provides information for restricted stock units for the year ended December 31, 2022: Shares Weighted Average Grant Date Fair Value Nonvested at December 31, 2021 1,016,146 $ 328.87 Granted 548,856 463.10 Vested (390,593) 279.34 Forfeited (91,957) 379.94 Nonvested at December 31, 2022 1,082,452 405.62 The following table summarizes information regarding stock option and restricted stock unit activity during 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Total intrinsic value of stock options exercised $ 14 $ 68 $ 25 Total fair value of stock options vested 14 7 6 Total intrinsic value of restricted stock vested 205 164 56 Total fair value of restricted stock vested 126 68 47

Variable Interest Entities

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Dec. 31, 2022
Investments In Variable Interest Entities [Abstract]
Variable Interest Entities	Variable Interest Entities Our involvement with VIEs includes our investments in venture capital and private equity funds, debt funds, private and public portfolio companies, qualified affordable housing projects and subordinated debt instruments. The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of December 31, 2022, and December 31, 2021: (Dollars in millions) Consolidated VIEs Unconsolidated VIEs Maximum Exposure to Loss in Unconsolidated VIEs December 31, 2022: Assets: Cash and cash equivalents $ 20 $ — $ — Non-marketable and other equity securities (1) 735 1,457 1,457 AIR and other assets (2) 8 6 — Total assets $ 763 $ 1,463 $ 1,457 Liabilities: Other liabilities (1) $ 31 $ 759 $ — Long term debt (2) — 91 — Total liabilities $ 31 $ 850 $ — December 31, 2021: Assets: Cash and cash equivalents $ 13 $ — $ — Non-marketable and other equity securities (1) 768 1,233 1,233 AIR and other assets (2) 31 6 — Total assets $ 812 $ 1,239 $ 1,233 Liabilities: Other liabilities (1) $ 18 $ 482 $ — Long term debt (2) — 90 — Total liabilities $ 18 $ 572 $ — (1) Included in our unconsolidated non-marketable and other equity securities portfolio at December 31, 2022, and December 31, 2021, are investments in qualified affordable housing projects of $1.3 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $754 million and $482 million, respectively. (2) Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million, respectively, at December 31, 2022, and $6 million and $90 million, respectfully, at December 31, 2021. Non-marketable and other equity securities Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies and qualified affordable housing projects. Many of these are investments held by SVB Financial in third-party funds in which we do not have controlling or significant variable interests. These investments represent our unconsolidated VIEs in the table above. Our non-marketable and other equity securities portfolio also includes investments from SVB Capital. SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. We have a controlling and significant variable interest in four of these SVB Capital funds and consolidate these funds for financial reporting purposes. Most investments are generally nonredeemable and distributions are expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreement. Subject to applicable regulatory requirements, including the Volcker Rule, we also make commitments to invest in venture capital and private equity funds. For additional details, see Note 21—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments.” The Bank also has variable interests in low income housing tax credit funds, in connection with fulfilling its responsibilities under the CRA, that are designed to generate a return primarily through the realization of federal tax credits. These investments are typically limited partnerships in which the general partner, other than the Bank, holds the power over significant activities of the VIE; therefore, these investments are not consolidated. For additional information on our investments in qualified affordable housing projects, see Note 9—“Investment Securities." As of December 31, 2022, our exposure to loss with respect to the consolidated VIEs is limited to our net assets of $732 million and our exposure to loss for our unconsolidated VIEs is equal to our investment in these assets of $1.5 billion.

Reserves on Deposit with the Fe

Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock	12 Months Ended
	Dec. 31, 2022
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]
Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock	Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock The cash balances at the Federal Reserve are classified as cash and cash equivalents. As a member of the FHLB and FRB, we are required to hold shares of FHLB and FRB stock under the Bank's borrowing agreement. FHLB and FRB stock are recorded at cost as a component of other assets, and any cash dividends received are recorded as a component of other noninterest income. The table below provides information on the shares held at the FHLB and FRB for the years ended and as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 FHLB stock holdings $ 418 $ 26 FRB stock holdings 302 81

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
Cash and Cash Equivalents	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents The following table details our cash and cash equivalents as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Cash and due from banks $ 1,293 $ 2,168 Interest-bearing deposits with the FRB 7,823 5,686 Interest-bearing deposits with other institutions 3,965 5,773 Securities purchased under agreements to resell (1) 722 607 Other short-term investment securities — 352 Total cash and cash equivalents $ 13,803 $ 14,586 (1) At December 31, 2022, and December 31, 2021, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $734 million and $620 million, respectively. None of these securities were sold or repledged as of December 31, 2022, and December 31, 2021. Additional information regarding our securities purchased under agreements to resell for 2022 and 2021 are as follows: Year ended December 31, (Dollars in millions) 2022 2021 Average securities purchased under agreements to resell $ 290 $ 286 Maximum amount outstanding at any month-end during the year 721 762

Investment Securities

Investment Securities	12 Months Ended
Investment Securities	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment Securities Our investment securities portfolio consists of (i) an AFS securities portfolio and a HTM securities portfolio, both of which represent interest-earning investment securities and (ii) a non-marketable and other equity securities portfolio, which primarily represents investments managed as part of our funds management business, investments in qualified affordable housing projects, as well as public equity securities held as a result of equity warrant assets exercised. AFS Securities The major components of our AFS investment securities portfolio at December 31, 2022, and 2021 are as follows: December 31, 2022 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 17,206 $ — $ (1,071) $ 16,135 U.S. agency debentures 120 — (19) 101 Foreign government debt securities 1,209 — (121) 1,088 Residential MBS: Agency-issued MBS 7,701 — (1,098) 6,603 Agency-issued CMO—fixed rate 762 — (84) 678 Agency-issued CMBS 1,604 — (140) 1,464 Total AFS securities (1) $ 28,602 $ — $ (2,533) $ 26,069 (1) Securities pledged as collateral for securities sold under agreements to repurchase totaled $530 million. For additional information, see Note 15—“Short-Term Borrowings and Long-Term Debt." December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 15,799 $ 121 $ (70) $ 15,850 U.S. agency debentures 200 — (4) 196 Foreign government debt securities 61 — — 61 Residential MBS: Agency-issued MBS 8,786 13 (210) 8,589 Agency-issued CMO—fixed rate 988 3 (9) 982 Agency-issued CMBS 1,536 27 (20) 1,543 Total AFS securities (1) $ 27,370 $ 164 $ (313) $ 27,221 (1) Securities pledged as collateral for securities sold under agreements to repurchase totaled $61 million. For additional information, see Note 15—“Short-Term Borrowings and Long-Term Debt." The following table summarizes sale activity of AFS securities as recorded in the line item “Gains (losses) on investment securities, net," a component of noninterest income: Year ended December 31, (Dollars in millions) 2022 2021 2020 Sales proceeds $ 9,495 $ 1,591 $ 2,654 Net realized gains and losses: Gross realized gains 146 31 61 Gross realized losses (125) — — Net realized gains (losses) $ 21 $ 31 $ 61 The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss position for less than 12 months, or 12 months or longer, as of December 31, 2022, and December 31, 2021: December 31, 2022 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities, at fair value: U.S. Treasury securities $ 11,946 $ (717) $ 4,189 $ (354) $ 16,135 $ (1,071) U.S. agency debentures — — 101 (19) 101 (19) Foreign government debt securities 1,088 (121) — — 1,088 (121) Residential MBS: Agency-issued MBS 1,744 (203) 4,859 (895) 6,603 (1,098) Agency-issued CMO —fixed rate 136 (11) 542 (73) 678 (84) Agency-issued CMBS 810 (57) 653 (83) 1,463 (140) Total AFS securities (1) $ 15,724 $ (1,109) $ 10,344 $ (1,424) $ 26,068 $ (2,533) (1) As of December 31, 2022, we identified a total of 810 investments that were in unrealized loss positions with 346 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of December 31, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of December 31, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of December 31, 2022. December 31, 2021 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 7,777 $ (70) $ — $ — $ 7,777 $ (70) U.S. agency debentures 196 (4) — — 196 (4) Residential MBS: Agency-issued MBS 8,280 (210) — — 8,280 (210) Agency-issued CMO —fixed rate 740 (9) — — 740 (9) Agency-issued CMBS 603 (11) 163 (9) 766 (20) Total AFS securities (1) $ 17,596 $ (304) $ 163 $ (9) $ 17,759 $ (313) (1) As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021. The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of December 31, 2022, by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. December 31, 2022 (Dollars in millions) Total One Year After One After Five After U.S. Treasury securities $ 16,135 $ 983 $ 14,373 $ 779 $ — U.S. agency debentures 101 — 33 68 — Foreign government debt securities 1,088 101 52 935 — Residential MBS: Agency-issued MBS 6,603 — — 43 6,560 Agency-issued CMO—fixed rate 678 — — — 678 Agency-issued CMBS 1,464 — 326 1,138 — Total $ 26,069 $ 1,084 $ 14,784 $ 2,963 $ 7,238 HTM Securities During the year ended December 31, 2021, we re-designated certain securities from the classification of AFS to HTM. The securities re-designated consisted of agency-issued CMO's, CMBS', MBS' and U.S. agency debentures with a total carrying value of $8.8 billion. At the time of re-designation the securities included $132 million of pretax net unrealized losses in other comprehensive income and are being amortized over the life of the securities in a manner consistent with the amortization of a premium or discount. Our decision to re-designate the securities was based on our ability and intent to hold these securities to maturity. Factors used in assessing the ability to hold these securities to maturity were future liquidity needs and sources of funding. HTM securities are carried on the balance sheet at amortized cost and the changes in the value of these securities, other than an ACL, are not reported on the financial statements. There were no re-designations during 2022. The components of our HTM investment securities portfolio at December 31, 2022, and December 31, 2021, are as follows: December 31, 2022 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL (2) Net Carry Value HTM securities, at cost: U.S. agency debentures (1) $ 486 $ — $ (52) $ 434 $ — $ 486 Residential MBS: Agency-issued MBS 57,705 — (9,349) 48,356 — 57,705 Agency-issued CMO—fixed rate 10,461 — (1,885) 8,576 — 10,461 Agency-issued CMO—variable rate 79 — (2) 77 — 79 Agency-issued CMBS 14,471 — (2,494) 11,977 — 14,471 Municipal bonds and notes 7,417 2 (1,269) 6,150 1 7,416 Corporate bonds 708 — (109) 599 5 703 Total HTM securities $ 91,327 $ 2 $ (15,160) $ 76,169 $ 6 $ 91,321 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the SBA, an independent agency of the United States. (2) Refer to Note 2—“Summary of Significant Accounting Policies” for more information on our credit loss methodology. December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL (2) Net Carry Value HTM securities, at amortized cost: U.S. agency debentures (1) $ 609 $ 8 $ (2) $ 615 $ — $ 609 Residential MBS: Agency-issued MBS 64,439 124 (887) 63,676 — 64,439 Agency-issued CMO—fixed rate 10,226 9 (145) 10,090 — 10,226 Agency-issued CMO—variable rate 100 1 — 101 — 100 Agency-issued CMBS 14,959 39 (277) 14,721 — 14,959 Municipal bonds and notes 7,157 185 (27) 7,315 1 7,156 Corporate bonds 712 2 (5) 709 6 706 Total HTM securities $ 98,202 $ 368 $ (1,343) $ 97,227 $ 7 $ 98,195 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the SBA, an independent agency of the United States. (2) Refer to Note 2—“Summary of Significant Accounting Policies” for more information on our credit loss methodology. Allowance for Credit Losses for HTM Securities For the year ended December 31, 2022, HTM securities beginning ACL balance was $7 million, the reduction of credit losses was $1 million, and the ending ACL balance was $6 million. For the year ended December 31, 2021 HTM securities beginning ACL balance of less than $1 million, a provision for credit losses of $7 million and an ending ACL balance of $7 million. Credit Quality Indicators On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Municipal bonds and notes: Aaa $ 4,263 $ 3,774 Aa1 1,843 2,031 Aa2 1,113 1,154 Aa3 171 172 A1 27 26 Total municipal bonds and notes $ 7,417 $ 7,157 Corporate bonds: Aaa $ 39 $ 39 Aa2 42 42 Aa3 127 105 A1 280 251 A2 209 264 A3 11 11 Total corporate bonds $ 708 $ 712 The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of December 31, 2022. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30, years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments; however, we expect to collect substantially all of the recorded investment on these securities. December 31, 2022 Total One Year After One Year to After Five Years to After (Dollars in millions) Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value U.S. agency debentures $ 486 $ 434 $ 1 $ 1 $ 118 $ 111 $ 367 $ 322 $ — $ — Residential MBS: Agency-issued MBS 57,705 48,356 — — 25 24 1,066 994 56,614 47,338 Agency-issued CMO—fixed rate 10,461 8,576 — — 90 86 129 120 10,242 8,370 Agency-issued CMO—variable rate 79 77 — — — — — — 79 77 Agency-issued CMBS 14,471 11,977 39 38 153 141 966 810 13,313 10,988 Municipal bonds and notes 7,416 6,150 29 29 235 224 1,362 1,244 5,790 4,653 Corporate bonds 703 599 — — 115 103 588 496 — — Total $ 91,321 $ 76,169 $ 69 $ 68 $ 736 $ 689 $ 4,478 $ 3,986 $ 86,038 $ 71,426 Non-marketable and Other Equity Securities The major components of our non-marketable and other equity securities portfolio at December 31, 2022, and December 31, 2021, are as follows: December 31, (Dollars in millions) 2022 2021 Non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments (1) $ 147 $ 130 Unconsolidated venture capital and private equity fund investments (2) 110 208 Other investments without a readily determinable fair value (3) 183 164 Other equity securities in public companies (fair value accounting) (4) 32 117 Non-marketable securities (equity method accounting) (5): Venture capital and private equity fund investments 605 671 Debt funds 5 5 Other investments 276 294 Investments in qualified affordable housing projects, net (6) 1,306 954 Total non-marketable and other equity securities $ 2,664 $ 2,543 (1) The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at December 31, 2022, and December 31, 2021, (fair value accounting): December 31, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Strategic Investors Fund, LP $ 2 12.6 % $ 2 12.6 % Capital Preferred Return Fund, LP 28 20.0 61 20.0 Growth Partners, LP 24 33.0 67 33.0 Redwood Evergreen Fund, LP 93 100.0 — — Total consolidated venture capital and private equity fund investments $ 147 $ 130 (2) The carrying value represents investments in 136 and 150 funds (primarily venture capital funds) at December 31, 2022, and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30 th for our December 31 st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. (3) These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted. The following table shows the carrying amount of other investments without a readily determinable fair value at December 31, 2022, and the amounts recognized in earnings for the year ended December 31, 2022, and on a cumulative basis: (Dollars in millions) Year ended December 31, 2022 Cumulative Adjustments Measurement alternative: Carrying value at December 31, 2022 $ 183 Carrying value adjustments: Impairment $ (23) $ (24) Upward changes for observable prices — 52 Downward changes for observable prices (6) (11) (4) Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income. (5) The following table shows the carrying value and our ownership percentage of each investment at December 31, 2022, and December 31, 2021 (equity method accounting): December 31, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Venture capital and private equity fund investments: Strategic Investors Fund II, LP $ 2 8.6 % $ 3 8.6 % Strategic Investors Fund III, LP 12 5.9 25 5.9 Strategic Investors Fund IV, LP 21 5.0 36 5.0 Strategic Investors Fund V funds 58 Various 87 Various CP II, LP (i) 1 5.1 2 5.1 Other venture capital and private equity fund investments 511 Various 518 Various Total venture capital and private equity fund investments $ 605 $ 671 Debt funds: Gold Hill Capital 2008, LP (ii) $ 4 15.5 % $ 4 15.5 % Other debt funds 1 Various 1 Various Total debt funds $ 5 $ 5 Other investments: SPD Silicon Valley Bank Co., Ltd. $ 146 50.0 % $ 154 50.0 % Other investments 130 Various 140 Various Total other investments $ 276 $ 294 (i) Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP. (ii) Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent. (6) The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of "other liabilities" on our consolidated balance sheets at December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Investments in qualified affordable housing projects, net $ 1,306 $ 954 Other liabilities 754 482 The following table presents other information relating to our investments in qualified affordable housing projects for the years ended 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Tax credits and other tax benefits recognized $ 99 $ 77 $ 57 Amortization expense included in provision for income taxes (i) 80 64 44 (i) All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes. The following table presents the net gains and losses on non-marketable and other equity securities in 2022, 2021 and 2020 as recorded in the line item “Gains (losses) on investment securities, net," a component of noninterest income: Year ended December 31, (Dollars in millions) 2022 2021 2020 Net gains (losses) on non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments $ (101) $ 71 $ 32 Unconsolidated venture capital and private equity fund investments (86) 75 60 Other investments without a readily determinable fair value (26) 75 — Other equity securities in public companies (fair value accounting) (52) 23 105 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (49) 474 162 Debt funds (1) 2 — Other investments 9 10 1 Total net gains (losses) on non-marketable and other equity securities $ (306) $ 730 $ 360 Less: realized net gains (losses) on sales of non-marketable and other equity securities (19) 85 24 Net gains (losses) on non-marketable and other equity securities still held $ (287) $ 645 $ 336

Loans and Allowance for Credit

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments	Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments We serve a variety of commercial clients in the private equity/venture capital, technology, life science/healthcare, commercial real estate and premium wine sectors. Loans made to private equity/venture capital firm clients typically enable them to fund investments prior to their receipt of funds from capital calls and are reported under the Global Fund Banking class of financing receivable below. Our technology clients generally tend to be in the industries of hardware (such as semiconductors, communications, data, storage and electronics), software/internet (such as infrastructure software, applications, software services, digital content and advertising technology) and ERI. Our life science/healthcare clients primarily tend to be in the industries of biotechnology, medical devices, healthcare information technology and healthcare services. Loans to our technology and life science/healthcare clients are reported under the Investor Dependent, Cash Flow Dependent — SLBO and Innovation C&I classes of financing receivable below. Commercial real estate loans are generally acquisition financing for commercial properties such as office buildings, retail properties, apartment buildings and industrial/warehouse space, which moving forward, will predominantly support the innovation economy segments. We also make commercial and industrial loans, such as working capital lines and term loans for equipment and fixed assets, to clients that are not in the technology and life science/healthcare industries, which are reported in the Other C&I class of financing receivable below. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality. In addition to commercial loans, we make consumer loans through SVB Private and provide real estate secured loans to eligible employees through our EHOP. We also provide community development loans made as part of our responsibilities under the CRA. The majority of these loans are included within the Other and CRE loan class below and are primarily secured by real estate. Additionally, beginning in April 2020, we accepted applications under the PPP administered by the SBA under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) and originated loans to qualified small businesses. PPP funds under the CARES Act were disbursed throughout 2020 and up to June 30, 2021. Loan Portfolio Segments and Classes of Financing Receivables The composition of loans at amortized cost basis broken out by class of financing receivable at December 31, 2022, and December 31, 2021, respectively, is presented in the following table: December 31, (Dollars in millions) 2022 2021 Global fund banking $ 41,269 $ 37,958 Investor dependent: Early stage 1,950 1,593 Growth stage 4,763 3,951 Total investor dependent 6,713 5,544 Cash flow dependent — SLBO 1,966 1,798 Innovation C&I 8,609 6,673 Private bank 10,477 8,743 CRE 2,583 2,670 Premium wine 1,158 985 Other C&I 1,019 1,257 Other 433 317 PPP 23 331 Total loans (1) (2) (3) $ 74,250 $ 66,276 ACL (636) (422) Net loans $ 73,614 $ 65,854 (1) Total loans at amortized cost is net of unearned income, deferred fees and costs and net unamortized premiums and discounts of $283 million and $250 million at December 31, 2022, and December 31, 2021, respectively. (2) Included within our total loan portfolio are credit card loans of $555 million and $583 million at December 31, 2022, and December 31, 2021, respectively. (3) Included within our total loan portfolio are construction loans of $539 million and $367 million at December 31, 2022, and December 31, 2021, respectively. Credit Quality Indicators For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass,” with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures and translate to an internal rating of “Criticized.” All of our nonaccrual loans are risk-rated 8 or 9 and are classified with the internal rating of “Nonperforming.” Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators on a quarterly basis for performance and appropriateness of risk ratings as part of our evaluation process for our ACL for loans. The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of December 31, 2022, and December 31, 2021. Term Loans by Origination Year December 31, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 543 $ 90 $ 55 $ 29 $ 1 $ 5 $ 40,539 $ 3 $ — $ 41,265 Criticized — — — — — — 4 — — 4 Nonperforming — — — — — — — — — — Total global fund banking $ 543 $ 90 $ 55 $ 29 $ 1 $ 5 $ 40,543 $ 3 $ — $ 41,269 Investor dependent: Early stage: Risk rating: Pass $ 910 $ 480 $ 44 $ 12 $ 1 $ — $ 182 $ — $ — $ 1,629 Criticized 130 120 18 5 — — 31 — — 304 Nonperforming 5 7 1 2 — — 2 — — 17 Total early stage $ 1,045 $ 607 $ 63 $ 19 $ 1 $ — $ 215 $ — $ — $ 1,950 Growth stage: Risk rating: Pass $ 2,358 $ 1,175 $ 283 $ 34 $ 8 $ 2 $ 300 $ 5 $ — $ 4,165 Criticized 186 233 81 5 3 3 32 — — 543 Nonperforming 20 31 — — — — 4 — — 55 Total growth stage $ 2,564 $ 1,439 $ 364 $ 39 $ 11 $ 5 $ 336 $ 5 $ — $ 4,763 Total investor dependent $ 3,609 $ 2,046 $ 427 $ 58 $ 12 $ 5 $ 551 $ 5 $ — $ 6,713 Cash flow dependent — SLBO: Risk rating: Pass $ 930 $ 550 $ 169 $ 162 $ 14 $ 19 $ 37 $ — $ — $ 1,881 Criticized 17 34 16 — 2 11 5 — — 85 Nonperforming — — — — — — — — — — Total cash flow dependent — SLBO $ 947 $ 584 $ 185 $ 162 $ 16 $ 30 $ 42 $ — $ — $ 1,966 Innovation C&I: Risk rating: Pass $ 2,554 $ 1,309 $ 495 $ 157 $ 5 $ 35 $ 3,152 $ — $ — $ 7,707 Criticized 65 224 168 33 11 — 373 — — 874 Nonperforming 7 — — — — — 21 — — 28 Total innovation C&I $ 2,626 $ 1,533 $ 663 $ 190 $ 16 $ 35 $ 3,546 $ — $ — $ 8,609 Private bank: Risk rating: Pass $ 2,782 $ 2,754 $ 1,718 $ 912 $ 427 $ 978 $ 832 $ 12 $ — $ 10,415 Criticized — 16 — 2 1 14 4 — — 37 Nonperforming — — 1 2 1 20 1 — — 25 Total private bank $ 2,782 $ 2,770 $ 1,719 $ 916 $ 429 $ 1,012 $ 837 $ 12 $ — $ 10,477 CRE Risk rating: Pass $ 519 $ 276 $ 193 $ 211 $ 144 $ 802 $ 102 $ 5 $ — $ 2,252 Criticized — 11 39 133 14 112 17 — — 326 Nonperforming — — — 5 — — — — — 5 Total CRE $ 519 $ 287 $ 232 $ 349 $ 158 $ 914 $ 119 $ 5 $ — $ 2,583 Premium wine: Risk rating: Pass $ 309 $ 209 $ 90 $ 135 $ 43 $ 135 $ 163 $ 33 $ — $ 1,117 Criticized 1 5 — 7 9 9 10 — — 41 Nonperforming — — — — — — — — — — Total premium wine $ 310 $ 214 $ 90 $ 142 $ 52 $ 144 $ 173 $ 33 $ — $ 1,158 Other C&I Term Loans by Origination Year December 31, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Risk rating: Pass $ 34 $ 141 $ 156 $ 64 $ 81 $ 284 $ 207 $ 10 $ — $ 977 Criticized 2 — 1 4 1 22 9 1 — 40 Nonperforming — — 1 — — 1 — — — 2 Total other C&I $ 36 $ 141 $ 158 $ 68 $ 82 $ 307 $ 216 $ 11 $ — $ 1,019 Other: Risk rating: Pass $ 114 $ 189 $ 148 $ 29 $ — $ — $ 9 $ 2 $ (75) $ 416 Criticized — 7 2 8 — — — — — 17 Nonperforming — — — — — — — — — — Total other $ 114 $ 196 $ 150 $ 37 $ — $ — $ 9 $ 2 $ (75) $ 433 PPP: Risk rating: Pass $ — $ 12 $ 3 $ — $ — $ — $ — $ — $ — $ 15 Criticized — 3 5 — — — — — — 8 Nonperforming — — — — — — — — — — Total PPP $ — $ 15 $ 8 $ — $ — $ — $ — $ — $ — $ 23 Total loans $ 11,486 $ 7,876 $ 3,687 $ 1,951 $ 766 $ 2,452 $ 46,036 $ 71 $ (75) $ 74,250 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level. Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 764 $ 115 $ 36 $ 6 $ 8 $ 4 $ 36,955 $ — $ — $ 37,888 Criticized 50 18 — — — 1 1 — — 70 Nonperforming — — — — — — — — — — Total global fund banking $ 814 $ 133 $ 36 $ 6 $ 8 $ 5 $ 36,956 $ — $ — $ 37,958 Investor dependent: Early stage: Risk rating: Pass $ 754 $ 287 $ 122 $ 26 $ 6 $ 1 $ 171 $ — $ — $ 1,367 Criticized 64 87 30 5 — — 29 — — 215 Nonperforming 2 5 3 — — — 1 — — 11 Total early stage $ 820 $ 379 $ 155 $ 31 $ 6 $ 1 $ 201 $ — $ — $ 1,593 Growth stage: Risk rating: Pass $ 2,072 $ 910 $ 265 $ 78 $ 14 $ 1 $ 286 $ 5 $ — $ 3,631 Criticized 159 85 27 6 3 — 34 — — 314 Nonperforming 2 — 1 2 — — 1 — — 6 Total growth stage $ 2,233 $ 995 $ 293 $ 86 $ 17 $ 1 $ 321 $ 5 $ — $ 3,951 Total investor dependent $ 3,053 $ 1,374 $ 448 $ 117 $ 23 $ 2 $ 522 $ 5 $ — $ 5,544 Cash flow dependent – SLBO: Risk rating: Pass $ 875 $ 384 $ 252 $ 72 $ 76 $ 2 $ 35 $ — $ — $ 1,696 Criticized — — 20 25 — 13 10 — — 68 Nonperforming — — 12 10 7 — 5 — — 34 Total cash flow dependent — SLBO $ 875 $ 384 $ 284 $ 107 $ 83 $ 15 $ 50 $ — $ — $ 1,798 Innovation C&I: Risk rating: Pass $ 2,230 $ 1,058 $ 288 $ 123 $ 58 $ — $ 2,411 $ — $ — $ 6,168 Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Criticized 64 130 62 12 — — 236 — — 504 Nonperforming — — — — — — 1 — — 1 Total Innovation C&I $ 2,294 $ 1,188 $ 350 $ 135 $ 58 $ — $ 2,648 $ — $ — $ 6,673 Private bank: Risk rating: Pass $ 2,952 $ 2,015 $ 1,122 $ 520 $ 432 $ 952 $ 705 $ 8 $ — $ 8,706 Criticized — — 2 — 2 9 3 — — 16 Nonperforming — — 2 9 — 8 2 — — 21 Total private bank $ 2,952 $ 2,015 $ 1,126 $ 529 $ 434 $ 969 $ 710 $ 8 $ — $ 8,743 CRE: Risk rating: Pass $ 326 $ 215 $ 344 $ 155 $ 236 $ 868 $ 110 $ 2 $ — $ 2,256 Criticized 3 39 114 37 47 139 18 12 — 409 Nonperforming — — 5 — — — — — — 5 Total CRE $ 329 $ 254 $ 463 $ 192 $ 283 $ 1,007 $ 128 $ 14 $ — $ 2,670 Premium wine: Risk rating: Pass $ 217 $ 112 $ 156 $ 69 $ 71 $ 162 $ 125 $ 34 $ — $ 946 Criticized 1 7 11 9 — — 11 — — 39 Nonperforming — — — — — — — — — — Total Premium wine $ 218 $ 119 $ 167 $ 78 $ 71 $ 162 $ 136 $ 34 $ — $ 985 Other C&I: Risk rating: Pass $ 181 $ 175 $ 82 $ 86 $ 28 $ 301 $ 350 $ 11 $ — $ 1,214 Criticized 5 6 6 7 2 — 8 5 — 39 Nonperforming — — — 2 — 1 1 — — 4 Total other C&I $ 186 $ 181 $ 88 $ 95 $ 30 $ 302 $ 359 $ 16 $ — $ 1,257 Other: Risk rating: Pass $ 61 $ 144 $ 82 $ 20 $ 14 $ — $ 7 $ — $ (21) $ 307 Criticized — 7 1 — 2 — — — — 10 Nonperforming — — — — — — — — — — Total other $ 61 $ 151 $ 83 $ 20 $ 16 $ — $ 7 $ — $ (21) $ 317 PPP: Risk rating: Pass $ 226 $ 72 $ — $ — $ — $ — $ — $ — $ — $ 298 Criticized 22 9 — — — — — — — 31 Nonperforming 2 — — — — — — — — 2 Total PPP $ 250 $ 81 $ — $ — $ — $ — $ — $ — $ — $ 331 Total loans $ 11,032 $ 5,880 $ 3,045 $ 1,279 $ 1,006 $ 2,462 $ 41,516 $ 77 $ (21) $ 66,276 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level. Allowance for Credit Losses: Loans As of December 31, 2022, the ACL for loans increased by $214 million from December 31, 2021, driven primarily by loan growth and the continued deterioration in projected economic conditions. The Moody's Analytics' December 2022 forecast was utilized in our quantitative model for the ACL as of December 31, 2022. The forecast assumptions reflected deterioration in the gross domestic product growth rate and unemployment rate, as well as a projected shrinkage of the housing price index. The overall impact of these assumptions was a worse forecast than that used at December 31, 2021. We determined the forecast to be representative of our outlook for the economy given the available information at year end. We do not estimate expected credit losses on AIR on loans, as AIR is reversed or written off when the full collection of the AIR related to a loan becomes doubtful. AIR on loans totaled $402 million as of December 31, 2022, and $171 million as of December 31, 2021, and is reported in "Accrued interest receivable and other assets" in our consolidated balance sheets. The following tables summarize the activity relating to our ACL for loans for 2022, 2021 and 2020 broken out by portfolio segment: Year ended December 31, 2022 Beginning Balance December 31, 2021 Charge-offs Recoveries Provision (Reduction) for Loans Foreign Currency Translation Adjustments Ending Balance December 31, 2022 (Dollars in millions) Global fund banking $ 67 $ — $ 7 $ 36 $ — $ 110 Investor dependent 146 (79) 20 184 2 $ 273 Cash flow dependent and Innovation C&I 118 (19) 1 55 — $ 155 Private bank 33 — 2 15 — $ 50 CRE 36 — — (11) — $ 25 Other C&I 14 (4) 1 2 — $ 13 Premium wine and other 8 (1) 1 7 (5) $ 10 Total ACL $ 422 $ (103) $ 32 $ 288 $ (3) $ 636 Year ended December 31, 2021 Beginning Balance December 31, 2020 Initial Allowance on PCD Loans Charge-offs Recoveries Provision (Reduction) for Loans (1) Ending Balance December 31, 2021 (Dollars in millions) Global fund banking (2) $ 46 $ — $ (80) $ — $ 101 $ 67 Investor dependent 213 — (46) 18 (39) 146 Cash flow dependent and Innovation C&I 125 — (8) 6 (5) 118 Private bank 53 1 (3) — (18) 33 CRE — 17 — — 19 36 Other C&I — 4 — — 10 14 Premium wine and other 9 — (1) — — 8 PPP 2 — — — (2) — Total ACL $ 448 $ 22 $ (138) $ 24 $ 66 $ 422 (1) The provision for loans for the year ended December 31, 2021, includes a post-combination initial provision of $44 million related to non-PCD loans from the Boston Private acquisition. (2) Global fund banking activity for the year ended December 31, 2021, includes the impact of an $80 million charge-off related to fraudulent activity on one loan as disclosed in previous filings. Year ended December 31, 2020 Beginning Balance at December 31, 2019 Impact of Adopting ASC 326 Charge-offs Recoveries Provision (Reduction) for Loans Foreign Currency Translation Adjustments Ending Balance at December 31, 2020 (Dollars in millions) Global fund banking $ 107 $ (70) $ — $ — $ 9 $ — $ 46 Investor dependent 82 72 (89) 25 125 (2) 213 Cash flow dependent and Innovation C&I 81 (1) (11) 3 53 — 125 Private bank 22 12 (2) — 21 — 53 Premium wine and other 13 12 (1) 1 (21) 5 9 PPP — — — — 2 — 2 Total ACL $ 305 $ 25 $ (103) $ 29 $ 189 $ 3 $ 448 The following table summarizes the aging of our loans broken out by class of financing receivables as of December 31, 2022, and December 31, 2021: (Dollars in millions) 30 - 59 60 - 89 90 or More Days Past Due Total Past Due Current Total 90 Days or More Past Due, Still December 31, 2022: Global fund banking $ 20 $ — $ — $ 20 $ 41,249 $ 41,269 $ — Investor dependent: Early stage 11 13 2 26 1,924 1,950 — Growth stage 26 — 3 29 4,734 4,763 — Total investor dependent 37 13 5 55 6,658 6,713 — Cash flow dependent - SLBO — — — — 1,966 1,966 — Innovation C&I 2 1 — 3 8,606 8,609 — Private bank 22 2 17 41 10,436 10,477 1 CRE 10 1 — 11 2,572 2,583 — Premium wine 3 — — 3 1,155 1,158 — Other C&I 2 — 2 4 1,015 1,019 — Other — — — — 433 433 — PPP — — 5 5 18 23 4 Total loans (1) $ 96 $ 17 $ 29 $ 142 $ 74,108 $ 74,250 $ 5 December 31, 2021: Global fund banking $ — $ — $ — $ — $ 37,958 $ 37,958 $ — Investor dependent: Early stage 6 5 — 11 1,582 1,593 — Growth stage 16 — — 16 3,935 3,951 — Total investor dependent 22 5 — 27 5,517 5,544 — Cash flow dependent - SLBO — — — — 1,798 1,798 — Innovation C&I 7 — 7 14 6,659 6,673 7 Private bank 28 1 12 41 8,702 8,743 — CRE 1 — — 1 2,669 2,670 — Premium wine 3 — — 3 982 985 — Other C&I 1 2 1 4 1,253 1,257 — Other — — — — 317 317 — PPP 1 — — 1 330 331 — Total loans $ 63 $ 8 $ 20 $ 91 $ 66,185 $ 66,276 $ 7 Nonaccrual Loans The following table summarizes our nonaccrual loans with no ACL at December 31, 2022, and December 31, 2021: December 31, 2022 December 31, 2021 (Dollars in millions) Nonaccrual Loans Nonaccrual Loans with no ACL Nonaccrual Loans Nonaccrual Loans with no ACL Investor dependent: Early stage $ 17 $ — $ 11 $ — Growth stage 55 3 6 — Total investor dependent 72 3 17 — Cash flow dependent - SLBO — — 34 — Innovation C&I 28 — 1 1 Private bank 25 7 21 8 CRE 5 — 5 — Other C&I 2 1 4 — PPP — — 2 — Total nonaccrual loans $ 132 $ 11 $ 84 $ 9 Troubled Debt Restructurings As of December 31, 2022, we had 36 TDRs with a total carrying value of $90 million where concessions have been granted to borrowers experiencing financial difficulties in an attempt to maximize collection. We had no unfunded commitments available for funding to the clients associated with these TDRs as of December 31, 2022. As of December 31, 2021, we had 62 TDRs with a total carrying value of $96 million where concessions have been granted to borrowers experiencing financial difficulties in an attempt to maximize collection. There were no unfunded commitments available for funding to the clients associated with these TDRs as of December 31, 2021. The following table summarizes our loans modified in TDRs, broken out by class of financing receivables, as of December 31, 2022 and December 31, 2021: (Dollars in millions) December 31, 2022 December 31, 2021 Loans modified in TDRs: Investor dependent: Early stage $ 1 $ 12 Growth stage 30 3 Total investor dependent 31 15 Cash flow dependent - SLBO — 34 Innovation C&I 1 — Private bank 24 12 CRE 33 33 Other C&I 1 2 Total loans modified in TDRs $ 90 $ 96 The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivables, for modifications made during 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Loans modified in TDRs during the period: Investor dependent: Early stage $ — $ 12 $ 6 Growth stage 30 — 26 Total investor dependent 30 12 32 Cash flow dependent - SLBO — 12 22 Innovation C&I 1 — 1 Private bank 17 4 — CRE 5 29 — Premium wine — — 1 Total loans modified in TDRs during the period (1) $ 53 $ 57 $ 56 (1) There were $110 million, $6 million and $31 million of partial charge-offs during 2022, 2021 and 2020, respectively. During 2022, $52 million of new TDRs were modified through payment deferrals granted to our clients and $1 million were modified through interest rate reductions. During 2021, $31 million of new TDRs were modified through payment deferrals granted to our clients, $2 million were modified through interest rate reductions, $2 million were modified through settlements, and $22 million were modified through a combination of the above. During 2020, $55 million of new TDRs were modified through payment deferrals, and $1 million were modified through partial forgiveness of principal. Of loans modified in TDRs within the previous 12 months, $1 million in Investor Dependent - Early Stage and $1 million in Innovation C&I defaulted on the modified terms during the year ended December 31, 2022. There were no defaults of loans modified in TDRs during the year ended December 31, 2021. There were $1 million in defaults on TDRs during the year ended December 31, 2020 in Premium Wine. Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the ACL for loans, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and nonaccrual loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs, we determined that no change to our reserving methodology for TDRs was necessary to determine the ACL for loans as of December 31, 2022. ACL: Unfunded Credit Commitments We maintain a separate ACL for unfunded credit commitments that is determined using a methodology that is inherently similar to the methodology used for calculating the ACL for loans. At December 31, 2022 , our ACL estimates utilized the Moody's economic forecasts from December 2022 as mentioned above. The ACL for unfunded commitments increased by $132 million from prior year, driven primarily by continued growth in our outstanding commitments, as well as the same deterioration in projected economic conditions described above. The following table summarizes the activity relating to our ACL for unfunded credit commitments for 2022, 2021 and 2020: December 31, (Dollars in millions) 2022 2021 2020 ACL: unfunded credit commitments, beginning balance $ 171 $ 121 $ 68 Impact of adopting ASC 326 — — 23 Provision for credit losses 133 50 30 Foreign currency translation adjustments (1) — — ACL: unfunded credit commitments, ending balance (1) $ 303 $ 171 $ 121 (1) The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our consolidated balance sheets. See Note 21—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” for additional disclosures related to our commitments to extend credit.

Premises and Equipment

Premises and Equipment	12 Months Ended
Premises and Equipment	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Premises and Equipment	Premises and Equipment Premises and equipment at December 31, 2022, and December 31, 2021, consisted of the following: December 31, (Dollars in millions) 2022 2021 Computer software $ 581 $ 408 Computer hardware 116 102 Leasehold improvements 164 149 Furniture and equipment 59 53 Building 3 3 Total 923 715 Accumulated depreciation and amortization (529) (445) Premises and equipment, net $ 394 $ 270

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2022
Leases [Abstract]
Leases	Leases We have operating leases for our corporate offices and certain equipment utilized at those properties. We are obligated under a number of noncancellable operating leases for premises and equipment that expire at various dates, through 2057, and in most instances, include options to renew or extend at market rates and terms. Such leases may provide for periodic adjustments of rentals during the term of the lease based on changes in various economic indicators. Total recorded balances for the lease assets and liabilities are as follows: December 31, (Dollars in millions) 2022 2021 Assets: Right-of-use assets - operating leases $ 335 $ 313 Liabilities: Lease liabilities - operating leases 413 388 The components of our lease cost and supplemental cash flow information related to leases for the years ended 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Operating lease cost $ 68 $ 90 $ 69 Short-term lease cost — — 1 Variable lease cost 6 4 4 Less: sublease income (3) (4) (2) Total lease expense, net $ 71 $ 90 $ 72 Supplemental cash flows information: Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 81 $ 66 $ 50 Noncash items during the period: Lease obligations in exchange for obtaining right-of-use assets: Operating leases $ 88 $ 187 $ 75 The table below presents additional information related to the Company's leases as of December 31, 2022 and December 31, 2021: December 31, 2022 2021 Weighted-average remaining term (in years) - operating leases 7.70 7.29 Weighted-average discount rate - operating leases (1) 2.25 % 1.83 % (1) The incremental borrowing rate used to calculate the lease liability was determined based on the facts and circumstances of the economic environment and the Company’s credit standing as of the effective date of the respective leases. Additionally, the total lease term and total lease payments were also considered in determining the rate. Based on these considerations, the Company identified credit terms available under its existing credit lines which represent a collateralized borrowing rate that has varying credit terms that could be matched to total lease terms and total lease payments in ultimately determining the implied borrowing rate in each lease contract. The following table presents our undiscounted future cash payments for our operating lease liabilities as of December 31, 2022: Years ended December 31, Operating Leases 2023 $ 85 2024 76 2025 64 2026 49 2027 39 2028 and thereafter 146 Total lease payments $ 459 Less: imputed interest (46) Total lease liabilities $ 413 Lease Exits Following the acquisition of Boston Private, we decided to exit various leased office locations during 2021 and market these spaces for sublease. When a company plans to utilize an ROU asset for less than it was initially intended, ASC 842, Leases , requires an evaluation for impairment and disclosure in accordance with ASC 360-10-45-2, Impairment or Disposal of Long-Lived Assets . We have recognized $3 million and $39 million of impairment charges related to these leased office for the years ended December 31, 2022 and December 31, 2021, respectively, and have included impairment and lease exit related expenses in the “Merger-related charges” in our Consolidated Statement of Income.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
Goodwill and Other Intangible Assets	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill Goodwill was $375 million at both December 31, 2022 and December 31, 2021. The changes in goodwill were as follows for the years ended December 31, 2022 and December 31, 2021: (Dollars in millions) Goodwill Beginning balance at December 31, 2020 $ 143 Acquisitions (1) 232 Ending balance at December 31, 2021 $ 375 Acquisitions — Impairment — Ending balance at December 31, 2022 $ 375 (1) Goodwill was recognized for the acquisitions of Boston Private effective July 1, 2021 and MoffettNathanson LLC effective December 10, 2021. During 2022, we completed our annual goodwill impairment test as of October 1, 2022, utilizing information as of September 30, 2022, and as a result, we determined there was no impairment as of December 31, 2022. For more information on our annual impairment policies, see Note 2—“Summary of Significant Accounting Policies. " Other Intangible Assets The following table presents the gross carrying amount and accumulated amortization of other intangible assets as of December 31, 2022, and December 31, 2021: December 31, 2022 December 31, 2021 (Dollars in millions) Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Other intangible assets: Customer relationships $ 135 $ 30 $ 105 $ 135 $ 16 $ 119 Other 57 26 31 57 16 41 Total other intangible assets, net $ 192 $ 56 $ 136 $ 192 $ 32 $ 160 Amortization expense recognized on intangible assets was $24 million, $15 million and $5 million for the years ended 2022, 2021 and 2020. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of December 31, 2022: Years ended December 31, Other 2023 $ 22 2024 20 2025 17 2026 15 2027 12 2028 and thereafter 50 Total future amortization expense $ 136

Deposits

Deposits	12 Months Ended
Deposits	Dec. 31, 2022
Deposits [Abstract]
Deposits	Deposits The following table presents the composition of our deposits as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Noninterest-bearing demand $ 80,753 $ 125,851 Interest-bearing checking and savings accounts 32,916 5,106 Money market 52,032 54,842 Money market deposits in foreign offices 51 696 Sweep deposits in foreign offices 664 969 Time 6,693 1,739 Total deposits $ 173,109 $ 189,203

Short-Term Borrowings and Long-

Short-Term Borrowings and Long-Term Debt	12 Months Ended
Short-Term Borrowings and Long-Term Debt	Dec. 31, 2022
Debt Disclosure [Abstract]
Short-Term Borrowings and Long-Term Debt	Short-Term Borrowings and Long-Term Debt Carrying Value (Dollars in millions) Maturity Principal value at December 31, 2022 December 31, 2022 December 31, 2021 Short-term borrowings: Securities sold under agreements to repurchase (1) $ 525 $ 525 $ 61 Other short-term borrowings (2) 40 40 10 FHLB advances 13,000 13,000 — Total short-term borrowings $ 13,565 $ 71 Long-term debt: 3.50% Senior Notes January 29, 2025 350 349 $ 349 3.125% Senior Notes June 5, 2030 500 496 496 1.800% Senior Notes February 2, 2031 500 495 494 2.100% Senior Notes May 15, 2028 500 497 496 1.800% Senior Notes October 28, 2026 650 646 645 4.345% Senior Fixed Rate/Floating Rate Notes April 29, 2028 350 348 — 4.570% Senior Fixed Rate/Floating Rate Notes April 29, 2033 450 448 — Junior subordinated debentures Various 100 91 90 FHLB advances Various 2,000 2,000 — Total long-term debt $ 5,370 $ 2,570 (1) Securities sold under repurchase agreements are effectively short-term borrowings collateralized by U.S. Treasury securities, U.S. agency securities and foreign government debt securities and contracted on an overnight basis. Our total unused and available borrowing capacity under our master repurchase agreements with various financial institutions totaled $35.0 billion at December 31, 2022. (2) Represents cash collateral received from certain counterparties in excess of net derivative receivables balances. The aggregate annual maturities of long-term debt obligations as of December 31, 2022, are as follows: Year ended December 31, Amount 2023 $ 2,000 2024 — 2025 349 2026 646 2027 — 2028 and thereafter 2,375 Total $ 5,370 Interest expense related to short-term borrowings and long-term debt was $326 million, $48 million and $25 million in 2022, 2021 and 2020, respectively. The weighted average interest rate associated with our short-term borrowings was 2.9 percent as of December 31, 2022, and 0.2 percent as of December 31, 2021. Short-term and Long-term Federal Credit Facilities We have certain facilities in place to enable us to access short- and long-term borrowings on a secured and unsecured basis. Our secured facilities include collateral pledged to the FHLB of San Francisco and the discount window at the FRB (using both fixed income securities and loans as collateral). Our unsecured facility consists of our uncommitted federal funds lines. As of December 31, 2022, the Company had short-term FHLB advances totaling $13.0 billion and long-term FHLB advances of $2.0 billion, which consists of two $1 billion borrowings with maturities on November 1 and 2, 2023. The long-term borrowings pay monthly for loan backed collateral and semi-annually for securities backed collateral, with a net weighted average fixed rate of 4.69%. Collateral pledged to the FHLB of San Francisco was comprised primarily of fixed income investment securities and loans with a carrying value of $44.9 billion and $7.3 billion at December 31, 2022, and December 31, 2021, of which $25.9 billion and $6.3 billion was available to support additional borrowings at December 31, 2022, and December 31, 2021, respectively. As of December 31, 2022, collateral pledged to the discount window at the FRB was comprised of fixed income investment securities and had a carrying value of $5.3 billion, all of which was unused and available to support additional borrowings. Our total unused and available borrowing capacity for our uncommitted federal funds lines totaled $3.2 billion at December 31, 2022. Long-term Debt 3.50% Senior Notes In January 2015, SVB Financial issued $350 million of 3.50% Senior Notes due in January 2025 ("3.50% Senior Notes"). We received net proceeds of approximately $346 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 3.50% Senior Notes at December 31, 2022, was $349 million, which is reflective of $1 million of debt issuance costs and a discount of less than $1 million. 3.125% Senior Notes On June 5, 2020, the Company issued $500 million of 3.125% Senior Notes due in June 2030 ("3.125% Senior Notes"). The 3.125% Senior Notes may be redeemed by us, at our option, at any time prior to March 5, 2030, at a redemption price equal to the full aggregate principal amount plus a “make-whole” premium payment. We received net proceeds from this offering of approximately $496 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 3.125% Senior Notes at December 31, 2022, was $496 million, which is reflective of $4 million of debt issuance costs and a discount of less than $1 million. 1.800% Senior Notes On February 2, 2021 the Company issued $500 million of 1.800% Senior Notes due February 2031 ("1.800% Senior Notes due 2031"), with interest payments starting August 2, 2021, and payable on February 2 and August 2 of each year. The notes are senior unsecured obligations of SVB Financial Group and rank equally with all of our other unsecured and unsubordinated indebtedness. We received net proceeds from this offering of approximately $494 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 1.800% Senior Notes at December 31, 2022, was $495 million, which is reflective of $4 million of debt issuance costs and a $1 million discount. 2.100% Senior Notes On May 13, 2021 the Company issued $500 million of 2.100% Senior Notes due May 2028 ("2.100% Senior Notes"), with interest payments starting November 15, 2021, and payable on May 15 and November 15 of each year. The notes are senior unsecured obligations of SVB Financial Group and rank equally with all of our other unsecured and unsubordinated indebtedness. We received net proceeds from this offering of approximately $496 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 2.100% Senior Notes at December 31, 2022, was $497 million, which is reflective of $3 million of debt issuance costs and less than a $1 million discount. 1.800% Senior Notes On October 28, 2021 the Company issued $650 million of 1.800% Senior Notes due October 2026 ("1.800% Senior Notes due 2026"), with interest payments starting April 28, 2022. The notes are senior unsecured obligations of SVB Financial Group and rank equally with all of our other unsecured and unsubordinated indebtedness. We received net proceeds from this offering of approximately $644 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 1.800% Senior Notes at December 31, 2022, was $646 million, which is reflective of $3 million of debt issuance costs and a $1 million discount. 4.345% Senior Fixed Rate/Floating Rate Notes On April 29, 2022 the Company issued $350 million of 4.435% Senior Fixed Rate/Floating Rate Notes due April 2028 ("4.345% Senior Fixed Rate/Floating Rate Notes " ) with fixed interest payable on April 29 and October 29 of each year, commencing on October 29, 2022, and ending on April 29, 2027. Beginning on April 29, 2027, the 4.345% Senior Fixed Rate/Floating Rate Notes will begin quarterly floating interest payments on July 29, 2027, October 29, 2027, January 29, 2028, at a floating rate of compounded SOFR plus 1.713%. The 4.345% Senior Fixed Rate/Floating Rate Notes will be redeemable at SVB Financial Group's option, in whole but not in part, on April 29, 2027, and on or after the 30th day prior to the 2028 maturity date at a redemption price equal to 100% of the principal amount of the Senior Notes due 2028, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. We received net proceeds of approximately $348 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 4.345% Senior Notes at December 31, 2022, was $348 million, which is reflective of $2 million of debt issuance costs. 4.570% Senior Fixed Rate/Floating Rate Notes On April 29, 2022 the Company issued $450 million of 4.570% Senior Fixed Rate/Floating Rate Notes due April 2033 ("4.570% Senior Fixed Rate/Floating Rate Notes ") with fixed interest payable on April 29 and October 29 of each year, commencing on October 29, 2022, and ending on April 29, 2032. Beginning on April 29, 2032, the 4.570% Senior Fixed Rate/Floating Rate Notes will begin quarterly interest payments on July 29, 2032, October 29, 2032, January 29, 2033, and October 29, 2033, at a floating rate of compounded SOFR plus 1.967%. The 4.570% Senior Fixed Rate/Floating Rate Notes will be redeemable at SVB Financial Group's option, in whole but not in part, on April 29, 2032, and on or after the 90th day prior to the 2033 maturity date at a redemption price equal to 100% of the principal amount of the Senior Notes due 2033, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. We received net proceeds of approximately $447 million after deducting underwriting discounts and commissions and issuance costs. The balance of our 4.570% Senior Notes at December 31, 2022, was $448 million, which is reflective of $2 million of debt issuance costs. Junior Subordinated Debentures On July 1, 2021, SVB Financial Group assumed two statutory trusts during the merger with Boston Private. These trusts were formed for the purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures. These statutory trusts created by legacy Boston Private are not consolidated within the financial statements; however, the total junior subordinated debentures payable to the preferred stockholders of statutory trusts are reported as long-term debt in the financial statements. The preferred securities represent an undivided beneficial interest in the assets of the trusts. We own all of the trusts' common securities. The trusts' only assets are the junior subordinated debentures issued to it by Boston Private on substantially the same payment terms as the trusts' preferred securities. Boston Private Capital Trust II Junior Subordinated Debentures ("Trust II") As of December 31, 2022, there are $100 million of trust preferred securities outstanding. The preferred trust securities issued by Trust II pay interest quarterly based on a floating three-month rate of LIBOR plus 1.68% which are cumulative. So long as the Company is not in default in the payment of interest on the junior subordinated debentures, the Company has the right under the indenture to defer payments of interest for up to 20 consecutive quarterly periods. The Company does not currently intend to exercise its right to defer interest payments on the junior debentures issued to Trust II. If the Company defers interest payments, it would be subject to certain restrictions relating to the payment of dividends on or purchases of its capital stock and payments on its debt securities ranking equal with or junior to the junior subordinated debentures. The effective interest rate on the junior subordinated debentures was 2.676%. The junior subordinated debentures will mature on December 30, 2035. As of December 31, 2022, the carrying value of the Company's investment in Trust II was $3 million, which represents the total amount of common securities in such trust. Boston Private Capital Trust I Junior Subordinated Debenture ("Trust I") As of December 31, 2022, there are less than $1 million of the convertible trust preferred securities outstanding. The convertible trust preferred securities issued by Trust I pay interest quarterly and have a fixed distribution rate of 4.875%. The quarterly distributions are cumulative. The effective interest rate for the junior subordinated debentures was 4.875% . The junior subordinated convertible debentures will mature on October 1, 2034. As of December 31, 2022, the carrying value of the Company's investment in Trust I was $3 million, which represents the total amount of common securities in such trust.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
Derivative Financial Instruments	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments We primarily use derivative financial instruments to manage interest rate risk and currency exchange rate risk and to assist customers with their risk management objectives, which may include currency exchange rate risks and interest rate risks. Also, in connection with negotiating credit facilities and certain other services, we often obtain equity warrant assets, giving us the right to acquire stock in private, venture-backed companies in the technology and life science/healthcare industries. Interest Rate Risk Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our interest rate sensitive assets and liabilities and changes in market interest rates. To manage interest rate risk on our interest rate sensitive assets, we have entered into interest rate swap contracts to hedge against future changes in interest rates. Fair Value Hedges To manage interest rate risk on our AFS securities portfolio, we enter into pay-fixed, receive-floating interest rate swap contracts to hedge against exposure to changes in the fair value of the securities resulting from changes in interest rates. We designate these interest rate swap contracts as fair value hedges that qualify for hedge accounting under ASC 815, Derivatives and Hedging ("ASC 815"). In 2021, we elected to account for a portion of the fair value hedges using the last-of-layer method as outlined in ASC 815. All hedges using the last-of-layer method were terminated in 2022. We record the interest rate swaps in the line items "accrued interest receivable and other assets" and "other liabilities" on our consolidated balance sheet. For qualifying fair value hedges, both the changes in the fair value of the derivative and the portion of the fair value adjustments associated with the last-of-layer attributable to the hedged risk are recognized into earnings as they occur. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "investment securities" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. In conjunction with the assessment of effectiveness, we assess the hedged item to ensure it is expected to be outstanding at the hedged item’s assumed maturity date and the last-of-layer method of accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any remaining fair value basis adjustments are allocated to the individual assets in the portfolio and amortized into earnings over a period consistent with the amortization of other discounts and premiums associated with the respective assets. As allowed under ASC 815, we apply the "shortcut" method of accounting to a portion of our fair value hedges which assumes there is perfect effectiveness. The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our consolidated balance sheets as of December 31, 2022, and December 31, 2021: Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets (Dollars in millions) Amortized Cost Basis of the Hedged Assets Active Terminated December 31, 2022 AFS securities $ 563 $ (2) $ (290) December 31, 2021 AFS securities (1) $ 15,260 $ (131) $ 6 (1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million. Cash Flow Hedges To manage interest rate risk on our variable-interest rate loan portfolio, we enter into interest rate swap contracts to hedge against future changes in interest rates by using hedging instruments to lock in future cash inflows that would otherwise be impacted by movements in the market interest rates. We designate these interest rate swap contracts as cash flow hedges that qualify for hedge accounting under ASC 815 and record them in the line items "accrued interest receivable and other assets" and "other liabilities" on our consolidated balance sheet. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in AOCI and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in AOCI are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. As of March 31, 2020, all derivatives previously classified as hedges with notional balances totaling $5.0 billion and a net asset fair value of $228 million were terminated. As of December 31, 2022, the total unrealized gains on terminated cash flow hedges remaining in AOCI is $60 million, or $43 million net of tax. The unrealized gains will be reclassified into interest income as the underlying forecasted transactions impact earnings through the original maturity of the hedged forecasted transactions. The total remaining term over which the unrealized gains will be reclassified into earnings is approximately two years Currency Exchange Risk Derivatives not designated as hedging instruments We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure risk associated with the net difference between foreign currency denominated assets and liabilities. Gains or losses from changes in currency rates on foreign currency denominated instruments are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. We may experience ineffectiveness in the economic hedging relationship, because the instruments are revalued based upon changes in the currency’s spot rate on the principal value, while the forwards are revalued on a discounted cash flow basis. We record forward agreements in gain positions in the line item "accrued interest receivable and other assets" and loss positions in the line item "other liabilities" on our consolidated balance sheet, while net changes in fair value are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. Derivatives designated as hedging instruments We enter into net investment hedges to hedge against the foreign currency risk of a net investment in foreign operations. Certain foreign exchange contracts are designated as net investment hedges to minimize our exposure to variability in the foreign currency translation of net investments in non-U.S. subsidiaries. For qualifying net investment hedges under ASC 815, changes in the spot rate of the net investment hedges of foreign operations are recorded in OCI in the line item "foreign currency translation (losses) gains, net of hedges." We assess hedge effectiveness under ASC 815 at least quarterly to ensure all hedges remain effective and hedge accounting can be applied. Net investment hedge pretax losses of $18 million were recognized in AOCI related to foreign exchange contracts for the year ending December 31, 2022. Other Derivative Instruments We issue loans to clients with conversion features allowing SVBFG to convert the contingent conversion rights to stock in private or public companies. All of our contingent conversion rights qualify as derivatives and are reported at fair value as a component of "accrued interest receivable and other assets" on our consolidated balance sheet. Any changes in fair value after the grant date are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income. We enter into total return swaps related to certain of our equity funds, which manages the risk of exposure from the volatility of equity investments in the funds. We do not designate any total return swaps as derivative instruments that qualify for hedge accounting. Gains or losses from changes in fair value are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income. Also included in our derivative instruments are equity warrant assets and client forward, option, swap and interest rate contracts. For further description of these other derivative instruments, refer to Note 2—“Summary of Significant Accounting Policies.” Counterparty Credit Risk We are exposed to credit risk if counterparties to our derivative contracts do not perform as expected. We mitigate counterparty credit risk through credit approvals, limits, monitoring procedures and by obtaining collateral, as appropriate. With respect to measuring counterparty credit risk for derivative instruments, we measure the fair value of a group of financial assets and financial liabilities on a net risk basis by counterparty portfolio. The total notional or contractual amounts and fair value of our derivative financial instruments at December 31, 2022, and December 31, 2021, were as follows: December 31, 2022 December 31, 2021 Notional or Fair Value Notional or Fair Value (Dollars in millions) Derivative Assets (1) Derivative Liabilities (1) Derivative Assets (1) Derivative Liabilities (1) Derivatives designated as hedging instruments: Interest rate risks: Interest rate swaps (2) $ 550 $ — $ — $ 10,700 $ 18 $ — Currency exchange risks: Foreign exchange contracts 778 17 — — — — Foreign exchange contracts 616 — 56 — — — Total derivatives designated as hedging instruments 17 56 18 — Derivatives not designated as hedging instruments: Currency exchange risks: Foreign exchange contracts 1,763 42 — 701 16 — Foreign exchange contracts 2,184 — 29 62 — 2 Other derivative instruments: Equity warrant assets 375 383 — 322 277 — Contingent conversion rights 92 12 — — — — Client foreign exchange contracts 10,145 262 — 8,245 146 — Client foreign exchange contracts 9,960 — 257 7,764 — 126 Total return swaps 119 40 — — — — Client foreign currency options 866 19 — 688 9 — Client foreign currency options 866 — 19 688 — 9 Client interest rate derivatives (2) 2,391 128 — 2,178 99 — Client interest rate derivatives (2) 2,709 — 195 2,315 — 101 Total derivatives not designated as hedging instruments 886 500 547 238 Total gross derivatives 903 556 565 238 Less: netting adjustment (3) (351) (223) (137) (120) Total derivatives $ 552 $ 333 $ 428 $ 118 (1) Derivative assets and liabilities are included in "accrued interest receivable and other assets " and " other liabilities " , respectively, on our consolidated balance sheets. (2) The amount reported reflects reductions of approximately $74 million and $112 million of derivative assets at December 31, 2022, and 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses. (3) For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $31 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at December 31, 2022, and December 31, 2021, respectively. A summary of our derivative activity and the related impact on our consolidated statements of income for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) Statement of income location 2022 2021 2020 Derivatives designated as hedging instruments: Interest rate risks: Amounts reclassified from AOCI into income Interest income - loans $ 56 $ 63 $ 50 Change in fair value of interest rate swaps hedging investment securities Interest income - investment securities taxable 387 138 — Change in fair value of hedged investment securities Interest income - investment securities taxable (387) (139) — Net gains associated with interest rate risk derivatives $ 56 $ 62 $ 50 Derivatives not designated as hedging instruments: Currency exchange risks: (Losses) gains on revaluations of internal foreign currency instruments, net Other noninterest income $ (42) $ (43) $ 39 Gains (losses) on internal foreign exchange forward contracts, net Other noninterest income 32 43 (40) Net losses associated with internal currency risk $ (10) $ — $ (1) Other derivative instruments: Gains on revaluations of client foreign currency instruments, net Other noninterest income $ 23 $ 17 $ 3 Losses on client foreign exchange forward contracts, net Other noninterest income (10) (17) (3) Net gains associated with client currency risk $ 13 $ — $ — Gains on total return swaps Other noninterest income $ 40 $ — $ — Net gains on equity warrant assets Gains on equity warrant assets, net $ 148 $ 560 $ 237 Net gains on other derivatives Other noninterest income $ 5 $ 2 $ 28 Balance Sheet Offsetting Certain of our derivative and other financial instruments are subject to enforceable master netting arrangements with our counterparties. These agreements provide for the net settlement of multiple contracts with a single counterparty through a single payment, in a single currency, in the event of default on or termination of any one contract. The following table summarizes our assets subject to enforceable master netting arrangements as of December 31, 2022, and December 31, 2021: (Dollars in millions) Gross Amounts of Recognized Assets Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Assets Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount Financial Instruments Cash Collateral Received December 31, 2022: Derivatives $ 382 $ (144) $ (207) $ 31 $ — $ 31 Reverse repurchase, securities borrowing and similar arrangements 722 — — 722 (722) — Total $ 1,104 $ (144) $ (207) $ 753 $ (722) $ 31 December 31, 2021: Derivatives $ 165 $ (87) $ (50) $ 28 $ — $ 28 Reverse repurchase, securities borrowing and similar arrangements 607 — — 607 (607) — Total $ 772 $ (87) $ (50) $ 635 $ (607) $ 28 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation. The following table summarizes our liabilities subject to enforceable master netting arrangements as of December 31, 2022, and December 31, 2021: (Dollars in millions) Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Liabilities Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount Financial Instruments Cash Collateral Pledged December 31, 2022: Derivatives $ 234 $ (144) $ (79) $ 11 $ — $ 11 Repurchase, securities lending and similar arrangements 525 — — 525 — 525 Total $ 759 $ (144) $ (79) $ 536 $ — $ 536 December 31, 2021: Derivatives $ 148 $ (87) $ (33) $ 28 $ — $ 28 Repurchase, securities lending and similar arrangements 61 — — 61 — 61 Total $ 209 $ (87) $ (33) $ 89 $ — $ 89 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Noninterest Income

Noninterest Income	12 Months Ended
Noninterest Income	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Noninterest Income	Noninterest Income All of the Company's revenue from contracts with customers within the scope of ASC 606, Revenue from Contracts with Customers , is recognized within noninterest income. Included below is a summary of noninterest income for the years ended December 31, 2022, December 31, 2021 and December 31, 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Noninterest income: (Losses) gains on investment securities, net $ (285) $ 761 $ 421 Gains on equity warrant assets, net 148 560 237 Client investment fees 386 75 132 Wealth management and trust fees 83 44 — Foreign exchange fees 285 262 179 Credit card fees 150 131 98 Deposit service charges 126 112 90 Lending related fees 94 76 57 Letters of credit and standby letters of credit fees 57 51 47 Investment banking revenue 420 459 414 Commissions 98 79 67 Other 166 128 98 Total noninterest income $ 1,728 $ 2,738 $ 1,840 Gains (losses) on investment securities, net Net gains (losses) on investment securities include both gains and losses from our non-marketable and other equity securities, which include public equity securities held as a result of exercised equity warrant assets, gains and losses from sales of our AFS debt securities portfolio, when applicable, and carried interest. Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt and credit funds, private and public portfolio companies, which include public equity securities held as a result of exercised equity warrant assets, and qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains and losses from non-marketable and other equity securities for any single period are typically driven by valuation changes. The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (e.g., lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes. Carried interest is comprised of preferential allocations of profits recognizable when the return on assets of our individual managed fund of funds and direct venture funds exceeds certain performance targets and is payable to us, as the general partners of the managed funds. The carried interest we earn is often shared with employees, who are also members of the general partner entities. We record carried interest on a quarterly basis by measuring fund performance to date versus the performance target. For our unconsolidated managed funds, carried interest is recorded as gains on investment securities, net. For our consolidated managed funds, it is recorded as a component of net income attributable to NCI. Carried interest allocated to others is recorded as a component of net income attributable to NCI. Any carried interest paid to us (or our employees) may be subject to reversal to the extent fund performance declines to a level where inception to date carried interest is lower than actual payments made by the funds. The limited partnership agreements for our funds provide that carried interest is generally not paid to the general partners until the funds have provided a full return of contributed capital to the limited partners. Accrued, but unpaid carried interest may be subject to reversal to the extent that the fund performance declines to a level where inception-to-date carried interest is less than prior amounts recognized. Carried interest income is accounted for under an ownership model based on ASC 323, Equity Method of Accounting and ASC 810, Consolidation. Our AFS securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk. Gains and losses on investment securities are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our investment-related activities. A summary of gains and losses on investment securities for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Gains (losses) on non-marketable and other equity securities, net $ (306) $ 730 $ 360 Gains (losses) on sales of AFS debt securities, net 21 31 61 Total gains (losses) on investment securities, net $ (285) $ 761 $ 421 Gains on equity warrant assets, net In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income. Gains on equity warrant assets, net are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of net gains on equity warrant assets for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Equity warrant assets: Gains on exercises, net $ 45 $ 446 $ 179 Terminations (4) (2) (2) Changes in fair value, net 107 116 60 Total net gains on equity warrant assets $ 148 $ 560 $ 237 Client investment fees Client investment fees include fees earned from discretionary investment management services for managing clients’ portfolios based on their investment policies, strategies and objectives. Revenue is recognized on a monthly basis upon completion of our performance obligation, and consideration is typically received in the subsequent month. Included in our sweep money market fees are Rule 12(b)-1 fees, revenue sharing and customer transactional-based fees. Rule 12(b)-1 fees and revenue sharing are recognized as earned based on client funds that are invested in the period, typically monthly. Transactional based fees are earned and recognized on fixed income securities and repurchase agreements when the transaction is executed on the clients' behalf. Amounts paid to third-party service providers are predominantly expensed, such that client investment fees are recorded gross of payments made to third parties. A summary of client investment fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Client investment fees by type: Sweep money market fees $ 215 $ 43 $ 74 Asset management fees (1) 57 31 43 Repurchase agreement fees 114 1 15 Total client investment fees (2) $ 386 $ 75 $ 132 (1) Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management. (2) Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet. Wealth management and trust fees Wealth management fees are earned for providing wealth management, retirement plan advisory, family office, financial planning and other financial advisory services to clients. The Company’s performance obligation under these contracts is satisfied over time as the services are provided. Fees are recognized monthly based on the average monthly, beginning-of-quarter, or, for a small number of clients, end-of-quarter market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. Fees are also recognized monthly based either on a fixed fee amount or the quarter-end (in arrears) market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. No performance-based incentives are earned under wealth management contracts. Receivables are recorded on the consolidated balance sheets in the "Accrued interest receivable and other assets" line item. Trust fees are earned when the Company is appointed as trustee for clients. As trustee, the Company administers the client’s trust and manages the assets of the trust, including investments and property. The Company’s performance obligation under these agreements is satisfied over time as the administration and management services are provided. Fees are recognized monthly or, in certain circumstances, quarterly based on a percentage of the market value of the account as outlined in the agreement. Payment frequency is defined in the individual contracts, which primarily stipulate monthly in arrears. No performance-based incentives are earned on trust fee contracts. Receivables are recorded on the consolidated balance sheets in the "Accrued interest receivable and other assets" line item. A summary of wealth management and trust fees for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Wealth management and trust fees by type: Wealth management fees $ 75 $ 40 $ — Trust fees 8 4 — Total wealth management and trust fees $ 83 $ 44 $ — Foreign exchange fees Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients, primarily from spot contracts. Foreign exchange spot contract fees recognized upon the completion of a single performance obligation are recognized within the scope of ASC 606. Foreign exchange contracts and option premium fees are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of foreign exchange fee income by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Foreign exchange fees by instrument type: Foreign exchange contract commissions $ 282 $ 260 $ 178 Option premium fees 3 2 1 Total foreign exchange fees $ 285 $ 262 $ 179 Credit card fees Credit card fees include interchange income from credit and debit cards and fees earned from processing transactions for merchants. Interchange income is earned after satisfying our performance obligation of providing nightly settlement services to a payment network. Costs related to rewards programs are recorded when the rewards are earned by the customer and presented as a reduction to interchange fee income. Rewards programs continue to be accounted for under ASC 310, Receivables . Our performance obligations for merchant service fees are to transmit data and funds between the merchant and the payment network. Credit card interchange and merchant service fees are earned daily upon completion of transaction settlement services. Annual card service fees are recognized on a straight-line basis over a 12-month period and continue to be accounted for under ASC 310, Receivables . A summary of credit card fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Credit card fees by instrument type: Card interchange fees, net $ 117 $ 108 $ 76 Merchant service fees 26 18 18 Card service fees 7 5 4 Total credit card fees $ 150 $ 131 $ 98 Deposit service charges Deposit service charges include fees earned from performing cash management activities and other deposit account services. Deposit services include, but are not limited to, the following: receivables services, which include merchant services, remote capture, lockbox, electronic deposit capture and fraud control services. Payment and cash management products and services include wire transfer and automated clearing house payment services to enable clients to transfer funds more quickly, as well as business bill pay, business credit and debit cards, account analysis and disbursement services. Deposit service charges are recognized over the period in which the related performance obligation is provided, generally on a monthly basis. Lending related fees Unused commitment fees, minimum finance fees and unused line fees are recognized as earned on a monthly basis. Fees that qualify for syndication treatment are recognized at the completion of the syndicated loan deal for which the fees were received. Lending related fees are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our lending-related activities. A summary of lending related fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Lending related fees by instrument type: Unused commitment fees $ 70 $ 59 $ 42 Other 24 17 15 Total lending related fees $ 94 $ 76 $ 57 Letters of credit and standby letters of credit fees Standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Fees generated from letters of credit and standby letters of credit are deferred as a component of other liabilities and recognized in noninterest income over the commitment period using the straight-line method, based on the likelihood that the commitment being drawn down will be remote. Letters of credit and standby letters of credit fees are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our lending related activities. Investment banking revenue We earn investment banking revenue from clients for providing services related to securities underwriting, private placements and advisory services on strategic matters such as mergers and acquisitions. Underwriting fees are attributable to public and private offerings of equity and debt securities and are recognized at the point in time when the offering has been deemed to be completed by the lead manager of the underwriting group. Once the offering is completed, the performance obligation has been satisfied and we recognize the applicable management fee as well as the underwriting fee, net of consideration payable to customers. Private placement fees are recognized at the point in time when the private placement is completed, which is generally when the client accepts capital from the fund raise. Advisory fees from mergers and acquisitions engagements are generally recognized at the point in time when the related transaction is completed. Expenses are deferred only to the extent they are explicitly reimbursable by the client, and the related revenue is recognized at a point in time. All other deal-related expenses are expensed as incurred. We have determined that we act as principal in the majority of these transactions and therefore present expenses gross within other operating expenses. A summary of investment banking revenue by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Investment banking revenue: Underwriting fees $ 163 $ 304 $ 353 Advisory fees 214 90 40 Private placements and other 43 65 21 Total investment banking revenue $ 420 $ 459 $ 414 Commissions Commissions include commissions received from customers for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The execution of each trade order represents a distinct performance obligation, and the transaction price is fixed at the point in time or trade order execution. Trade execution is satisfied at the point in time that the customer has control of the asset and as such, fees are recorded on a trade date basis. The Company also earns subscription fees for market intelligence services that are recognized over the period in which they are delivered. Fees received before the subscription period ends are initially recorded as deferred revenue (a contract liability) in other liabilities in our consolidated balance sheet. Other Other noninterest income primarily includes income from fund management fees, gains from conversion of convertible debt options and service revenue. Fund management fees are comprised of fees charged directly to our managed funds of funds and direct venture funds. Fund management fees are based upon the contractual terms of the limited partnership agreements and are generally recognized as earned over the specified contract period, which is generally equal to the life of the individual fund. Fund management fees are calculated as a percentage of committed capital and collected quarterly in advance and recognized over the quarter. Fund management fees for certain of our limited partnership agreements are calculated as a percentage of distributions made by the funds, and revenue is recorded only at the time of a distribution event. As distribution events are not predetermined for these certain funds, management fees are considered variable and constrained under ASC 606. Gains from conversion of convertible debt options represent unrealized valuation gains on loan conversion derivative assets, and realized gains from the conversion of debt instruments, convertible into a third party’s common stock upon a triggering event such as an IPO. Gains from conversion of convertible debt options are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our derivative-related activities. Other service revenue primarily consists of gains or losses from changes in fair value of total return swaps, dividend income on FHLB/FRB stock, correspondent bank rebate income, incentive fees, or performance fees related to carried interest and other fee income. We recognize revenue when our performance obligations are met and record revenues on a daily/monthly, quarterly, semi-annual or annual basis. For event driven revenue sources, we recognize revenue when: (i) persuasive evidence of an arrangement exists, (ii) we have performed the service, provided we have no other remaining obligations to the customer, (iii) the fee is fixed or determinable and (iv) collectability is probable. A summary of other noninterest income by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Other noninterest income by instrument type: Fund management fees $ 59 $ 67 $ 39 Net gains (losses) on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1) 3 — (1) Gains from conversion of convertible debt options — — 30 Gains on total return swaps 40 — — Other service revenue 64 61 30 Total other noninterest income $ 166 $ 128 $ 98 (1) Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments. Disaggregation of Revenue from Contracts with Customers The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the years ended December 31, 2022, December 31, 2021 and December 31, 2020: Year ended December 31, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 384 $ — $ — $ — $ 2 $ 386 Wealth management and trust fees — 83 — — — 83 Card interchange fees, gross 223 1 — — 3 227 Merchant service fees 25 1 — — — 26 Deposit service charges 124 1 — — 1 126 Investment banking revenue — — — 420 — 420 Commissions — — — 98 — 98 Fund management fees 2 — 52 5 — 59 Other (1) 71 1 6 — — 78 Total revenue from contracts with customers $ 829 $ 87 $ 58 $ 523 $ 6 $ 1,503 Revenues outside the scope of ASC 606 (2) 278 9 (168) (18) 124 225 Total noninterest income $ 1,107 $ 96 $ (110) $ 505 $ 130 $ 1,728 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of NCI. NCI is included within “Other Items." Year ended December 31, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 73 $ 2 $ — $ — $ — $ 75 Wealth management and trust fees — 44 — — — 44 Card interchange fees, gross 198 1 — — 2 201 Merchant service fees 17 1 — — — 18 Deposit service charges 109 1 — — 2 112 Investment banking revenue — — — 459 — 459 Commissions — — — 79 — 79 Fund management fees — — 62 5 — 67 Other (1) 243 2 13 — 1 259 Total revenue from contracts with customers $ 640 $ 51 $ 75 $ 543 $ 5 $ 1,314 Revenues outside the scope of ASC 606 (2) 66 7 412 65 874 1,424 Total noninterest income $ 706 $ 58 $ 487 $ 608 $ 879 $ 2,738 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of NCI. NCI is included within “Other Items." Year ended December 31, 2020 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 129 $ 3 $ — $ — $ — $ 132 Card interchange fees, gross 127 1 — — 2 130 Merchant service fees 17 1 — — — 18 Deposit service charges 90 — — — — 90 Investment banking revenue — — — 414 — 414 Commissions — — — 67 — 67 Fund management fees — — 32 7 — 39 Other (1) 162 — 4 — 1 167 Total revenue from contracts with customers $ 525 $ 5 $ 36 $ 488 $ 3 $ 1,057 Revenues outside the scope of ASC 606 (2) 79 — 190 9 505 783 Total noninterest income $ 604 $ 5 $ 226 $ 497 $ 508 $ 1,840 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s and SVB Capital’s components of noninterest income are shown net of NCI. NCI is included within “Other Items."

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of our income before income taxes by U.S and foreign for 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 U.S $ 1,996 $ 2,624 $ 1,673 Foreign 176 100 69 Income before income tax expense $ 2,172 $ 2,724 $ 1,742 The components of our provision for income taxes for 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Current provision: Federal $ 34 $ 409 $ 282 State (100) 224 141 Foreign 38 26 18 Deferred expense (benefit): Federal 330 5 6 State 254 (11) 2 Foreign 7 (2) (1) Income tax expense $ 563 $ 651 $ 448 Our effective tax rate is calculated by dividing income tax expense by the sum of income before income tax expense and the net income attributable to NCI. The reconciliation between the federal statutory income tax rate and our effective income tax rate for 2022, 2021 and 2020 is as follows: December 31, (Dollars in millions) 2022 2021 2020 Federal statutory income tax rate 21.0 % 21.0 % 21.0 % State income taxes, net of the federal tax effect 6.8 7.5 6.8 Share-based compensation expense on incentive stock options and ESPP (0.8) (1.6) (0.3) Qualified affordable housing project tax credits (0.4) (0.2) (0.5) Tax-exempt interest income (1.6) (1.0) (0.8) Other, net 0.2 0.5 0.8 Effective income tax rate 25.2 % 26.2 % 27.0 % Deferred tax assets and liabilities at December 31, 2022, and December 31, 2021, consisted of the following: December 31, (Dollars in millions) 2022 2021 Deferred tax assets: Allowance for credit losses $ 260 $ 170 Share-based compensation expense 36 26 Accrued compensation 82 77 Loans and debt securities — 113 Lease liability 112 105 Net operating loss carryforwards 1,650 7 Other 205 56 Deferred tax assets 2,345 554 Valuation allowance (6) (7) Net deferred tax assets after valuation allowance 2,339 547 Deferred tax liabilities: Derivative equity warrant assets (80) (82) Net unrealized gains on cash flow hedge derivatives (17) (33) Loans and debt securities (1,773) — Non-marketable and other equity securities (128) (219) Premises and equipment (54) (41) Right-of-use asset and deferred rent assets (89) (81) Goodwill and intangibles (24) (24) Merger-related fair value adjustments (15) (28) Other (6) (15) Deferred tax liabilities (2,186) (523) Net deferred tax assets (liabilities) $ 153 $ 24 Net Deferred Tax Assets At December 31, 2022, total U.S. federal net operating loss carryforwards were $6.4 billion, state net operating loss carryforwards were $4.5 billion, foreign net operating loss carryforwards were $22 million, foreign tax credit carryforwards were $43 million and state general business tax credit carryforwards were $16 million. The U.S. federal net operating loss carryforwards have an unlimited carryforward, the state net operating loss carryforwards expire at various dates beginning 2027, foreign net operating loss carryforwards expire at various dates beginning 2028, foreign tax credit carryforwards expire at various dates beginning 2029 and the state general business tax credit carryforwards expire at various dates beginning 2028. Currently, we believe that it is more likely than not that the benefit from the foreign net operating loss carryforwards, which are associated with our Canada operations, will not be realized in the near term due to uncertainties in the timing of future profitability in the course of business. In recognition of this, we have a valuation allowance of $6 million on the deferred tax assets related to our Canadian net operating loss carryforwards as of December 31, 2022. We believe it is more likely than not that the remaining deferred tax assets will be realized against future taxable income. Therefore, no valuation allowance was provided for the remaining deferred tax assets. We are subject to income tax and non-income based taxes by the U.S. federal tax authorities as well as various state and foreign tax authorities. The U.S. and the state of California are major tax filing jurisdictions. We are subject to examination by the IRS and tax authorities in various state, local and foreign tax jurisdictions. For California, tax years 2013-2014 are under appeals with the Office of Tax Appeals, and tax years 2015-2016 are under examination. Our U.S. federal tax returns remain open to examination for 2019 and subsequent tax years. California tax returns remain open to examination for 2018 and subsequent tax years. At December 31, 2022, our unrecognized tax benefit was $37 million, the recognition of which would reduce our income tax expense by $29 million. We are unable to estimate the unrecognized tax benefit that will materially change in the next 12 months. We recognize interest and penalties related to income tax matters as part of income before income taxes. Interest and penalties were not material for the years ended December 31, 2022, December 31, 2021 and December 31, 2020. A summary of changes in our unrecognized tax benefit (including interest and penalties) for 2022, 2021 and 2020 is as follows: (Dollars in millions) Reconciliation of Unrecognized Tax Benefit Interest and Penalties Total Balance at December 31, 2019 $ 13 $ 1 $ 14 Additions for tax positions for current year 5 — 5 Additions for tax positions for prior years 1 1 2 Reduction for tax positions for prior years (1) — (1) Lapse of the applicable statute of limitations (1) — (1) Reduction as a result of settlement (1) — (1) Balance at December 31, 2020 $ 16 $ 2 $ 18 Additions for tax positions for current year 21 — 21 Additions for tax positions for prior years — 1 1 Reduction for tax positions for prior years — — — Lapse of the applicable statute of limitations — — — Reduction as a result of settlement — — — Balance at December 31, 2021 $ 37 $ 3 $ 40 Additions for tax positions for current year 7 — 7 Additions for tax positions for prior years 1 2 3 Reduction for tax positions for prior years (4) — (4) Lapse of the applicable statute of limitations (2) (1) (3) Reduction as a result of settlement (2) — (2) Balance at December 31, 2022 $ 37 $ 4 $ 41

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Dec. 31, 2022
Retirement Benefits [Abstract]
Employee Compensation and Benefit Plans	Employee Benefit Plans Deferred Compensation Plan Under the Deferred Compensation Plan (the “DC Plan”), eligible employees may elect to defer up to 50 percent of their base salary and/or up to 100 percent of any eligible bonus payment earned during the plan year. Any amounts deferred under the DC Plan will be invested and administered by us (or such person we designate). We generally do not match employee deferrals to the DC Plan. From time to time, we may also offer deferred special retention incentives and employer contributions under this plan to key plan participants. The deferred incentives and employer contributions are eligible for investment in the DC Plan during the retention qualifying period or vesting period. Voluntary deferrals under the DC Plan were $13 million, $8 million and $6 million in 2022, 2021 and 2020, respectively. The DC Plan overall had investment losses of $9 million in 2022 and gains of $7 million and $8 million in 2021 and 2020, respectively. 401(k) and ESOP The 401(k) Plan and ESOP, collectively referred to as the “Plan”, is a combined 401(k) tax-deferred savings plan and employee stock ownership plan in which most regular U.S. employees are eligible to participate. Discretionary ESOP and profit-sharing contributions, based on our company performance, are made by us to all eligible individuals employed by us on the last day of the fiscal year. We may elect to contribute cash or our common stock (or a combination of cash and stock), in an amount not exceeding 10 percent of the employee's eligible pay earned in the fiscal year. The ESOP and/or profit-sharing contributions vest in equal annual increments over a participant's first five years of service (thereafter, all subsequent ESOP and/or profit-sharing contributions are fully vested). For 2022, 2021 and 2020, 12,449, 6,100 and 12,094 shares, respectively, were allocated to participants in the ESOP. Expenses incurred related to the Plan were $74 million, $54 million and $36 million as of December 31, 2022, December 31, 2021, and December 31, 2020, respectively.

Related Parties

Related Parties	12 Months Ended
Related Parties	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Parties	Related Parties We have no material related party transactions requiring disclosure. In the ordinary course of business, the Bank may extend credit to related parties, including executive officers, directors, principal shareholders and their related interests. Additionally, we also provide real estate secured loans to eligible employees through our EHOP.

Off-Balance Sheet Arrangements,

Off-Balance Sheet Arrangements, Guarantees and Other Commitments	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Off-Balance Sheet Arrangements, Guarantees and Other Commitments	Off-Balance Sheet Arrangements, Guarantees and Other Commitments In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our clients. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. Some of these instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract. Commitments to Extend Credit A commitment to extend credit is a formal agreement to lend funds to a client as long as there is no violation of any condition established in the agreement. Such commitments generally have fixed expiration dates, or other termination clauses, and usually require a fee paid by the client upon us issuing the commitment. The following table summarizes information related to our commitments to extend credit as of December 31, 2022, and December 31, 2021, respectively: December 31, (Dollars in millions) 2022 2021 Loan commitments (1) $ 58,891 $ 40,327 Standby letters of credit (2) 3,567 3,612 Commercial letters of credit (3) 83 77 Total unfunded credit commitments $ 62,541 $ 44,016 Allowance for unfunded credit commitments (4) 303 171 (1) Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements. (2) See below for additional information on our standby letters of credit. (3) Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature. (4) Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit. Our potential exposure to credit loss for commitments to extend credit, in the event of nonperformance by the other party to the financial instrument, is the contractual amount of the available unused loan commitment. We use the same credit approval and monitoring process in extending credit commitments as we do in making loans. The actual liquidity needs and the credit risk that we have experienced have historically been lower than the contractual amount of commitments to extend credit because a significant portion of these commitments expire without being drawn upon. We evaluate each potential borrower and the necessary collateral on an individual basis. The type of collateral varies, but may include real property, intellectual property, bank deposits or business and personal assets. The credit risk associated with these commitments is considered in the allowance for unfunded credit commitments. Standby Letters of Credit Standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. We provide two types of standby letters of credit: performance and financial standby letters of credit. Performance standby letters of credit are issued to guarantee the performance of a client to a third party when certain specified future events have occurred and are primarily used to support performance instruments such as bid bonds, performance bonds, lease obligations, repayment of loans and past due notices. Financial standby letters of credit are conditional commitments issued by us to guarantee the payment by a client to a third party (beneficiary) and are primarily used to support many types of domestic and international payments. These standby letters of credit have fixed expiration dates and generally require a fee to be paid by the client at the time we issue the commitment. The credit risk involved in issuing letters of credit is essentially the same as that involved with extending credit commitments to clients, and accordingly, we use a credit evaluation process and collateral requirements similar to those for credit commitments. When necessary, our standby letters of credit often are cash secured by our clients. The actual liquidity needs and the credit risk that we have experienced historically have been lower than the contractual amount of letters of credit issued because a significant portion of these conditional commitments expire without being drawn upon. The table below summarizes our standby letters of credit at December 31, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged. (Dollars in millions) Expires In One Year or Less Expires After One Year Total Amount Outstanding Maximum Amount of Future Payments Financial standby letters of credit $ 3,363 $ 115 $ 3,478 $ 3,478 Performance standby letters of credit 80 9 89 89 Total $ 3,443 $ 124 $ 3,567 $ 3,567 Deferred fees related to financial and performance standby letters of credit were $20 million at both December 31, 2022, and December 31, 2021. Commitments to Invest in Venture Capital and Private Equity Funds We make commitments to invest in venture capital and private equity funds, which generally make investments in privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to call most of the capital commitments over 5 to 7 years, and in certain cases, the funds may not call 100% of committed capital. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions and the nature and type of industry in which the privately held companies operate. The following table details our total capital commitments, unfunded capital commitments and our ownership percentage in each fund at December 31, 2022: (Dollars in millions) SVBFG Capital Commitments SVBFG Unfunded SVBFG Ownership of each Fund Redwood Evergreen Fund, LP $ 250 $ 108 100.0 % CP II, LP (1) 1 — 5.1 Capital Preferred Return Fund, LP 13 — 20.0 Growth Partners, LP 25 1 33.0 Strategic Investors Fund, LP 15 1 12.6 Strategic Investors Fund II, LP 15 1 8.6 Strategic Investors Fund III, LP 15 1 5.9 Strategic Investors Fund IV, LP 12 2 5.0 Strategic Investors Fund V funds 1 — Various Other venture capital and private equity fund investments (equity method accounting) 18 5 Various Debt funds (equity method accounting) 59 — Various Other fund investments (2) 275 45 Various Total $ 699 $ 164 (1) Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP. (2) Represents commitments to 143 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund. At December 31, 2022, we had $3 million of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the NCI).

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
Fair Value of Financial Instruments	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements Our AFS securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding the valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements. The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) Balance at December 31, 2022 Assets AFS securities: U.S. Treasury securities $ 16,135 $ — $ — $ — $ 16,135 U.S. agency debentures — 101 — — 101 Foreign government debt securities 1,088 — — — 1,088 Residential MBS: Agency-issued MBS — 6,603 — — 6,603 Agency-issued CMO—fixed rate — 678 — — 678 Agency-issued CMBS — 1,464 — — 1,464 Total AFS securities 17,223 8,846 — — 26,069 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 257 Other equity securities in public companies 31 1 — — 32 Total non-marketable and other equity securities (fair value 31 1 — — 289 Other assets: Derivative assets — 508 — (351) 157 Equity warrant assets — 6 377 — 383 Contingent conversion rights — — 12 — 12 Other assets 4 — — — 4 Total assets $ 17,258 $ 9,361 $ 389 $ (351) $ 26,914 Liabilities Derivative liabilities $ — $ 556 $ — $ (223) $ 333 Other liabilities 4 — — — 4 Total liabilities $ 4 $ 556 $ — $ (223) $ 337 (1) Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties. The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments Balance at December 31, 2021 Assets: AFS securities: U.S. Treasury securities $ 15,850 $ — $ — $ — $ 15,850 U.S. agency debentures — 196 — — 196 Foreign government debt securities 61 — — — 61 Residential MBS: Agency-issued MBS — 8,589 — — 8,589 Agency-issued CMO—fixed rate — 982 — — 982 Agency-issued CMBS — 1,543 — — 1,543 Total AFS securities 15,911 11,310 — — 27,221 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 338 Other equity securities in public companies 43 74 — — 117 Total non-marketable and other equity securities (fair value accounting) 43 74 — — 455 Other assets: Derivative assets (2) — 288 — (137) 151 Equity warrant assets — 8 269 — 277 Other assets 8 — — — 8 Total assets $ 15,962 $ 11,680 $ 269 $ (137) $ 28,112 Liabilities: Derivative liabilities (2) $ — $ 238 $ — $ (120) $ 118 Other liabilities 8 — — — 8 Total liabilities $ 8 $ 238 $ — $ (120) $ 126 The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for 2022, 2021 and 2020, respectively: (Dollars in millions) Beginning Total Net Gains (Losses) Included in Net Income Sales/Exits Issuances Transfers Out of Level 3 Ending Year ended December 31, 2022: Equity warrant assets (1) $ 269 $ 153 $ (71) $ 30 $ (4) $ 377 Contingent conversion rights (2) — (1) — 13 — 12 Year ended December 31, 2021: Equity warrant assets (1) 192 561 (502) 24 (6) 269 Year ended December 31, 2020: Equity warrant assets (1) 161 229 (215) 19 (2) 192 (1) Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income. The following table presents the amount of net unrealized gains and losses included in earnings (which is inclusive of NCI) attributable to Level 3 assets still held at December 31, 2022, and December 31, 2021, respectively: Year ended December 31, (Dollars in millions) 2022 2021 Other assets: Equity warrant assets (1) $ 111 $ 119 Contingent conversion rights (2) (1) — Total unrealized gains, net $ 110 $ 119 (1) Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income. The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of current sales restrictions to which these securities are subject, the actual sales of securities and the timing of such actual sales. The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at December 31, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value. (Dollars in millions) Fair Value Valuation Technique Significant Unobservable Inputs Input Range Weighted Average December 31, 2022: Equity warrant assets (private portfolio) $ 377 Black-Scholes option pricing model Volatility 23.2% - 48.7% 41.2 % Risk-Free interest rate 3.4 - 4.8 4.3 Marketability discount (2) 16.5 16.5 Remaining life assumption (3) 40.0 40.0 Contingent conversion rights (private portfolio) 12 Private company equity pricing (4) (4) (4) December 31, 2021: Equity warrant assets (public portfolio) $ 2 Black-Scholes option pricing model Volatility 27.8% - 55.0% 43.7 % Risk-Free interest rate 0.6 - 1.5 1.1 Sales restrictions discount (1) 10.0 - 20.0 10.7 Equity warrant assets (private portfolio) 267 Black-Scholes option pricing model Volatility 24.7 - 55.0 43.0 Risk-Free interest rate 0.06 - 1.4 0.8 Marketability discount (2) 20.1 20.1 Remaining life assumption (3) 40.0 40.0 (1) We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions which typically range from three (2) Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount. (3) We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At December 31, 2022, the weighted average contractual remaining term was 6.1 years, compared to our estimated remaining life of 2.4 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption. (4) In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company, and a weighted average or range of values of the unobservable inputs is not meaningful. During 2022, 2021 and 2020, we did not have any transfers between Level 3 and Level 1. All other transfers from Level 3 to Level 2 during 2022, 2021 and 2020 were due to the transfer of equity warrant assets from our private portfolio to our public portfolio (see our Level 3 reconciliation above). Financial Instruments not Carried at Fair Value The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at December 31, 2022 and December 31, 2021: Estimated Fair Value (Dollars in millions) Carrying Amount Total Level 1 Level 2 Level 3 December 31, 2022: Financial assets: Cash and cash equivalents $ 13,803 $ 13,803 $ 13,803 $ — $ — HTM securities 91,321 76,169 — 76,169 — Non-marketable securities not measured at net asset value 441 441 — — 441 Non-marketable securities measured at net asset value 628 628 — — — Net Loans 73,614 74,602 — — 74,602 FHLB and FRB stock 720 720 — — 720 Financial liabilities: Short-term borrowings 13,565 13,565 — 13,565 — Non-maturity deposits (1) 166,416 166,416 166,416 — — Time deposits 6,693 6,479 — 6,479 — FHLB Advances 2,000 2,000 — 2,000 — 3.50% Senior Notes due 2025 349 337 — 337 — 3.125% Senior Notes due 2030 496 412 — 412 — 1.800% Senior Notes due 2031 495 364 — 364 — 2.100% Senior Notes due 2028 497 417 — 417 — 1.800% Senior Notes due 2026 646 570 — 570 — 4.345% Senior Fixed Rate/Floating Rate Notes due 2028 348 331 — 331 — 4.570% Senior Fixed Rate/Floating Rate Notes due 2033 448 397 — 397 — Junior subordinated debentures 91 96 — 96 — Off-balance sheet financial assets: Commitments to extend credit — 52 — — 52 December 31, 2021: Financial assets: Cash and cash equivalents $ 14,586 $ 14,586 $ 14,586 $ — $ — HTM securities 98,195 97,227 — 97,227 — Non-marketable securities not measured at net asset value 424 424 — — 424 Non-marketable securities measured at net asset value 710 710 — — — Net loans 65,854 67,335 — — 67,335 FHLB and FRB stock 107 107 — — 107 Financial liabilities: Short-term borrowings 71 71 — 71 — Non-maturity deposits (1) 187,464 187,464 187,464 — — Time deposits 1,739 1,728 — 1,728 — 3.50% Senior Notes 349 370 — 370 — 3.125% senior Notes 496 526 — 526 — 1.800% Senior Notes due 2031 494 474 — 474 — 2.100% Senior Notes due 2028 496 501 — 501 — 1.800% Senior Notes due 2026 645 649 — 649 — Junior subordinated debentures 90 92 — 92 — Off-balance sheet financial assets: Commitments to extend credit — 47 — — 47 (1) Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits. Investments in Entities that Calculate Net Asset Value Per Share Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed. Alternatively, we expect distributions, if any, to be received primarily through IPO and M&A activity of the underlying assets of the fund. Subject to applicable requirements under the Volcker Rule, we do not have any plans to sell any of these fund investments. If we decide to sell these investments in the future, the investee fund’s management must approve the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30 th for our December 31 st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of December 31, 2022: (Dollars in millions) Carrying Amount Fair Value Unfunded Commitments Non-marketable securities (fair value accounting): Venture capital and private equity fund investments (1) $ 257 $ 257 $ 18 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (2) 605 605 9 Debt funds (2) 5 5 — Other investments (2) 18 18 1 Total $ 885 $ 885 $ 28 (1) Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $40 million and $2 million, respectively, attributable to NCI. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds. (2) Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

Regulatory Matters

Regulatory Matters	12 Months Ended
Regulatory Matters	Dec. 31, 2022
Banking and Thrift, Other Disclosure [Abstract]
Regulatory Matters	Regulatory Matters SVB Financial and the Bank are subject to various regulatory capital adequacy requirements administered by the Federal Reserve Board and the DFPI. The Federal Deposit Insurance Corporation Improvement Act of 1991 additionally requires that the federal regulatory agencies adopt regulations defining five capital categories for banks: well-capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized. We are also subject to a comprehensive capital framework for U.S. banking organizations established by the federal banking agencies (the “Capital Rules”), which implement the Basel III regulatory capital reforms and changes required by the Dodd-Frank Act. There are three categories of capital under the Capital Rules: CET 1, additional Tier 1 and Tier 2. Pursuant to the Capital Rules, the minimum capital ratios applicable to SVB Financial and the Bank are as follows: • 4.5% CET 1 capital to risk-weighted assets; • 6.0% Tier 1 capital (CET 1 plus Additional Tier 1 capital) to risk-weighted assets; • 8.0% Total capital (Tier 1 plus Tier 2 capital) to risk-weighted assets; and • 4.0% Tier 1 capital to average consolidated assets (the “leverage ratio”). We must also meet a 2.5% “buffer” of CET 1 capital to avoid constraints on capital distributions, such as dividends and equity repurchases and certain bonus compensation for executive officers. The severity of the constraints would depend on the amount of the shortfall and the banking organization’s “eligible retained income”. As of December 31, 2022, both SVB Financial and the Bank exceeded the required ratios under the Capital Rules and were considered “well-capitalized” for regulatory purposes under existing capital guidelines as well. The following table presents the capital ratios for the Company and the Bank under federal regulatory guidelines, compared to the minimum regulatory capital requirements, as of December 31, 2022, and December 31, 2021: Capital Ratios Capital Amounts (Dollars in millions) Actual Required Minimum (1) Well Capitalized Minimum Actual Required Minimum (1) Well Capitalized Minimum December 31, 2022: CET1 risk-based capital: SVB Financial 12.05 % 7.0 % N/A $ 13,697 $ 7,954 N/A Bank 15.26 7.0 6.5 16,995 7,795 $ 7,238 Tier 1 risk-based capital: SVB Financial 15.40 8.5 6.0 17,504 9,658 6,818 Bank 15.26 8.5 8.0 16,995 9,465 8,908 Total risk-based capital: SVB Financial 16.18 10.5 10.0 18,380 11,931 11,363 Bank 16.05 10.5 10.0 17,871 11,692 11,135 Tier 1 leverage: SVB Financial 8.11 4.0 N/A 17,504 8,630 N/A Bank 7.96 4.0 5.0 16,995 8,537 10,672 December 31, 2021: CET1 risk-based capital: SVB Financial 12.09 % 7.0 % N/A $ 12,186 $ 7,057 N/A Bank 14.89 7.0 6.5 14,622 6,875 $ 6,384 Tier 1 risk-based capital: SVB Financial 16.08 8.5 6.0 16,206 8,569 6,049 Bank 14.89 8.5 8.0 14,622 8,348 7,857 Total risk-based capital: SVB Financial 16.58 10.5 10.0 16,712 10,585 10,081 Bank 15.40 10.5 10.0 15,129 10,313 9,821 Tier 1 leverage: SVB Financial 7.93 4.0 N/A 16,206 8,175 N/A Bank 7.24 4.0 5.0 14,622 8,075 10,094 N/A "Well-Capitalized Minimum" CET1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies. (1) The percentages represent the minimum capital ratios plus, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.

Segment Reporting

Segment Reporting	12 Months Ended
Segment Reporting	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting We have four reportable segments for management reporting purposes: Silicon Valley Bank, SVB Private, SVB Capital and SVB Securities. The results of our reportable and operating segments are based on our internal management reporting process. We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reporting segments. During the quarter ended March 31, 2022, we reevaluated our segments. Based on this reevaluation, the Premium Wine reporting division was moved from Silicon Valley Bank to the SVB Private segment. These changes were made to reflect the manner in which the Company is organized for purposes of making operating decisions and assessing performance. For the year ended December 31, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been recast to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reclassification of historical segment information has no effect on the Company's previously reported consolidated balance sheets, statements of income, or cash flows, and the change did not have any impact on the determination of the reporting units used to assess impairment under ASC 350, Intangibles - Goodwill and Other . Our Silicon Valley Bank and SVB Private segments' primary source of revenue is from net interest income, which is primarily the difference between interest earned on loans, net of FTP and interest paid on deposits, net of FTP. Accordingly, these segments are reported using net interest income, net of FTP. FTP is an internal measurement framework designed to assess the financial impact of a financial institution’s sources and uses of funds. It is the mechanism by which a funding credit is given for deposits raised, and a funding charge is made for funded loans. FTP is calculated at an instrument level based on account characteristics. We also evaluate performance based on provision for credit losses, noninterest income and noninterest expense, which are presented as components of segment operating profit or loss. In calculating each operating segment’s noninterest expense, we consider the direct costs incurred by the operating segment as well as certain allocated direct costs. As part of this review, we allocate certain corporate overhead costs to a corporate account. We do not allocate income tax expense, the provisions for unfunded credit commitments, or HTM securities (included in provision for credit losses) to our segments. Additionally, our management reporting model is predicated on average asset balances; therefore, period-end asset balances are not presented for segment reporting purposes. Changes in an individual client’s primary relationship designation have resulted, and in the future may result, in the inclusion of certain clients in different segments in different periods. Unlike financial reporting, which benefits from the comprehensive structure provided by GAAP, our internal management reporting process is highly subjective, as there is no comprehensive, authoritative guidance for management reporting. Our management reporting process measures the performance of our operating segments based on our internal operating structure, which is subject to change from time to time, and is not necessarily comparable with similar information for other financial services companies. For reporting purposes, SVB Financial Group has four operating segments for which we report our financial information: • Silicon Valley Bank is our commercial bank which offers products and services provided by the Bank and its subsidiaries to commercial clients in key innovation markets. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance and other services. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets. Our commercial bank consists of services provided to clients in the Healthcare and Technology industries, as well as private equity and venture capital firms, and includes clients from international operations in EMEA, Asia and Canada. • SVB Private is our private bank and wealth management segment of the Bank. SVB Private provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support as well as high net worth clients acquired from Boston Private and our premium wine clients. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, other secured and unsecured lending products and vineyard development loans, as well as planning-based financial strategies, wealth management, family office, financial planning, tax planning and trust services. In addition, we provide real estate secured loans to eligible employees through our EHOP. • SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and fund of funds that invest in other venture capital funds, as well as debt funds that provide lending and other financing solutions. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees. • SVB Securities is an investment bank focused on the innovation economy and operates as a wholly-owned subsidiary of SVB Financial Group. SVB Securities provides investment banking services across all major sub-sectors of Healthcare and Technology. Healthcare sub-sectors include Biopharma, Digital Health and HealthTech, Healthcare Services, Medical Devices and Tools and Diagnostics. Technology sub-sectors include Consumer Internet, Commerce Enablement and Marketing Software, Digital Infrastructure and Tech-Enabled Services, Education Technology, Enterprise Software, Industrial Technology and FinTech. SVB Securities focuses on four main product and service offerings: Capital Raising, M&A Advisory, Equity Research and Sales and Trading. The summary financial results of our operating segments are presented along with a reconciliation to our consolidated results. Our segment information for 2022, 2021 and 2020 is as follows: (Dollars in millions) Silicon Valley Bank (1) SVB Private SVB Capital (1) SVB Securities (1) Other Items (2) (3) Total Year ended December 31, 2022 Net interest income $ 4,118 $ 407 $ — $ 3 $ (43) $ 4,485 Provision for credit losses (277) (10) — — (133) (420) Noninterest income 1,107 96 (110) 505 130 1,728 Noninterest expense (4) (1,557) (361) (70) (603) (1,030) (3,621) Income (loss) before income tax expense (5) $ 3,391 $ 132 $ (180) $ (95) $ (1,076) $ 2,172 Total average loans, amortized cost $ 54,647 $ 14,934 $ — $ — $ 708 $ 70,289 Total average assets (6) (7) 175,221 16,637 942 936 22,367 216,103 Total average deposits 172,106 12,884 — — 771 185,761 Year ended December 31, 2021 Net interest income (8) $ 2,914 $ 226 $ — $ 1 $ 38 $ 3,179 Provision for credit losses (55) (14) — — (54) (123) Noninterest income 706 58 487 608 879 2,738 Noninterest expense (4) (8) (1,266) (223) (71) (561) (949) (3,070) Income (loss) before income tax expense (5) (8) $ 2,299 $ 47 $ 416 $ 48 $ (86) $ 2,724 Total average loans, amortized cost (8) $ 43,145 $ 9,986 $ — $ — $ 1,416 $ 54,547 Total average assets (6) (7) (8) 140,362 11,171 700 830 12,948 166,011 Total average deposits (8) 138,057 8,924 — — 966 147,947 Year ended December 31, 2020 Net interest income (8) $ 1,990 $ 112 $ — $ 1 $ 54 $ 2,157 Provision for credit losses (166) (21) — — (33) (220) Noninterest income 604 5 226 497 508 1,840 Noninterest expense (4) (8) (1,011) (55) (51) (379) (539) (2,035) Income (loss) before income tax expense (5) (8) $ 1,417 $ 41 $ 175 $ 119 $ (10) $ 1,742 Total average loans, amortized cost (8) $ 30,116 $ 5,298 $ — $ — $ 1,852 $ 37,266 Total average assets (6) (7) (8) 73,929 5,335 437 557 5,534 85,792 Total average deposits (8) 71,911 2,388 — — 717 75,016 (1) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of NII, noninterest income, noninterest expense and total average assets are shown net of NCI for all periods presented. NCI is included within "Other Items." (2) The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. NII consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses. (3) Noninterest income included in “Other Items” decreased $749M in 2022. The decrease is driven by lower warrant and investment gains. (4) The Silicon Valley Bank segment includes direct depreciation and amortization of $49 million, $34 million and $25 million for December 31, 2022, December 31, 2021, and December 31, 2020, respectively. (5) The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates. (6) Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP. (7) Included in the total average assets is goodwill of $174 million and $138 million for SVB Securities for the year ended December 31, 2022, and December 31, 2021, respectively, and $201 million and $87 million for SVB Private for the years ended December 31, 2022, and December 31, 2021. (8) For the years ended December 31, 2022, December 31, 2021, and December 31, 2020, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

Parent Company Only Condensed F

Parent Company Only Condensed Financial Information	12 Months Ended
Parent Company Only Condensed Financial Information	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Parent Company Only Condensed Financial Information	Parent Company Only Condensed Financial Information The condensed balance sheets of SVB Financial at December 31, 2022, and December 31, 2021, and the related condensed statements of income, comprehensive income and cash flows for December 31, 2022, December 31, 2021, and December 31, 2020, are presented below: Condensed Balance Sheets December 31, (Dollars in millions) 2022 2021 Assets: Cash and cash equivalents $ 2,258 $ 2,324 Investment securities 491 731 Loans, amortized cost 1 1 Lease right-of-use assets 102 82 Other assets 475 387 Investment in subsidiaries: Bank subsidiary 15,456 14,795 Nonbank subsidiaries 896 894 Total assets $ 19,679 $ 19,214 Liabilities and SVBFG stockholders’ equity: Long-term debt $ 3,370 $ 2,570 Lease liabilities 135 113 Other liabilities 170 295 Total liabilities $ 3,675 $ 2,978 SVBFG stockholders’ equity 16,004 16,236 Total liabilities and SVBFG stockholders’ equity $ 19,679 $ 19,214 Condensed Statements of Income Year ended December 31, (Dollars in millions) 2022 2021 2020 Interest income $ 1 $ 3 $ 3 Interest expense (91) (48) (22) Dividend income from bank subsidiary 294 — 50 Gains on equity warrant assets, net 146 554 227 Gains (losses) on investment securities, net (179) 197 158 Fund management fees and other noninterest income 54 68 62 General and administrative expenses (284) (298) (121) Income tax benefit (expense) 143 (212) (146) Income before net income of subsidiaries 84 264 211 Equity in undistributed net income of bank subsidiary 1,741 1,294 776 Equity in undistributed net income (loss) of nonbank subsidiaries (153) 275 221 Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Preferred stock dividends (163) (63) (17) Net income available to common stockholders $ 1,509 $ 1,770 $ 1,191 Condensed Statements of Comprehensive Income Year ended December 31, (Dollars in millions) 2022 2021 2020 Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Other comprehensive income (loss), net of tax: Foreign currency translation gains (losses) (37) (1) 12 Changes in unrealized holding gains (losses) on AFS securities (39) (3) — Changes in fair value on bank cash flow hedges, net of reclassification adjustments in bank net income (6) (46) 131 Equity in other comprehensive income (loss) of bank and nonbank subsidiaries (1,883) (341) 395 Other comprehensive income (loss), net of tax (1,965) (391) 538 Total comprehensive income $ (293) $ 1,442 $ 1,746 Condensed Statements of Cash Flows Year ended December 31, (Dollars in millions) 2022 2021 2020 Cash flows from operating activities: Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Adjustments to reconcile net income to net cash provided by (used for) operating activities: Gains on equity warrant assets, net (146) (554) (227) Gains (losses) on investment securities, net 179 (197) (158) Gains on derivatives, net — — (30) Distributions of earnings from investment securities 33 60 65 Net income of bank subsidiary (2,035) (1,294) (826) Net income (loss) on nonbank subsidiaries 153 (275) (221) Cash dividends from bank subsidiary 294 — 50 Amortization of share-based compensation 183 136 84 (Increase) decrease in other assets 35 (40) 17 Increase (decrease) in other liabilities (129) 58 99 Other, net 1 2 14 Net cash provided by (used for) operating activities 240 (271) 75 Cash flows from investing activities: Net decrease in investment securities from purchases, sales and maturities 49 533 123 Net decrease in loans — — 15 Increase in investment in bank subsidiary (773) (1,240) (69) Capital infusion in bank subsidiary — (5,750) (700) (Increase) decrease in investment in nonbank subsidiaries (192) 47 4 Business acquisitions — 1,081 (27) Net cash used for investing activities (916) (5,329) (654) Cash flows from financing activities: Proceeds from issuance long-term debt 795 1,636 495 Proceeds from the issuance of common stock, net (22) 2,374 31 Net proceeds from the issuance of preferred stock — 3,306 — Payment of preferred stock dividends (163) (63) (17) Common stock repurchase — — (60) Net cash provided by financing activities 610 7,253 449 Net increase (decrease) in cash and cash equivalents (66) 1,653 (130) Cash and cash equivalents at beginning of period 2,324 671 801 Cash and cash equivalents at end of period $ 2,258 $ 2,324 $ 671

Legal Matters

Legal Matters	12 Months Ended
Legal Matters	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Legal Matters	Legal Matters To the extent we believe any potential loss relating to such matters may have a material impact on our liquidity, consolidated financial position, results of operations, and/or our business as a whole and is reasonably possible but not probable, we aim to disclose information relating to such potential loss. Assessments of litigation and claims exposure are difficult because they involve inherently unpredictable factors including, but not limited to, the following: (i) whether the proceeding is in the early stages of litigation, (ii) whether damages are unspecified, unsupported, or uncertain, (iii) whether there is a potential for punitive or other pecuniary damages, (iv) whether the matter involves legal uncertainties, including novel issues of law, (v) whether the matter involves multiple parties and/or jurisdictions, (vi) whether discovery has not begun or is not complete, (vii) whether meaningful settlement discussions have commenced and (viii) whether the lawsuit involves class allegations. Assessments of class action litigation, which is generally more complex than other types of litigation, are particularly difficult, especially in the early stages of the proceeding when it is not known whether a class will be certified or how a potential class, if certified, will be defined. As a result, even if a loss is reasonably possible, the Company may be unable to estimate reasonably possible losses with respect to some matters. We also aim to disclose information relating to any material potential loss that is probable but not reasonably estimable. In such cases, where reasonably practicable, we aim to provide an estimate of loss or range of potential loss. No disclosures are generally made for any loss contingencies that are deemed to be remote. Silicon Valley Bank is among the lenders named as defendants in a complaint originally filed on September 27, 2016 by Unicom Systems, Inc. (“Unicom”) in Los Angeles County Superior Court. The lawsuit alleges breach of the syndicated 2015 Credit Agreement between Unicom and the defendants, breach of the implied covenant of good faith and fair dealing, and seeks monetary damages and declaratory relief. Pursuant to the Credit Agreement and California law, the matter has been referred to a duly appointed judicial referee for trial. The parties have engaged in extensive fact discovery, which is now complete, with expert witness depositions to follow in the next few months. Trial is currently scheduled to take place over a three week period in October and November 2023. The Company currently estimates that it is reasonably possible that it may experience a loss in relation to the Unicom matter. However, for various reasons including the current stage of the proceedings, the uncertainty regarding damage claims and certain of the other factors noted above, the Company is unable to estimate the reasonably possible loss or range of losses at this time. Based upon information available to us, our review of lawsuits and claims filed or pending against us to date and consultation with our outside legal counsel, we have not recognized a material accrual liability for any such matters, nor do we currently expect that these matters will result in a material liability to the Company. However, the outcome of litigation and other legal and regulatory matters is inherently uncertain, and it is possible that one or more of such matters currently pending or threatened could have an unanticipated material adverse effect on our liquidity, consolidated financial position, results of operations and/or our business as a whole, in the future.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Accounting Policies [Abstract]
Use of Estimates and Assumptions	Use of Estimates and Assumptions The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments and 5) income taxes.
Principles of Consolidation and Presentation	Principles of Consolidation and Presentation Our consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. We consolidate entities in which we have a controlling financial interest. Before we determine whether we have a controlling financial interest, we must evaluate whether the entity is a voting interest entity or a variable interest entity ("VIE"). VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support and, as a group, lack one of the following characteristics: (i) the power to direct the activities that most significantly impact the entity’s economic performance, (ii) the obligation to absorb the expected losses of the entity or (iii) the right to receive the expected returns of the entity. We hold a controlling financial interest in a VIE when we are the primary beneficiary. A primary beneficiary is the party that has both: (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses or receive benefits of a VIE that could potentially be significant to a VIE. Generally, the parties that make management and investment decisions, or parties that can unilaterally remove such decision-makers are deemed to have the power to direct the activities of a VIE. When assessing whether we have the obligation to absorb losses or the right to receive benefits from the VIE, we consider all of our economic interests in the VIE, including any fees and other compensation received for providing investment and management services if that compensation is not customary and commensurate with the services provided. Voting interest entities are entities that (i) have sufficient equity to finance their activities and (ii) provide the equity investors power to make significant decisions relating to the entity’s operations. For such entities, we have a controlling financial interest if we hold a majority of voting rights.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, cash balances due from banks, interest-earning deposits, Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities. For the consolidated statements of cash flows, we consider cash equivalents to be investments that are readily convertible to known amounts of cash, so near to their maturity that they present an insignificant risk of change in fair value due to changes in market interest rates, and purchased in conjunction with our cash management activities.
Available-for-Sale and Held-to-Maturity Securities	Available-for-Sale Securities and the Allowance for Credit Losses on Available-for-Sale Securities Our AFS securities portfolio is a fixed income investment portfolio that is managed to earn an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification and meeting our asset and liability management objectives. The accretion of discounts and amortization of premiums over the contractual terms of the underlying securities are included in interest income. We apply the retrospective method of amortization for discounts and premiums to prepayable AFS securities. When the estimated remaining lives of securities changes, the related premium or discount is adjusted with a corresponding cumulative charge or benefit to interest income. Sales of AFS securities use the specific identification method. AFS securities are recorded at fair value. Unrealized gains and losses on AFS securities, net of applicable taxes, are reported in AOCI, a separate component of SVBFG's stockholders' equity. Impairment losses on AFS securities are recognized through earnings when we intend to sell an AFS security, or it is more likely than not that we will be required to sell the security before recovery of its amortized cost. Additionally, we evaluate whether a credit loss exists for securities that we intend to hold. We consider all factors in determining whether a credit loss exists, including the period over which the debt security is expected to recover. A credit impairment is recognized through a valuation allowance against the security with an offset through earnings. The allowance is limited to the amount that its fair value is less than the amortized cost basis. Held-to-Maturity Securities and the Allowance for Credit Losses on Held-to-Maturity Securities Debt securities purchased with the positive intent and ability to hold to its maturity are classified as HTM securities and are recorded at amortized cost, net of any ACL. We apply the retrospective method of amortization for discounts and premiums to prepayable HTM securities. When the estimated remaining lives of securities changes, the related premium or discount is adjusted with a corresponding cumulative charge or benefit to interest income. We measure ECL on HTM securities on a collective basis by major security type and standard credit rating. Certain securities in our HTM securities portfolio are either explicitly or implicitly guaranteed by the U.S. government, are highly rated by major rating agencies and have a long history of no credit losses. With respect to these securities, we consider the risk of credit loss to be zero and, therefore, we do not record an ECL. The estimate of ECL on our HTM securities that are not guaranteed by the U.S. government considers historical credit loss information and severity of loss in the event of default and leverages external data adjusted for current conditions. A reasonable and supportable forecast period of one year is applied, with immediate reversion to long-term average historical loss rates when remaining contractual lives of securities exceed one year. We do not estimate ECL on AIR from HTM securities as AIR is reversed or written off when the full collection of the AIR related to a security becomes doubtful. AIR from HTM securities totaled $211 million at December 31, 2022, and $225 million at December 31, 2021, and is excluded from the amortized cost disclosures within our HTM security disclosures in Note 9—“Investment Securities” as it is included and reported separately within "Accrued interest receivable and other assets" in our consolidated balance sheets. ECL on HTM securities that do not share common risk characteristics with our collective portfolio are individually measured based on net realizable value, or the difference between the discounted value of the expected future cash flows and the recorded amortized cost basis of the security.
Non-Marketable and Other Securities	Non-Marketable and Other Equity Securities Non-marketable and other equity securities include investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised and investments in qualified affordable housing projects. A majority of these investments are managed through our SVB Capital funds business in funds of funds and direct venture funds. Our accounting for investments in non-marketable and
Fair Value Accounting	Fair Value AccountingOur consolidated managed funds qualify as investment companies and therefore report their investments at estimated fair value, with unrealized gains and losses reflected as gains on investment securities, net, a component of noninterest income. The portion of any investment gains or losses attributable to other limited partners is reflected as net income attributable to NCI and adjusts our net income to reflect its percentage ownership. Our consolidated managed funds of funds make investments in venture capital and private equity funds.Our direct investments in public portfolio companies are valued based on quoted market prices less a discount if the securities are subject to certain security-specific sale restrictions. Gains or losses resulting from changes in the net asset value are recorded as gains on investment securities, net, a component of noninterest income.
Other Investments without a Readily Determinable Fair Value	Other Investments without a Readily Determinable Fair Value Our direct investments in private companies do not have a readily determinable fair value. We measure these investments at cost less impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments from the same issuer. Such changes are recognized through earnings. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have certain security-specific sale restrictions or other features that indicate a discount to fair value is warranted. Our investments in unconsolidated funds where we do not have the ability to exercise significant influence over their operating and financial policies are valued using the net asset value as obtained from the general partners of the fund investments, because the funds do not have a readily determinable fair value. The general partners of these funds prepare their financial statements using guidance consistent with fair value accounting. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period. Gains or losses resulting from changes in the net asset value are recorded as gains on investment securities, net, a component of noninterest income.
Equity Method	Equity Method Our equity method non-marketable securities consist of investments in venture capital and private equity funds, privately-held companies, debt funds, renewable energy investments and joint ventures. Our equity method non-marketable securities and related accounting policies are described as follows: • Equity securities and investments in limited partnerships, such as preferred or common stock in privately-held companies in which we have the ability to exercise significant influence over the investees' operating and financial policies through voting interests, board involvement or other influence are accounted for under the equity method and • The Bank's joint venture bank in China (SPD-SVB), for which we have 50 percent ownership, is accounted for under the equity method. We recognize our proportionate share of the results of operations of these equity method investees in our results of operations, based on the most current financial information available from the investee. We may use the hypothetical liquidation at book value method for investments that involve complex equity structures where liquidation rights are not proportional to the underlying percentage ownership interests. We review our investments accounted for under the equity method at least quarterly for possible other-than-temporary impairment. Our review typically includes an analysis of facts and circumstances for each investment, the expectations of the investment's future cash flows and capital needs, variability of its business and the company's exit strategy. For our fund investments, we use the net asset value per share as provided by the general partners of the fund investments. We account for differences between our measurement date and the date of the fund investment's net asset value by using the most recent available financial information from the investee general partner, for example September 30th, for our December 31st consolidated financial statements. We adjust the value of our investments for any contributions paid, distributions received from the investment and known significant fund transactions or market events about which we are aware through information provided by the fund managers or from publicly available transaction data during the reporting period. We reduce our investment value when we consider declines in value to be other-than-temporary and recognize the estimated loss as a loss on investment securities, a component of noninterest income.
Proportional Amortization Method	Proportional Amortization Method In order to fulfill our responsibilities under the CRA, we invest as a limited partner in low income housing partnerships that operate qualified affordable housing projects and generate tax benefits, including federal low income housing tax credits, for investors. The partnerships are deemed to be VIEs because they do not have sufficient equity investment at risk and are structured with non-substantive voting rights. We are not the primary beneficiary of the VIEs and do not consolidate them. Our investments in low income housing partnerships are recorded in non-marketable and other equity securities within our investment securities portfolio on the consolidated balance sheet. As a practical expedient, we amortize the investment in proportion to the allocated tax benefits under the proportional amortization method of accounting and present such benefits net of investment amortization in income tax expense.
Loans	Loans are reported at amortized cost which consists of the principal amount outstanding, net of unearned loan fees. Unearned loan fees reflect unamortized deferred loan origination and commitment fees net of unamortized deferred loan origination costs. In addition to cash loan fees, we often obtain equity warrant assets that give us an option to purchase a position in a client company's stock in consideration for providing credit facilities. The grant date fair values of these equity warrant assets are deemed to be loan fees and are deferred as unearned income and recognized as an adjustment of loan yield through loan interest income. The net amount of unearned loan fees is amortized into loan interest income over the contractual terms of the underlying loans and commitments using the constant effective yield method, adjusted for actual loan prepayment experience, or the straight-line method, as applicable.
Allowance for Credit Losses: Loans	The allowance for credit losses for loans considers credit risk and is adjusted by a provision for ECL charged to expense and reduced by the charge-off of loan amounts, net of recoveries. Our allowance for credit losses is an estimate of expected losses inherent with the Company's existing loans at the balance sheet date. Determining the appropriateness of the allowance is complex and requires judgment by management about the effect of matters that are inherently uncertain. Loan Portfolio Segments and Classes of Financing Receivables The process to estimate the ECL on loans involves procedures to appropriately consider the unique characteristics of our loan portfolio. Our eight portfolio segments are determined by using the following risk dimensions: (i) underwriting methodology, (ii) industry niche and (iii) life stage. The eight portfolio segments are further disaggregated into eleven classes of financing receivables and represents the level at which credit risk is monitored. Credit quality is assessed and monitored by evaluating various attributes, and the results of those evaluations are utilized in underwriting new loans and in our process to estimate ECL. For further information refer to Note 9—“Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments.” The following provides additional information regarding our portfolio segments and classes of financing receivables: • Global Fund Banking (segment and class) – The vast majority of our GFB portfolio segment consists of capital call lines of credit, the repayment of which is dependent on the payment of capital calls by the underlying limited partner investors in funds managed by certain private equity and venture capital firms. • Investor Dependent (segment) – Loans are made primarily to technology and life science/healthcare companies. These borrowers typically have modest or negative cash flows and rarely have an established record of profitable operations. Repayment of these loans may be dependent upon receipt by borrowers of additional equity financing from venture capital firms or other investors, or in some cases, a successful sale to a third party or an IPO. This portfolio segment is further disaggregated into two classes of financing receivables: ◦ Early-Stage (class) – Loans to pre-revenue, development-stage companies and companies that are in the early phases of commercialization, with revenues of up to $5 million. ◦ Growth Stage (class) – Loans to growth-stage enterprises. Within growth-stage enterprises, we consider companies with revenues between $5 million and $15 million, or pre-revenue clinical-stage biotechnology companies, to be Mid Stage, and companies with revenues in excess of $15 million to be Later Stage. • Cash Flow Dependent and Innovation C&I (segment) – Loans are made primarily to technology and life science/healthcare companies that are not Investor Dependent, for example repayment is not dependent on additional equity financing, a successful sale or an IPO. This portfolio segment consists of two classes of financing receivables: ◦ Cash Flow Dependent – SLBO (class) – Loans are typically used to assist a select group of private equity sponsors with the acquisition of businesses, are larger in size and repayment is generally dependent upon the cash flows of the combined entities. Acquired companies are typically established, later-stage businesses of scale and characterized by reasonable levels of leverage with loan structures that include meaningful financial covenants. The sponsor’s equity contribution is often 50 percent or more of the acquisition price. ◦ Innovation C&I (class) – Other C&I loans in innovation sectors such as technology and life science/healthcare industries. These loans are dependent on either the borrower’s cash flows or balance sheet for repayment. Cash flow dependent loans require the borrower to maintain cash flow from operations that is sufficient to service all debt. Borrowers must demonstrate normalized cash flow in excess of all fixed charges associated with operating the business. Balance sheet dependent loans include asset-backed loans and are structured to require constant current asset coverage (e.g., cash, cash equivalents, accounts receivable and, to a much lesser extent, inventory) in an amount that exceeds the outstanding debt. The repayment of these arrangements is dependent on the financial condition, and payment ability, of third parties with whom our clients do business. • Private Bank (segment and class) – Loans to our Private Bank clients who are primarily private equity/venture capital professionals and executives in the innovation companies as well as high net worth clients acquired from Boston Private. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, personal capital call lines of credit, lines of credit against liquid assets and other secured and unsecured lending products. In addition, we provide owner occupied commercial mortgages to Private Bank clients and real estate secured loans to eligible employees through our EHOP. • CRE (segment and class) – Generally acquisition financing loans for commercial properties such as office buildings, retail properties, apartment buildings and industrial/warehouse space. • Other C&I (segment and class) – Loans that include working capital and revolving lines of credit, as well as term loans for equipment and fixed assets. These loans are primarily to clients that are not in the technology and life sciences/healthcare industries. Additionally, this portfolio segment contains commercial tax-exempt loans to not-for-profit private schools, colleges, public charter schools and other not-for-profit organizations. • Premium Wine and Other (segment) – This portfolio segment consists of two classes of financing receivables: ◦ Premium Wine (class) – Loans to wine producers, vineyards and wine industry or hospitality businesses across the Western United States. A large portion of these loans are secured by real estate collateral such as vineyards and wineries. ◦ Other (class) – Primarily construction and land loans for financing new developments as well as financing for improvements to existing buildings. These also include our community development loans made as part of our responsibilities under the CRA. • PPP (segment and class) – Combined loans issued through the PPP. These loans represent clients across all portfolio segments and are guaranteed by the SBA. We maintain a systematic process for the evaluation of individual loans and portfolio segments for inherent risk of estimated credit losses for loans. At the time of approval, each loan in our portfolio is assigned a credit risk rating. Credit risk ratings are assigned on a scale of 1 to 10, with 1 representing loans with a low risk of nonpayment, 9 representing loans with the highest risk of nonpayment and 10 representing loans which have been charged-off. The credit risk ratings for each loan are monitored and updated on an ongoing basis. This credit risk rating process includes, but is not limited to, consideration of such factors as payment status, the financial condition and operating performance of the borrower, borrower compliance with loan covenants, underlying collateral values and performance trends, the degree of access to additional capital, the presence of credit enhancements such as third party guarantees (where applicable), the degree to which the borrower is sensitive to external factors and the depth and experience of the borrower's management team. Our policies require a committee of senior management to review, at least quarterly, credit relationships with a credit risk rating of 5 through 9 that exceed specific dollar values Expected Credit Loss Measurement The methodology for estimating the amount of ECL reported in the ACL is the sum of two main components: (i) ECL assessed on a collective basis for pools of loans that share similar risk characteristics which includes a qualitative adjustment based on management’s assessment of the risks that may lead to a future loan loss experience different from our historical loan loss experience and (ii) ECL assessed for individual loans that do not share similar risk characteristics with other loans. We do not estimate ECL on AIR on loans as AIR is reversed or written off against interest income when the full collection of the AIR related to a loan becomes doubtful, which is when loans are placed on nonaccrual status. AIR on loans totaled $402 million at December 31, 2022, and $171 million at December 31, 2021, and is excluded from the amortized cost disclosures in Note 10—“Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments”, as it is included and reported separately within "Accrued interest receivable and other assets" in our consolidated balance sheets. While the evaluation process of our ACL on loans uses historical and other objective information, the classification of loans and the estimate of the ACL for loans rely on the judgment and experience of our management. A committee comprised of senior management evaluates the appropriateness of the ACL for loans, which includes review of loan portfolio segmentation, quantitative models, internal and external data inputs, economic forecasts, credit risk ratings and qualitative adjustments. Loans That Share Similar Risk Characteristics with Other Loans We derive an estimated ECL assumption from a non-discounted cash flow approach based on our portfolio segments discussed above. This approach incorporates a calculation of three predictive metrics: (i) PD, (ii) LGD and (iii) EAD, over the estimated life of the exposure. PD and LGD assumptions are developed based on quantitative models and inherent risk of credit loss, both of which involve significant judgment. Renewals and extensions within our control are not considered in the estimated contractual term of a loan. The quantitative models are based on historical credit loss experience, adjusted for probability-weighted economic scenarios. These scenarios are used to support a reasonable and supportable forecast period of approximately three years for all portfolio segments. To the extent the remaining contractual lives of loans in the portfolio extend beyond the reasonable and supportable period, we revert to historical averages using a method that will gradually trend towards the mean historical loss over the remaining contractual lives of loans, adjusted for prepayments. The macroeconomic scenarios and their weighting are reviewed on a quarterly basis. We also apply a qualitative factor adjustment to the results obtained through our quantitative ECL models to consider model imprecision, emerging risk assessments, trends and other subjective factors that may not be adequately represented in quantitative ECL models. These adjustments to historical loss information are for asset-specific risk characteristics, and also reflect our assessment of the extent that current conditions and reasonable and supportable forecasts differ from conditions that existed during the period over which historical information was evaluated. These adjustments are aggregated to become our qualitative allocation. Based on our qualitative assessment estimate of changing risks in the lending environment, the qualitative allocation may vary significantly from period to period and may include, but is not limited to, consideration of the following factors: • Changes in lending policies and procedures, including changes in underwriting standards and collection, charge-off and recovery practices not considered elsewhere in estimating credit losses; • Changes in international, national, regional and local economic and business conditions and developments that affect the collectability of the portfolio, including the condition of various market segments; • Changes in the nature and volume of the portfolio and in the terms of loans; • Changes in the experience, ability and depth of lending management and other relevant staff; • Changes in the volume and severity of past due loans, the volume of nonaccrual loans and the volume and severity of adversely classified or graded loans; • Changes in the quality of our loan review system; • Changes in the value of underlying collateral for collateral-dependent loans; • The existence and effect of any concentrations of credit, and changes in the level of such concentrations; • The effect of other external factors such as competition and legal and regulatory requirements on the level of estimated credit losses in our existing portfolio; and • The effect of limitations of available data, model imprecision and recent macro-economic factors that may not be reflected in the forecast information. Loans That Do Not Share Similar Risk Characteristics We monitor our loan pools to ensure all assets therein continue to share similar risk characteristics with other financial assets inside the pool. Changes in credit risk, borrower circumstances or the recognition of write-offs may indicate that a loan's risk profile has changed, and the asset should be removed from its current pool. For a loan that does not share risk characteristics with other loans, ECL is measured based on the net realizable value, that is, the difference between the discounted value of the expected future cash flows and the amortized cost basis of the loan. When a loan is collateral-dependent and the repayment is expected to be provided substantially through the operation or sale of the collateral, the ECL is measured as the difference between the amortized cost basis of the loan and the fair value of the collateral. The fair value of the collateral will be determined by the most recent appraisal, as adjusted to reflect a reasonable marketing period for the sale of the asset(s) and an estimate of reasonable selling expenses. Collateral-dependent loans will have independent appraisals completed at least annually.
Allowance for Unfunded Credit Commitments	Allowance for Credit Losses: Unfunded Credit Commitments We maintain a separate ACL for unfunded credit commitments, which is included in other liabilities, and the related ECL in our provision for credit losses. We estimate the amount of expected losses by using historical trends to calculate a probability of an unfunded credit commitment being funded and derive historical lifetime expected loss factors for each portfolio segment similar to our funded loan ECL. The collectively assessed ECL for unfunded credit commitments also includes the same qualitative allocations applied for our funded loan ECL. For unfunded credit commitments related to loans that do not share similar risk characteristics with other loans, where applicable, a separate estimate of ECL will be included in our total ACL on unfunded credit commitments. Loan commitments that are determined to be unconditionally cancellable by the Company do not require an ACL on unfunded credit commitments.
Uncollectible Loans and Write-offs	Uncollectible Loans and Write-offs Our charge-off policy applies to all loans, regardless of portfolio segment. Commercial loans are considered for a full or partial charge-off in the event that principal or interest is over 180 days past due and the loan lacks sufficient collateral and it is not in the process of collection. Consumer loans are considered for a full or partial charge-off in the event that principal or interest is over 120 days past due and the loan lacks sufficient collateral and it is not in the process of collection. We also consider writing off loans in the event of any of the following circumstances: 1) the loan, or a portion of the loan is deemed uncollectible due to: (i) the borrower's inability to make recurring payments, (ii) material changes in the borrower's financial condition, or (iii) the expected sale of all or a portion of the borrower's business is insufficient to repay the loan in full, or 2) the loan has been identified for charge-off by regulatory authorities.
Troubled Debt Restructurings	Troubled Debt Restructurings A TDR arises from the modification of a loan where we have granted a concession to the borrower related to the borrower's financial difficulties that we would not have otherwise considered for economic or legal reasons. These concessions may include: (i) deferral of payment for more than an insignificant period of time that does not include sufficient offsetting borrower concessions, (ii) interest rate reductions, (iii) extension of the maturity date outside of ordinary course extension, (iv) principal forgiveness or (v) reduction of accrued interest. We use the factors in ASC 310-40, Receivables, Troubled Debt Restructurings by Creditors, in analyzing when a borrower is experiencing financial difficulty, and when we have granted a concession, both of which must be present for a restructuring to meet the criteria of a TDR. If we determine that a TDR exists, we measure impairment based on the present value of expected future cash flows discounted at the loan's effective interest rate, except that as a practical expedient, we may also measure impairment based on a loan's observable market price, or the fair value of the collateral less selling costs if the loan is a collateral-dependent loan. In April 2020, we implemented three loan payment deferral programs targeted to assist borrowers who were the most impacted by the COVID-19 pandemic. These programs included relief for venture-backed, private bank and wine borrowers who met certain criteria. For loans modified under these programs, in accordance with the provisions of Section 4013 of the CARES Act, we elected to not apply TDR classifications to borrowers who were current as of December 31, 2019. In addition, for loans that did not meet the CARES Act criteria, we applied the guidance in an interagency statement issued by bank regulatory agencies. Using this guidance, we may find that borrowers are not experiencing financial difficulty that may
Nonaccrual Loans	Nonaccrual Loans Loans are generally placed on nonaccrual status when they become 90 days past due as to principal or interest payments (unless the principal and interest are well secured and in the process of collection); or when we have determined, based upon currently known information, that the timely collection of principal or interest is not probable. When a loan is placed on nonaccrual status, the accrued interest and fees are reversed against interest income and the loan is accounted for using the cost recovery method thereafter until qualifying for return to accrual status. For a loan to be returned to accrual status, all delinquent principal and interest must become current in accordance with the terms of the loan agreement and future collection of remaining principal and interest must be deemed probable. We apply a cost recovery method in which all cash received is applied to the loan principal until it has been collected. Under this approach, interest income is recognized after total cash flows received exceed the recorded investment at the date of initial nonaccrual. All of our nonaccrual loans have credit risk ratings of 8 or 9 and are classified under the nonperforming category.
Purchase Credit-Deteriorated Loans	Purchased Credit-Deteriorated Loans Loans acquired where there is evidence of more than insignificant credit deterioration since origination are classified as PCD. We consider various factors in connection with this determination, including past due or nonaccrual status, credit risk rating declines and any write downs recorded based on the collectability of the asset, among other factors. PCD loans are recorded at their purchase price plus an ECL estimated at the time of acquisition, which represents the amortized cost basis of the asset. The difference between this amortized cost basis and the par value of the loan is the non-credit discount or premium, which is amortized into interest income over the life of the loan. Subsequent increases and decreases in the ACL related to purchased loans is recorded as provision expense.
Premises and Equipment	Premises and Equipment Premises and equipment are reported at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets or the terms of the related leases, whichever is shorter. The estimated useful lives by asset classification are as follows: Leasehold improvements Lesser of lease term or asset life Furniture and equipment 3-7 years Computer software 3-7 years Computer hardware 3-5 years We capitalize the costs of computer software developed or obtained for internal use, including costs related to developed software, purchased software licenses and certain implementation costs. Premises and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. For property and equipment that is retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and the resulting gain or loss is included in noninterest expense in consolidated net income.
Lease Obligations	Lease Obligations We have entered into leases for real estate and equipment. At the inception of the lease, each lease is evaluated to determine whether the lease will be accounted for as an operating or finance lease. We had no finance lease obligations at December 31, 2022, and December 31, 2021. We have made an accounting policy election not to recognize right-of-use assets and lease liabilities that arise from short-term leases for any class of underlying asset. In addition to excluding short-term leases, we have implemented an accounting policy in which non-lease components are not separated from lease components in the measurement of ROU asset and lease liabilities for all lease contracts. ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. The Company reviews ROU assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. ROU assets are reviewed for recoverability at the lowest level in which there are identifiable cash flows (“asset group”). The carrying amount of an asset group is not considered recoverable if it exceeds the sum of the undiscounted cash flows expected to result from its use and eventual disposition. If the asset group is determined not to be recoverable, then an impairment charge is recognized in the amount by which the carrying amount of the asset group exceeds its fair value. The resulting impairment charge, if any, is allocated to the underlying assets on a pro rata basis using their relative carrying amounts.
Business Combinations	Business Combinations Business combinations are accounted for under the acquisition method of accounting. Acquired assets, including separately identifiable intangible assets, and assumed liabilities are recorded at their acquisition-date estimated fair values. The excess of the cost of acquisition over these fair values is recognized as goodwill. During the measurement period, which cannot exceed one year from the acquisition date, changes to estimated fair values are recognized as an adjustment to goodwill. Certain transaction costs are expensed as incurred.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill is not amortized and is subject, at a minimum, to an annual impairment assessment. We may decide to complete a qualitative assessment to determine whether it is more likely than not, that the fair value of a reporting unit is below its carrying amount. As part of this qualitative analysis, we consider macroeconomic factors that might impact the entity’s performance such as changes in interest rates, changes in industry-specific factors and Gross Domestic Product ("GDP"). We also consider the reporting unit's competitive environment, including potential regulatory impact, the political landscape and market pressure. Further, we evaluate entity-specific financial performance of the reporting unit, changes in management or staffing, changes in overall strategy and other factors. If we choose to bypass this qualitative assessment, or we determine it is more likely than not that the fair value of a reporting unit is below its carrying amount, a quantitative assessment will be completed. Should we be required to calculate the fair value of the reporting unit, we would generally apply a discounted cash flow analysis that uses forecasted performance estimates, and a discount rate leveraging a reporting unit specific capital asset pricing model, which in turn uses assumptions related to market performance and various macroeconomic and reporting unit specific risks. We will evaluate goodwill for impairment more frequently if circumstances indicate that the fair value of our reporting units is less than their carrying value, including goodwill.
Fair Value Measurements	Fair Value Measurements Our AFS securities, derivative instruments and certain equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our consolidated financial statements. Fair Value Measurement-Definition and Hierarchy Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows: Level 1 Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities and certain marketable securities accounted for under fair value accounting. Level 2 Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities: AFS Securities: Valuations for the AFS securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third-parties so that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. Prices received from independent brokers represent a reasonable estimate of the fair value and are validated through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark interest rates, generally U.S. Treasury securities. Agency-issued MBS: Agency-issued MBS are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark interest rates taking into consideration estimated loan prepayment speeds. Agency-issued CMO: Agency-issued CMO are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above. Agency-issued CMBS: Fair value measurements of these securities are based on spreads to benchmark interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans. Derivative assets and liabilities: Fair value measurements of these assets and liabilities are priced based on the following: • Foreign exchange forward and option contract assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions. • Interest rate derivative and interest rate swap assets and liabilities are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty. • Total return swaps are based upon the performance of the reference asset, the variable coupon rate and spread of the floating leg of the contract. Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions, which typically range from three Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Level 3 The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets: Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement. Contingent conversion rights (public portfolio): Fair value measurements of contingent conversion rights of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain conversion rights that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed. Contingent conversion rights (private portfolio): Fair value measurements are based on consideration of a range of factors including, but not limited to, actual and forecasted enterprise values, probability of conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
Fee-based Services Revenue Recognition	Fee-based Services Revenue Recognition Refer to Note 17—“Noninterest Income” for our fee-based services revenue recognition policies for our contracts with customers.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Our federal, state and foreign income tax provisions are based upon taxes payable for the current year, current year changes in deferred taxes related to temporary differences between the tax basis and financial statement balances of assets and liabilities and a reserve for uncertain tax positions. Deferred tax assets and liabilities are included in the consolidated financial statements at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. A valuation allowance is provided, when it is determined based upon available evidence, that it is more likely than not that some portion of the deferred tax asset will not be realized. We file a consolidated federal income tax return, and consolidated, combined, or separate state income tax returns as appropriate. Our foreign incorporated subsidiaries file tax returns in the applicable foreign jurisdictions. Interest and penalties related to unrecognized tax benefits are recorded in other noninterest expense, a component of consolidated net income. We use the deferral method of accounting on investments that generate investment tax credits. Under this method, the investment tax credits are recognized as a reduction to the related asset.
Share-Based Compensation	Share-Based CompensationGenerally, for our stock-based awards granted, stock-based compensation expense is amortized on a straight-line basis over the requisite service period, including consideration of vesting conditions and anticipated forfeitures. The service period is reduced for a select number of awards that provide for continued vesting upon retirement if any of the grantees are retirement eligible at the date of grant (or will become retirement eligible during the vesting period). The fair value of stock options is measured using the Black-Scholes option-pricing model, and the fair value for restricted stock awards and restricted stock units is based on the quoted price of our common stock on the date of grant.
Earnings Per Share	Earnings Per Share Basic earnings per common share is computed using the weighted average number of common stock shares outstanding during the period. Diluted earnings per common share is computed using the weighted average number of common stock shares and potential common shares outstanding during the period. Potential common shares include stock options, ESPP shares and restricted stock units. Potential common shares are excluded from the computation if the effect is antidilutive.
Derivative Financial Instruments	Derivative Financial Instruments All derivative instruments are recorded on the balance sheet at fair value. The accounting for changes in fair value of a derivative financial instrument depends on whether the derivative financial instrument is designated and qualifies as part of a hedging relationship and, if so, the nature of the hedging activity. Changes in fair value are recognized through earnings for derivatives that do not qualify for hedge accounting treatment, or that have not been designated in a hedging relationship. Cash Flow Hedges For derivative instruments that are designated and qualify as a cash flow hedge, changes in the fair value of the derivative are recorded in AOCI and recognized in earnings as the hedged item affects earnings. To qualify for hedge accounting, a derivative must be highly effective at reducing exposure to the hedged risk. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item. We assess hedge effectiveness on a quarterly basis to ensure all hedges remain highly effective to ensure hedge accounting can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge, any amounts remaining as gain or loss in AOCI are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. Fair Value Hedges For derivative instruments that are designated and qualify as a fair value hedge, both the changes in the fair value of the derivative and the portion of the fair value adjustments associated with the portfolio attributable to the hedged risk will be recognized into earnings as they occur. To qualify for hedge accounting, a derivative must be highly effective at reducing the hedged risk exposure. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item. We assess hedge effectiveness on a quarterly basis to ensure all hedges remain highly effective and hedge accounting can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge, any remaining fair value basis adjustments are allocated to the individual assets in the portfolio and amortized into earnings over a period consistent with the amortization of other discounts and premiums associated with the respective assets. Net Investment Hedges For derivative instruments that are designated and qualify as a net investment hedge, the gain or loss from hedge revaluation is recorded in AOCI in the line item "foreign currency translation (losses) gains, net of hedges." We reassess hedge effectiveness at least quarterly. If the hedging relationship no longer exists or no longer qualifies for hedge accounting, any amounts remaining as gains or losses in AOCI are not reclassified into earnings until the sale or liquidation of the associated foreign operation. Equity Warrant Assets In connection with negotiated credit facilities and certain other services, we may obtain equity warrant assets giving us the right to acquire stock in primarily private, venture-backed companies in the technology and life science/healthcare industries. We hold these assets for prospective investment gains. We do not use them to hedge any economic risks nor do we use other derivative instruments to hedge economic risks stemming from equity warrant assets. In general, equity warrant assets entitle us to buy a specific number of shares of stock at a specific price within a specific time period. Certain equity warrant assets contain contingent provisions, which adjust the underlying number of shares or purchase price upon the occurrence of specified future events. Substantially all our warrant agreements qualify as derivatives and are reported at fair value as a component of other assets, on our consolidated balance sheet. The grant date fair values of equity warrant assets received in connection with the issuance of a credit facility are deemed to be loan fees and recognized as an adjustment of loan yield through loan interest income. Similar to other loan fees, the yield adjustment related to grant date fair value of warrants is recognized over the life of that credit facility. Any changes in fair value after the grant date are recognized as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income. We value our equity warrant assets using a Black-Scholes option pricing model, which incorporates the following significant inputs: • An underlying asset value, which is estimated based on current information available in valuation reports, including any information regarding subsequent rounds of funding or performance of a company. • Stated strike price, which can be adjusted for certain warrants upon the occurrence of subsequent funding rounds or other future events. • Price volatility or risk associated with possible changes in the warrant price. The volatility assumption is based on historical price volatility of publicly traded companies within indices similar in nature to the underlying client companies issuing the warrant. The actual volatility input is based on the mean and median volatility for an individual public company within an index for the past 16 quarters, from which an average volatility was derived. • Actual data on terminations and exercises of our warrants are used as the basis for determining the expected remaining life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or IPOs and alternatively may be cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events may cause the expected remaining life assumption to be shorter than the contractual term of the warrants. • The risk-free interest rate is derived from the Treasury yield curve and is calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. • Other adjustments, including a marketability discount, are estimated based on management's judgment about the general industry environment. • Number of shares and contingencies associated with obtaining warrant positions such as the funding of associated loans. When a company in the portfolio completes an IPO, or is acquired, we may exercise these equity warrant assets for shares or cash. In the event of an exercise for common stock shares, the basis or value in the common stock shares is reclassified from other assets to investment securities on the balance sheet on the latter of the exercise date or corporate action date. The common stock of public companies is classified as non-marketable and other equity securities. Changes in the fair value of the common stock is recorded as gains or losses on investments securities, in noninterest income, a component of consolidated net income. We account for these securities without a readily determinable fair value based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments, with changes recorded as gains or losses on investment securities, in noninterest income, a component of consolidated net income. Foreign Exchange Forwards and Foreign Currency Option Contracts We enter into foreign exchange forward contracts and foreign currency option contracts with clients involved in international activities, either as the purchaser or seller, depending upon the clients' need. We also enter into an opposite-way forward or option contract with a correspondent bank to economically hedge client contracts to mitigate the fair value risk to us from fluctuations in currency rates. Settlement, credit and operational risks remain. We also enter into forward contracts with correspondent banks to economically hedge currency exposure risk related to certain foreign currency denominated assets and liabilities. These contracts are not designated as hedging instruments and are recorded at fair value in our consolidated balance sheets. The contracts generally have terms of one year or less, although we may have contracts extending for up to five years. Generally, we have not experienced nonperformance on these contracts, have not incurred credit losses and anticipate performance by all counterparties to such agreements. Changes in the fair value of these contracts are recognized in consolidated net income under other noninterest income, a component of noninterest income. Period-end gross positive fair values are recorded in other assets and gross negative fair values are recorded in other liabilities. Interest Rate Contracts
Changes in Accounting Pronouncements	Changes in Accounting Principles During 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging. Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 16 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections, with retrospective application to the earliest period presented.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Ownership Interests in Investments Held Under Fair Value Accounting	A summary of our ownership interests in such funds as of December 31, 2022, is presented in the following table: Limited partnership Company Direct and Indirect Ownership in Limited Partnership Managed funds of funds Strategic Investors Fund, LP 12.6 % Capital Preferred Return Fund, LP 20.0 Growth Partners, LP 33.0 Redwood Evergreen Fund, LP 100.0
Maximum Estimated Useful Lives by Asset Classification	The estimated useful lives by asset classification are as follows: Leasehold improvements Lesser of lease term or asset life Furniture and equipment 3-7 years Computer software 3-7 years Computer hardware 3-5 years

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
Business Combination (Tables)	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The following table summarizes the allocation of the purchase price to the net assets of Boston Private as of July 1, 2021: (Dollars in millions) July 1, 2021 Cash paid $ 174 Share-based consideration 1,050 Replacement equity awards 10 Total purchase consideration $ 1,234 Fair value of net assets acquired 1,033 Goodwill $ 201
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the estimated fair value of assets acquired and liabilities assumed upon the finalization of the purchase: (Dollars in million) July 1, 2021 Assets acquired: Cash and cash equivalents $ 1,290 Investment securities 1,429 Loans 7,217 Premises and equipment 39 Intangible assets 104 Right-of-use assets 107 Other assets 284 Total assets acquired 10,470 Liabilities assumed: Deposits 8,983 Borrowings 132 Lease liabilities 103 Other liabilities 219 Total liabilities assumed 9,437 Fair value of net assets acquired $ 1,033
Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination	The following table summarizes the fair value and estimated useful lives of the other intangible assets at the date of acquisition: (Dollars in millions) Estimated Fair Value Weighted Average Estimated Useful Life - in Years Other intangible assets: Customer relationships $ 85 20 Other 19 6 Total other intangible assets $ 104
Schedule of Credit Deteriorated Loans Acquired As Part of Business Combination	The following table provides a summary of these PCD loans at acquisition: (Dollars in millions) July 1, 2021 Par value of PCD loans $ 1,368 PCD ACL at acquisition (22) Non-credit premium on PCD loans 43 Purchase price of PCD loans $ 1,389

Stockholders' Equity and EPS (T

Stockholders' Equity and EPS (Tables)	12 Months Ended
Stockholders' Equity and EPS (Tables)	Dec. 31, 2022
Equity and Earnings Per Share [Abstract]
Reclassification out of Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Income The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income for 2022, 2021 and 2020 : Year ended December 31, (Dollars in millions) Income Statement Location 2022 2021 2020 Reclassification adjustment for (gains) losses on AFS securities included in net income Gains (losses) on investment securities, net $ (21) $ (31) $ (61) Related tax expense (benefit) Income tax expense 6 9 17 Reclassification adjustment for (gains) losses on cash flow hedges included in net income Net interest income (56) (63) (50) Related tax expense (benefit) Income tax expense 16 17 14 Total reclassification adjustment for (gains) losses included in net income, net of tax $ (55) $ (68) $ (80)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income	The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for 2022, 2021 and 2020. Refer to Note 16—“Derivative Financial Instruments” for additional information regarding the termination of our cash flow hedges during the quarter ended March 31, 2020. Over the next 12 months, we expect that approximately $41 million in AOCI at December 31, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income. Year ended December 31, (Dollars in millions) 2022 2021 2020 Balance, beginning of period, net of tax $ 83 $ 130 $ (2) Net (decrease) increase in fair value, net of tax — (1) 168 Net realized (gain) loss reclassified to net income, net of tax (40) (46) (36) Balance, end of period, net of tax $ 43 $ 83 $ 130
Reconciliation of Basic EPS to Diluted EPS	The following is a reconciliation of basic EPS to diluted EPS for 2022, 2021 and 2020: Year ended December 31, (Dollars in millions except per share amounts, shares in thousands) 2022 2021 2020 Numerator: Net income available to common stockholders $ 1,509 $ 1,770 $ 1,191 Denominator: Weighted average common shares outstanding—basic 58,987 55,763 51,685 Weighted average effect of dilutive securities: Stock options and ESPP 168 283 151 Restricted stock units 361 592 248 Weighted average common shares outstanding—diluted 59,516 56,638 52,084 Earnings per common share: Basic $ 25.58 $ 31.74 $ 23.05 Diluted $ 25.35 $ 31.25 $ 22.87
Weighted Average Common Shares Excluded from Diluted EPS Calculation	The following table summarizes the weighted average common shares excluded from the diluted EPS calculation due to the antidilutive effect for 2022, 2021 and 2020: Year ended December 31, (Shares in thousands) 2022 2021 2020 Stock options 117 37 279 Restricted stock units 390 2 10 Total 507 39 289
Schedule of Preferred Stock	The following table summarizes our preferred stock at December 31, 2022: Series Description Amount outstanding (in millions) Carrying value Shares issued and outstanding Par Value Ownership interest per depositary share Liquidation preference per depositary share 2022 dividends paid per depositary share Series A 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock $ 350 $ 340 350,000 $ 0.001 1/40th $ 25 $ 1.31 Series B 4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 750 739 7,500 0.001 1/100th 1,000 41.00 Series C 4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 985 10,000 0.001 1/100th 1,000 40.00 Series D 4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 989 10,000 0.001 1/100th 1,000 44.51 Series E 4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 600 593 6,000 0.001 1/100th 1,000 49.22

Share-Based Compensation (Table

Share-Based Compensation (Tables)	12 Months Ended
Share-Based Compensation (Tables)	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share Based Compensation and Related Benefits	In 2022, 2021 and 2020, we recorded share-based compensation and related benefits as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Share-based compensation expense $ 183 $ 136 $ 84 Income tax benefit related to share-based compensation expense (39) (35) (20) Capitalized compensation costs 3 1 1
Unrecognized Share Based Compensation Expense	As of December 31, 2022, unrecognized share-based compensation expense was as follows: (Dollars in millions) Unrecognized Weighted Average Expected Recognition Period - in Years Stock options $ 13 2.39 years Restricted stock awards/units 235 2.68 years Total unrecognized share-based compensation expense $ 248
Weighted Average Assumptions and Fair Values Used for Employee Stock Options and Restricted Stock Units	The following weighted average assumptions and fair values were used for our employee stock options and restricted stock units: Equity Incentive Plan Awards 2022 2021 2020 Weighted average expected term of options - in years 4.7 4.7 4.6 Weighted average expected volatility of the Company's underlying common stock 46.1 % 43.5 % 41.9 % Risk-free interest rate 3.06 0.85 0.37 Expected dividend yield — — — Weighted average grant date fair value - stock options $ 202.81 $ 224.63 $ 66.44 Weighted average grant date fair value - restricted stock units 463.10 554.32 199.51
Weighted Average Assumptions and Fair Values Used for ESPP	The following weighted average assumptions and fair values were used for our ESPP: ESPP 2022 2021 2020 Expected term in years 0.5 0.5 0.5 Weighted average expected volatility of the Company's underlying common stock 43.5 % 36.2 % 51.9 % Risk-free interest rate 1.04 0.08 1.12 Expected dividend yield — — — Weighted average grant date fair value $ 156.24 $ 108.83 $ 69.54
Stock Option Information Related to Equity Incentive Plan	The table below provides stock option information for the year ended December 31, 2022: Options Weighted Weighted Average Remaining Contractual Life - in Years Aggregate Intrinsic Value of Outstanding at December 31, 2021 475,626 $ 260.77 Granted 77,888 477.80 Exercised (40,326) 184.75 Forfeited (23,546) 385.40 Outstanding at December 31, 2022 489,642 295.48 3.80 $ 11,968,937 Vested and expected to vest at December 31, 2022 480,972 293.91 3.77 11,851,281 Exercisable at December 31, 2022 300,872 238.23 2.84 9,528,647
Information for Restricted Stock Units under Equity Incentive Plan	The table below provides information for restricted stock units for the year ended December 31, 2022: Shares Weighted Average Grant Date Fair Value Nonvested at December 31, 2021 1,016,146 $ 328.87 Granted 548,856 463.10 Vested (390,593) 279.34 Forfeited (91,957) 379.94 Nonvested at December 31, 2022 1,082,452 405.62
Summary of Information Regarding Stock Option and Restricted Stock Activity	The following table summarizes information regarding stock option and restricted stock unit activity during 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Total intrinsic value of stock options exercised $ 14 $ 68 $ 25 Total fair value of stock options vested 14 7 6 Total intrinsic value of restricted stock vested 205 164 56 Total fair value of restricted stock vested 126 68 47

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	12 Months Ended
Variable Interest Entities (Tables)	Dec. 31, 2022
Investments In Variable Interest Entities [Abstract]
Schedule of Variable Interest Entities	The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of December 31, 2022, and December 31, 2021: (Dollars in millions) Consolidated VIEs Unconsolidated VIEs Maximum Exposure to Loss in Unconsolidated VIEs December 31, 2022: Assets: Cash and cash equivalents $ 20 $ — $ — Non-marketable and other equity securities (1) 735 1,457 1,457 AIR and other assets (2) 8 6 — Total assets $ 763 $ 1,463 $ 1,457 Liabilities: Other liabilities (1) $ 31 $ 759 $ — Long term debt (2) — 91 — Total liabilities $ 31 $ 850 $ — December 31, 2021: Assets: Cash and cash equivalents $ 13 $ — $ — Non-marketable and other equity securities (1) 768 1,233 1,233 AIR and other assets (2) 31 6 — Total assets $ 812 $ 1,239 $ 1,233 Liabilities: Other liabilities (1) $ 18 $ 482 $ — Long term debt (2) — 90 — Total liabilities $ 18 $ 572 $ — (1) Included in our unconsolidated non-marketable and other equity securities portfolio at December 31, 2022, and December 31, 2021, are investments in qualified affordable housing projects of $1.3 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $754 million and $482 million, respectively. (2) Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million, respectively, at December 31, 2022, and $6 million and $90 million, respectfully, at December 31, 2021.

Reserves on Deposit with the _2

Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock (Tables)	12 Months Ended
	Dec. 31, 2022
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]
Shares Held at Federal Reserve Bank and Federal Home Loan Bank	The table below provides information on the shares held at the FHLB and FRB for the years ended and as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 FHLB stock holdings $ 418 $ 26 FRB stock holdings 302 81

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	12 Months Ended
Cash and Cash Equivalents (Tables)	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	The following table details our cash and cash equivalents as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Cash and due from banks $ 1,293 $ 2,168 Interest-bearing deposits with the FRB 7,823 5,686 Interest-bearing deposits with other institutions 3,965 5,773 Securities purchased under agreements to resell (1) 722 607 Other short-term investment securities — 352 Total cash and cash equivalents $ 13,803 $ 14,586
Securities Purchased Under Agreements to Resell	Additional information regarding our securities purchased under agreements to resell for 2022 and 2021 are as follows: Year ended December 31, (Dollars in millions) 2022 2021 Average securities purchased under agreements to resell $ 290 $ 286 Maximum amount outstanding at any month-end during the year 721 762

Investment Securities (Tables)

Investment Securities (Tables)	12 Months Ended
Investment Securities (Tables)	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Major Components of Investment Securities Portfolio	The major components of our AFS investment securities portfolio at December 31, 2022, and 2021 are as follows: December 31, 2022 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 17,206 $ — $ (1,071) $ 16,135 U.S. agency debentures 120 — (19) 101 Foreign government debt securities 1,209 — (121) 1,088 Residential MBS: Agency-issued MBS 7,701 — (1,098) 6,603 Agency-issued CMO—fixed rate 762 — (84) 678 Agency-issued CMBS 1,604 — (140) 1,464 Total AFS securities (1) $ 28,602 $ — $ (2,533) $ 26,069 (1) Securities pledged as collateral for securities sold under agreements to repurchase totaled $530 million. For additional information, see Note 15—“Short-Term Borrowings and Long-Term Debt." December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 15,799 $ 121 $ (70) $ 15,850 U.S. agency debentures 200 — (4) 196 Foreign government debt securities 61 — — 61 Residential MBS: Agency-issued MBS 8,786 13 (210) 8,589 Agency-issued CMO—fixed rate 988 3 (9) 982 Agency-issued CMBS 1,536 27 (20) 1,543 Total AFS securities (1) $ 27,370 $ 164 $ (313) $ 27,221
Schedule of Realized Gain (Loss)	The following table summarizes sale activity of AFS securities as recorded in the line item “Gains (losses) on investment securities, net," a component of noninterest income: Year ended December 31, (Dollars in millions) 2022 2021 2020 Sales proceeds $ 9,495 $ 1,591 $ 2,654 Net realized gains and losses: Gross realized gains 146 31 61 Gross realized losses (125) — — Net realized gains (losses) $ 21 $ 31 $ 61
Summary of Unrealized Losses on Available for Sale Securities	The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss position for less than 12 months, or 12 months or longer, as of December 31, 2022, and December 31, 2021: December 31, 2022 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities, at fair value: U.S. Treasury securities $ 11,946 $ (717) $ 4,189 $ (354) $ 16,135 $ (1,071) U.S. agency debentures — — 101 (19) 101 (19) Foreign government debt securities 1,088 (121) — — 1,088 (121) Residential MBS: Agency-issued MBS 1,744 (203) 4,859 (895) 6,603 (1,098) Agency-issued CMO —fixed rate 136 (11) 542 (73) 678 (84) Agency-issued CMBS 810 (57) 653 (83) 1,463 (140) Total AFS securities (1) $ 15,724 $ (1,109) $ 10,344 $ (1,424) $ 26,068 $ (2,533) (1) As of December 31, 2022, we identified a total of 810 investments that were in unrealized loss positions with 346 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of December 31, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of December 31, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of December 31, 2022. December 31, 2021 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 7,777 $ (70) $ — $ — $ 7,777 $ (70) U.S. agency debentures 196 (4) — — 196 (4) Residential MBS: Agency-issued MBS 8,280 (210) — — 8,280 (210) Agency-issued CMO —fixed rate 740 (9) — — 740 (9) Agency-issued CMBS 603 (11) 163 (9) 766 (20) Total AFS securities (1) $ 17,596 $ (304) $ 163 $ (9) $ 17,759 $ (313) (1) As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021.
Summary of Remaining Contractual Principal Maturities and Fully Taxable Equivalent Yields on Securities	The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of December 31, 2022, by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. December 31, 2022 (Dollars in millions) Total One Year After One After Five After U.S. Treasury securities $ 16,135 $ 983 $ 14,373 $ 779 $ — U.S. agency debentures 101 — 33 68 — Foreign government debt securities 1,088 101 52 935 — Residential MBS: Agency-issued MBS 6,603 — — 43 6,560 Agency-issued CMO—fixed rate 678 — — — 678 Agency-issued CMBS 1,464 — 326 1,138 — Total $ 26,069 $ 1,084 $ 14,784 $ 2,963 $ 7,238 The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of December 31, 2022. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30, years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments; however, we expect to collect substantially all of the recorded investment on these securities. December 31, 2022 Total One Year After One Year to After Five Years to After (Dollars in millions) Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value U.S. agency debentures $ 486 $ 434 $ 1 $ 1 $ 118 $ 111 $ 367 $ 322 $ — $ — Residential MBS: Agency-issued MBS 57,705 48,356 — — 25 24 1,066 994 56,614 47,338 Agency-issued CMO—fixed rate 10,461 8,576 — — 90 86 129 120 10,242 8,370 Agency-issued CMO—variable rate 79 77 — — — — — — 79 77 Agency-issued CMBS 14,471 11,977 39 38 153 141 966 810 13,313 10,988 Municipal bonds and notes 7,416 6,150 29 29 235 224 1,362 1,244 5,790 4,653 Corporate bonds 703 599 — — 115 103 588 496 — — Total $ 91,321 $ 76,169 $ 69 $ 68 $ 736 $ 689 $ 4,478 $ 3,986 $ 86,038 $ 71,426
Held-to-maturity Securities	The components of our HTM investment securities portfolio at December 31, 2022, and December 31, 2021, are as follows: December 31, 2022 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL (2) Net Carry Value HTM securities, at cost: U.S. agency debentures (1) $ 486 $ — $ (52) $ 434 $ — $ 486 Residential MBS: Agency-issued MBS 57,705 — (9,349) 48,356 — 57,705 Agency-issued CMO—fixed rate 10,461 — (1,885) 8,576 — 10,461 Agency-issued CMO—variable rate 79 — (2) 77 — 79 Agency-issued CMBS 14,471 — (2,494) 11,977 — 14,471 Municipal bonds and notes 7,417 2 (1,269) 6,150 1 7,416 Corporate bonds 708 — (109) 599 5 703 Total HTM securities $ 91,327 $ 2 $ (15,160) $ 76,169 $ 6 $ 91,321 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the SBA, an independent agency of the United States. (2) Refer to Note 2—“Summary of Significant Accounting Policies” for more information on our credit loss methodology. December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL (2) Net Carry Value HTM securities, at amortized cost: U.S. agency debentures (1) $ 609 $ 8 $ (2) $ 615 $ — $ 609 Residential MBS: Agency-issued MBS 64,439 124 (887) 63,676 — 64,439 Agency-issued CMO—fixed rate 10,226 9 (145) 10,090 — 10,226 Agency-issued CMO—variable rate 100 1 — 101 — 100 Agency-issued CMBS 14,959 39 (277) 14,721 — 14,959 Municipal bonds and notes 7,157 185 (27) 7,315 1 7,156 Corporate bonds 712 2 (5) 709 6 706 Total HTM securities $ 98,202 $ 368 $ (1,343) $ 97,227 $ 7 $ 98,195 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the SBA, an independent agency of the United States. (2) Refer to Note 2—“Summary of Significant Accounting Policies” for more information on our credit loss methodology.
Schedule of Held-to-maturity Securities by Credit Quality Indicator	The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Municipal bonds and notes: Aaa $ 4,263 $ 3,774 Aa1 1,843 2,031 Aa2 1,113 1,154 Aa3 171 172 A1 27 26 Total municipal bonds and notes $ 7,417 $ 7,157 Corporate bonds: Aaa $ 39 $ 39 Aa2 42 42 Aa3 127 105 A1 280 251 A2 209 264 A3 11 11 Total corporate bonds $ 708 $ 712
Schedule of Nonmarketable and Other Securities	The major components of our non-marketable and other equity securities portfolio at December 31, 2022, and December 31, 2021, are as follows: December 31, (Dollars in millions) 2022 2021 Non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments (1) $ 147 $ 130 Unconsolidated venture capital and private equity fund investments (2) 110 208 Other investments without a readily determinable fair value (3) 183 164 Other equity securities in public companies (fair value accounting) (4) 32 117 Non-marketable securities (equity method accounting) (5): Venture capital and private equity fund investments 605 671 Debt funds 5 5 Other investments 276 294 Investments in qualified affordable housing projects, net (6) 1,306 954 Total non-marketable and other equity securities $ 2,664 $ 2,543 (1) The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at December 31, 2022, and December 31, 2021, (fair value accounting): December 31, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Strategic Investors Fund, LP $ 2 12.6 % $ 2 12.6 % Capital Preferred Return Fund, LP 28 20.0 61 20.0 Growth Partners, LP 24 33.0 67 33.0 Redwood Evergreen Fund, LP 93 100.0 — — Total consolidated venture capital and private equity fund investments $ 147 $ 130 (2) The carrying value represents investments in 136 and 150 funds (primarily venture capital funds) at December 31, 2022, and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30 th for our December 31 st consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. (3) These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted. The following table shows the carrying amount of other investments without a readily determinable fair value at December 31, 2022, and the amounts recognized in earnings for the year ended December 31, 2022, and on a cumulative basis: (Dollars in millions) Year ended December 31, 2022 Cumulative Adjustments Measurement alternative: Carrying value at December 31, 2022 $ 183 Carrying value adjustments: Impairment $ (23) $ (24) Upward changes for observable prices — 52 Downward changes for observable prices (6) (11) (4) Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income. (5) The following table shows the carrying value and our ownership percentage of each investment at December 31, 2022, and December 31, 2021 (equity method accounting): December 31, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Venture capital and private equity fund investments: Strategic Investors Fund II, LP $ 2 8.6 % $ 3 8.6 % Strategic Investors Fund III, LP 12 5.9 25 5.9 Strategic Investors Fund IV, LP 21 5.0 36 5.0 Strategic Investors Fund V funds 58 Various 87 Various CP II, LP (i) 1 5.1 2 5.1 Other venture capital and private equity fund investments 511 Various 518 Various Total venture capital and private equity fund investments $ 605 $ 671 Debt funds: Gold Hill Capital 2008, LP (ii) $ 4 15.5 % $ 4 15.5 % Other debt funds 1 Various 1 Various Total debt funds $ 5 $ 5 Other investments: SPD Silicon Valley Bank Co., Ltd. $ 146 50.0 % $ 154 50.0 % Other investments 130 Various 140 Various Total other investments $ 276 $ 294 (i) Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP. (ii) Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent. (6) The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of "other liabilities" on our consolidated balance sheets at December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Investments in qualified affordable housing projects, net $ 1,306 $ 954 Other liabilities 754 482 The following table presents other information relating to our investments in qualified affordable housing projects for the years ended 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Tax credits and other tax benefits recognized $ 99 $ 77 $ 57 Amortization expense included in provision for income taxes (i) 80 64 44 (i) All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes.
Net Gains and Losses on Non-marketable and Other Equity Securities	The following table presents the net gains and losses on non-marketable and other equity securities in 2022, 2021 and 2020 as recorded in the line item “Gains (losses) on investment securities, net," a component of noninterest income: Year ended December 31, (Dollars in millions) 2022 2021 2020 Net gains (losses) on non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments $ (101) $ 71 $ 32 Unconsolidated venture capital and private equity fund investments (86) 75 60 Other investments without a readily determinable fair value (26) 75 — Other equity securities in public companies (fair value accounting) (52) 23 105 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (49) 474 162 Debt funds (1) 2 — Other investments 9 10 1 Total net gains (losses) on non-marketable and other equity securities $ (306) $ 730 $ 360 Less: realized net gains (losses) on sales of non-marketable and other equity securities (19) 85 24 Net gains (losses) on non-marketable and other equity securities still held $ (287) $ 645 $ 336 Year ended December 31, (Dollars in millions) 2022 2021 2020 Gains (losses) on non-marketable and other equity securities, net $ (306) $ 730 $ 360 Gains (losses) on sales of AFS debt securities, net 21 31 61 Total gains (losses) on investment securities, net $ (285) $ 761 $ 421

Loans and Allowance for Credi_2

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Receivables [Abstract]
Composition of Loans at Amortized Cost Basis Broken Out by Risk-Based Segment	The composition of loans at amortized cost basis broken out by class of financing receivable at December 31, 2022, and December 31, 2021, respectively, is presented in the following table: December 31, (Dollars in millions) 2022 2021 Global fund banking $ 41,269 $ 37,958 Investor dependent: Early stage 1,950 1,593 Growth stage 4,763 3,951 Total investor dependent 6,713 5,544 Cash flow dependent — SLBO 1,966 1,798 Innovation C&I 8,609 6,673 Private bank 10,477 8,743 CRE 2,583 2,670 Premium wine 1,158 985 Other C&I 1,019 1,257 Other 433 317 PPP 23 331 Total loans (1) (2) (3) $ 74,250 $ 66,276 ACL (636) (422) Net loans $ 73,614 $ 65,854 (1) Total loans at amortized cost is net of unearned income, deferred fees and costs and net unamortized premiums and discounts of $283 million and $250 million at December 31, 2022, and December 31, 2021, respectively. (2) Included within our total loan portfolio are credit card loans of $555 million and $583 million at December 31, 2022, and December 31, 2021, respectively. (3) Included within our total loan portfolio are construction loans of $539 million and $367 million at December 31, 2022, and December 31, 2021, respectively.
Credit Quality Indicators, Broken Out by Risk-Based Segments and Vintage Year	The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of December 31, 2022, and December 31, 2021. Term Loans by Origination Year December 31, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 543 $ 90 $ 55 $ 29 $ 1 $ 5 $ 40,539 $ 3 $ — $ 41,265 Criticized — — — — — — 4 — — 4 Nonperforming — — — — — — — — — — Total global fund banking $ 543 $ 90 $ 55 $ 29 $ 1 $ 5 $ 40,543 $ 3 $ — $ 41,269 Investor dependent: Early stage: Risk rating: Pass $ 910 $ 480 $ 44 $ 12 $ 1 $ — $ 182 $ — $ — $ 1,629 Criticized 130 120 18 5 — — 31 — — 304 Nonperforming 5 7 1 2 — — 2 — — 17 Total early stage $ 1,045 $ 607 $ 63 $ 19 $ 1 $ — $ 215 $ — $ — $ 1,950 Growth stage: Risk rating: Pass $ 2,358 $ 1,175 $ 283 $ 34 $ 8 $ 2 $ 300 $ 5 $ — $ 4,165 Criticized 186 233 81 5 3 3 32 — — 543 Nonperforming 20 31 — — — — 4 — — 55 Total growth stage $ 2,564 $ 1,439 $ 364 $ 39 $ 11 $ 5 $ 336 $ 5 $ — $ 4,763 Total investor dependent $ 3,609 $ 2,046 $ 427 $ 58 $ 12 $ 5 $ 551 $ 5 $ — $ 6,713 Cash flow dependent — SLBO: Risk rating: Pass $ 930 $ 550 $ 169 $ 162 $ 14 $ 19 $ 37 $ — $ — $ 1,881 Criticized 17 34 16 — 2 11 5 — — 85 Nonperforming — — — — — — — — — — Total cash flow dependent — SLBO $ 947 $ 584 $ 185 $ 162 $ 16 $ 30 $ 42 $ — $ — $ 1,966 Innovation C&I: Risk rating: Pass $ 2,554 $ 1,309 $ 495 $ 157 $ 5 $ 35 $ 3,152 $ — $ — $ 7,707 Criticized 65 224 168 33 11 — 373 — — 874 Nonperforming 7 — — — — — 21 — — 28 Total innovation C&I $ 2,626 $ 1,533 $ 663 $ 190 $ 16 $ 35 $ 3,546 $ — $ — $ 8,609 Private bank: Risk rating: Pass $ 2,782 $ 2,754 $ 1,718 $ 912 $ 427 $ 978 $ 832 $ 12 $ — $ 10,415 Criticized — 16 — 2 1 14 4 — — 37 Nonperforming — — 1 2 1 20 1 — — 25 Total private bank $ 2,782 $ 2,770 $ 1,719 $ 916 $ 429 $ 1,012 $ 837 $ 12 $ — $ 10,477 CRE Risk rating: Pass $ 519 $ 276 $ 193 $ 211 $ 144 $ 802 $ 102 $ 5 $ — $ 2,252 Criticized — 11 39 133 14 112 17 — — 326 Nonperforming — — — 5 — — — — — 5 Total CRE $ 519 $ 287 $ 232 $ 349 $ 158 $ 914 $ 119 $ 5 $ — $ 2,583 Premium wine: Risk rating: Pass $ 309 $ 209 $ 90 $ 135 $ 43 $ 135 $ 163 $ 33 $ — $ 1,117 Criticized 1 5 — 7 9 9 10 — — 41 Nonperforming — — — — — — — — — — Total premium wine $ 310 $ 214 $ 90 $ 142 $ 52 $ 144 $ 173 $ 33 $ — $ 1,158 Other C&I Term Loans by Origination Year December 31, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Risk rating: Pass $ 34 $ 141 $ 156 $ 64 $ 81 $ 284 $ 207 $ 10 $ — $ 977 Criticized 2 — 1 4 1 22 9 1 — 40 Nonperforming — — 1 — — 1 — — — 2 Total other C&I $ 36 $ 141 $ 158 $ 68 $ 82 $ 307 $ 216 $ 11 $ — $ 1,019 Other: Risk rating: Pass $ 114 $ 189 $ 148 $ 29 $ — $ — $ 9 $ 2 $ (75) $ 416 Criticized — 7 2 8 — — — — — 17 Nonperforming — — — — — — — — — — Total other $ 114 $ 196 $ 150 $ 37 $ — $ — $ 9 $ 2 $ (75) $ 433 PPP: Risk rating: Pass $ — $ 12 $ 3 $ — $ — $ — $ — $ — $ — $ 15 Criticized — 3 5 — — — — — — 8 Nonperforming — — — — — — — — — — Total PPP $ — $ 15 $ 8 $ — $ — $ — $ — $ — $ — $ 23 Total loans $ 11,486 $ 7,876 $ 3,687 $ 1,951 $ 766 $ 2,452 $ 46,036 $ 71 $ (75) $ 74,250 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level. Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 764 $ 115 $ 36 $ 6 $ 8 $ 4 $ 36,955 $ — $ — $ 37,888 Criticized 50 18 — — — 1 1 — — 70 Nonperforming — — — — — — — — — — Total global fund banking $ 814 $ 133 $ 36 $ 6 $ 8 $ 5 $ 36,956 $ — $ — $ 37,958 Investor dependent: Early stage: Risk rating: Pass $ 754 $ 287 $ 122 $ 26 $ 6 $ 1 $ 171 $ — $ — $ 1,367 Criticized 64 87 30 5 — — 29 — — 215 Nonperforming 2 5 3 — — — 1 — — 11 Total early stage $ 820 $ 379 $ 155 $ 31 $ 6 $ 1 $ 201 $ — $ — $ 1,593 Growth stage: Risk rating: Pass $ 2,072 $ 910 $ 265 $ 78 $ 14 $ 1 $ 286 $ 5 $ — $ 3,631 Criticized 159 85 27 6 3 — 34 — — 314 Nonperforming 2 — 1 2 — — 1 — — 6 Total growth stage $ 2,233 $ 995 $ 293 $ 86 $ 17 $ 1 $ 321 $ 5 $ — $ 3,951 Total investor dependent $ 3,053 $ 1,374 $ 448 $ 117 $ 23 $ 2 $ 522 $ 5 $ — $ 5,544 Cash flow dependent – SLBO: Risk rating: Pass $ 875 $ 384 $ 252 $ 72 $ 76 $ 2 $ 35 $ — $ — $ 1,696 Criticized — — 20 25 — 13 10 — — 68 Nonperforming — — 12 10 7 — 5 — — 34 Total cash flow dependent — SLBO $ 875 $ 384 $ 284 $ 107 $ 83 $ 15 $ 50 $ — $ — $ 1,798 Innovation C&I: Risk rating: Pass $ 2,230 $ 1,058 $ 288 $ 123 $ 58 $ — $ 2,411 $ — $ — $ 6,168 Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Criticized 64 130 62 12 — — 236 — — 504 Nonperforming — — — — — — 1 — — 1 Total Innovation C&I $ 2,294 $ 1,188 $ 350 $ 135 $ 58 $ — $ 2,648 $ — $ — $ 6,673 Private bank: Risk rating: Pass $ 2,952 $ 2,015 $ 1,122 $ 520 $ 432 $ 952 $ 705 $ 8 $ — $ 8,706 Criticized — — 2 — 2 9 3 — — 16 Nonperforming — — 2 9 — 8 2 — — 21 Total private bank $ 2,952 $ 2,015 $ 1,126 $ 529 $ 434 $ 969 $ 710 $ 8 $ — $ 8,743 CRE: Risk rating: Pass $ 326 $ 215 $ 344 $ 155 $ 236 $ 868 $ 110 $ 2 $ — $ 2,256 Criticized 3 39 114 37 47 139 18 12 — 409 Nonperforming — — 5 — — — — — — 5 Total CRE $ 329 $ 254 $ 463 $ 192 $ 283 $ 1,007 $ 128 $ 14 $ — $ 2,670 Premium wine: Risk rating: Pass $ 217 $ 112 $ 156 $ 69 $ 71 $ 162 $ 125 $ 34 $ — $ 946 Criticized 1 7 11 9 — — 11 — — 39 Nonperforming — — — — — — — — — — Total Premium wine $ 218 $ 119 $ 167 $ 78 $ 71 $ 162 $ 136 $ 34 $ — $ 985 Other C&I: Risk rating: Pass $ 181 $ 175 $ 82 $ 86 $ 28 $ 301 $ 350 $ 11 $ — $ 1,214 Criticized 5 6 6 7 2 — 8 5 — 39 Nonperforming — — — 2 — 1 1 — — 4 Total other C&I $ 186 $ 181 $ 88 $ 95 $ 30 $ 302 $ 359 $ 16 $ — $ 1,257 Other: Risk rating: Pass $ 61 $ 144 $ 82 $ 20 $ 14 $ — $ 7 $ — $ (21) $ 307 Criticized — 7 1 — 2 — — — — 10 Nonperforming — — — — — — — — — — Total other $ 61 $ 151 $ 83 $ 20 $ 16 $ — $ 7 $ — $ (21) $ 317 PPP: Risk rating: Pass $ 226 $ 72 $ — $ — $ — $ — $ — $ — $ — $ 298 Criticized 22 9 — — — — — — — 31 Nonperforming 2 — — — — — — — — 2 Total PPP $ 250 $ 81 $ — $ — $ — $ — $ — $ — $ — $ 331 Total loans $ 11,032 $ 5,880 $ 3,045 $ 1,279 $ 1,006 $ 2,462 $ 41,516 $ 77 $ (21) $ 66,276 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level.
Activity Relating to Our Allowance for Credit Losses for Loans	The following tables summarize the activity relating to our ACL for loans for 2022, 2021 and 2020 broken out by portfolio segment: Year ended December 31, 2022 Beginning Balance December 31, 2021 Charge-offs Recoveries Provision (Reduction) for Loans Foreign Currency Translation Adjustments Ending Balance December 31, 2022 (Dollars in millions) Global fund banking $ 67 $ — $ 7 $ 36 $ — $ 110 Investor dependent 146 (79) 20 184 2 $ 273 Cash flow dependent and Innovation C&I 118 (19) 1 55 — $ 155 Private bank 33 — 2 15 — $ 50 CRE 36 — — (11) — $ 25 Other C&I 14 (4) 1 2 — $ 13 Premium wine and other 8 (1) 1 7 (5) $ 10 Total ACL $ 422 $ (103) $ 32 $ 288 $ (3) $ 636 Year ended December 31, 2021 Beginning Balance December 31, 2020 Initial Allowance on PCD Loans Charge-offs Recoveries Provision (Reduction) for Loans (1) Ending Balance December 31, 2021 (Dollars in millions) Global fund banking (2) $ 46 $ — $ (80) $ — $ 101 $ 67 Investor dependent 213 — (46) 18 (39) 146 Cash flow dependent and Innovation C&I 125 — (8) 6 (5) 118 Private bank 53 1 (3) — (18) 33 CRE — 17 — — 19 36 Other C&I — 4 — — 10 14 Premium wine and other 9 — (1) — — 8 PPP 2 — — — (2) — Total ACL $ 448 $ 22 $ (138) $ 24 $ 66 $ 422 (1) The provision for loans for the year ended December 31, 2021, includes a post-combination initial provision of $44 million related to non-PCD loans from the Boston Private acquisition. (2) Global fund banking activity for the year ended December 31, 2021, includes the impact of an $80 million charge-off related to fraudulent activity on one loan as disclosed in previous filings. Year ended December 31, 2020 Beginning Balance at December 31, 2019 Impact of Adopting ASC 326 Charge-offs Recoveries Provision (Reduction) for Loans Foreign Currency Translation Adjustments Ending Balance at December 31, 2020 (Dollars in millions) Global fund banking $ 107 $ (70) $ — $ — $ 9 $ — $ 46 Investor dependent 82 72 (89) 25 125 (2) 213 Cash flow dependent and Innovation C&I 81 (1) (11) 3 53 — 125 Private bank 22 12 (2) — 21 — 53 Premium wine and other 13 12 (1) 1 (21) 5 9 PPP — — — — 2 — 2 Total ACL $ 305 $ 25 $ (103) $ 29 $ 189 $ 3 $ 448
Aging of Gross Loans, Broken out by Portfolio Segment and Class of Financing Receivable	The following table summarizes the aging of our loans broken out by class of financing receivables as of December 31, 2022, and December 31, 2021: (Dollars in millions) 30 - 59 60 - 89 90 or More Days Past Due Total Past Due Current Total 90 Days or More Past Due, Still December 31, 2022: Global fund banking $ 20 $ — $ — $ 20 $ 41,249 $ 41,269 $ — Investor dependent: Early stage 11 13 2 26 1,924 1,950 — Growth stage 26 — 3 29 4,734 4,763 — Total investor dependent 37 13 5 55 6,658 6,713 — Cash flow dependent - SLBO — — — — 1,966 1,966 — Innovation C&I 2 1 — 3 8,606 8,609 — Private bank 22 2 17 41 10,436 10,477 1 CRE 10 1 — 11 2,572 2,583 — Premium wine 3 — — 3 1,155 1,158 — Other C&I 2 — 2 4 1,015 1,019 — Other — — — — 433 433 — PPP — — 5 5 18 23 4 Total loans (1) $ 96 $ 17 $ 29 $ 142 $ 74,108 $ 74,250 $ 5 December 31, 2021: Global fund banking $ — $ — $ — $ — $ 37,958 $ 37,958 $ — Investor dependent: Early stage 6 5 — 11 1,582 1,593 — Growth stage 16 — — 16 3,935 3,951 — Total investor dependent 22 5 — 27 5,517 5,544 — Cash flow dependent - SLBO — — — — 1,798 1,798 — Innovation C&I 7 — 7 14 6,659 6,673 7 Private bank 28 1 12 41 8,702 8,743 — CRE 1 — — 1 2,669 2,670 — Premium wine 3 — — 3 982 985 — Other C&I 1 2 1 4 1,253 1,257 — Other — — — — 317 317 — PPP 1 — — 1 330 331 — Total loans $ 63 $ 8 $ 20 $ 91 $ 66,185 $ 66,276 $ 7
Nonaccrual Loans with No Allowance for Credit Loss	The following table summarizes our nonaccrual loans with no ACL at December 31, 2022, and December 31, 2021: December 31, 2022 December 31, 2021 (Dollars in millions) Nonaccrual Loans Nonaccrual Loans with no ACL Nonaccrual Loans Nonaccrual Loans with no ACL Investor dependent: Early stage $ 17 $ — $ 11 $ — Growth stage 55 3 6 — Total investor dependent 72 3 17 — Cash flow dependent - SLBO — — 34 — Innovation C&I 28 — 1 1 Private bank 25 7 21 8 CRE 5 — 5 — Other C&I 2 1 4 — PPP — — 2 — Total nonaccrual loans $ 132 $ 11 $ 84 $ 9
Summary of Loans Modified in Troubled Debt Restructurings ("TDRs") by Portfolio Segment and Class of Financing Receivables	The following table summarizes our loans modified in TDRs, broken out by class of financing receivables, as of December 31, 2022 and December 31, 2021: (Dollars in millions) December 31, 2022 December 31, 2021 Loans modified in TDRs: Investor dependent: Early stage $ 1 $ 12 Growth stage 30 3 Total investor dependent 31 15 Cash flow dependent - SLBO — 34 Innovation C&I 1 — Private bank 24 12 CRE 33 33 Other C&I 1 2 Total loans modified in TDRs $ 90 $ 96
Recorded Investment in Loans Modified in TDRs	The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivables, for modifications made during 2022, 2021 and 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Loans modified in TDRs during the period: Investor dependent: Early stage $ — $ 12 $ 6 Growth stage 30 — 26 Total investor dependent 30 12 32 Cash flow dependent - SLBO — 12 22 Innovation C&I 1 — 1 Private bank 17 4 — CRE 5 29 — Premium wine — — 1 Total loans modified in TDRs during the period (1) $ 53 $ 57 $ 56 (1) There were $110 million, $6 million and $31 million of partial charge-offs during 2022, 2021 and 2020, respectively.
Allowance for Unfunded Commitments	The following table summarizes the activity relating to our ACL for unfunded credit commitments for 2022, 2021 and 2020: December 31, (Dollars in millions) 2022 2021 2020 ACL: unfunded credit commitments, beginning balance $ 171 $ 121 $ 68 Impact of adopting ASC 326 — — 23 Provision for credit losses 133 50 30 Foreign currency translation adjustments (1) — — ACL: unfunded credit commitments, ending balance (1) $ 303 $ 171 $ 121 (1) The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our consolidated balance sheets. See Note 21—“Off-Balance Sheet Arrangements, Guarantees and Other Commitments” for additional disclosures related to our commitments to extend credit.

Premises and Equipment (Tables)

Premises and Equipment (Tables)	12 Months Ended
Premises and Equipment (Tables)	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Premises and Equipment	Premises and equipment at December 31, 2022, and December 31, 2021, consisted of the following: December 31, (Dollars in millions) 2022 2021 Computer software $ 581 $ 408 Computer hardware 116 102 Leasehold improvements 164 149 Furniture and equipment 59 53 Building 3 3 Total 923 715 Accumulated depreciation and amortization (529) (445) Premises and equipment, net $ 394 $ 270

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2022
Leases [Abstract]
Schedule of Lease Assets And Liabilities	Total recorded balances for the lease assets and liabilities are as follows: December 31, (Dollars in millions) 2022 2021 Assets: Right-of-use assets - operating leases $ 335 $ 313 Liabilities: Lease liabilities - operating leases 413 388
Lease Expense Components	The components of our lease cost and supplemental cash flow information related to leases for the years ended 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Operating lease cost $ 68 $ 90 $ 69 Short-term lease cost — — 1 Variable lease cost 6 4 4 Less: sublease income (3) (4) (2) Total lease expense, net $ 71 $ 90 $ 72 Supplemental cash flows information: Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 81 $ 66 $ 50 Noncash items during the period: Lease obligations in exchange for obtaining right-of-use assets: Operating leases $ 88 $ 187 $ 75 The table below presents additional information related to the Company's leases as of December 31, 2022 and December 31, 2021: December 31, 2022 2021 Weighted-average remaining term (in years) - operating leases 7.70 7.29 Weighted-average discount rate - operating leases (1) 2.25 % 1.83 % (1) The incremental borrowing rate used to calculate the lease liability was determined based on the facts and circumstances of the economic environment and the Company’s credit standing as of the effective date of the respective leases. Additionally, the total lease term and total lease payments were also considered in determining the rate. Based on these considerations, the Company identified credit terms available under its existing credit lines which represent a collateralized borrowing rate that has varying credit terms that could be matched to total lease terms and total lease payments in ultimately determining the implied borrowing rate in each lease contract.
Lessee, Operating Lease, Liability, Maturity	The following table presents our undiscounted future cash payments for our operating lease liabilities as of December 31, 2022: Years ended December 31, Operating Leases 2023 $ 85 2024 76 2025 64 2026 49 2027 39 2028 and thereafter 146 Total lease payments $ 459 Less: imputed interest (46) Total lease liabilities $ 413

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
Goodwill and Other Intangible Assets (Tables)	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in goodwill were as follows for the years ended December 31, 2022 and December 31, 2021: (Dollars in millions) Goodwill Beginning balance at December 31, 2020 $ 143 Acquisitions (1) 232 Ending balance at December 31, 2021 $ 375 Acquisitions — Impairment — Ending balance at December 31, 2022 $ 375 (1) Goodwill was recognized for the acquisitions of Boston Private effective July 1, 2021 and MoffettNathanson LLC effective December 10, 2021.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table presents the gross carrying amount and accumulated amortization of other intangible assets as of December 31, 2022, and December 31, 2021: December 31, 2022 December 31, 2021 (Dollars in millions) Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Other intangible assets: Customer relationships $ 135 $ 30 $ 105 $ 135 $ 16 $ 119 Other 57 26 31 57 16 41 Total other intangible assets, net $ 192 $ 56 $ 136 $ 192 $ 32 $ 160
Finite-lived Intangible Assets Amortization Expense	Amortization expense recognized on intangible assets was $24 million, $15 million and $5 million for the years ended 2022, 2021 and 2020. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of December 31, 2022: Years ended December 31, Other 2023 $ 22 2024 20 2025 17 2026 15 2027 12 2028 and thereafter 50 Total future amortization expense $ 136

Deposits (Tables)

Deposits (Tables)	12 Months Ended
Deposits (Tables)	Dec. 31, 2022
Deposits [Abstract]
Composition of Deposits	The following table presents the composition of our deposits as of December 31, 2022, and December 31, 2021: December 31, (Dollars in millions) 2022 2021 Noninterest-bearing demand $ 80,753 $ 125,851 Interest-bearing checking and savings accounts 32,916 5,106 Money market 52,032 54,842 Money market deposits in foreign offices 51 696 Sweep deposits in foreign offices 664 969 Time 6,693 1,739 Total deposits $ 173,109 $ 189,203

Short-Term Borrowings and Lon_2

Short-Term Borrowings and Long-Term Debt (Tables)	12 Months Ended
Short-Term Borrowings and Long-Term Debt (Tables)	Dec. 31, 2022
Debt Disclosure [Abstract]
Outstanding Short Term Borrowings and Long Term Debt	The following table represents outstanding short-term borrowings and long-term debt as of December 31, 2022, and December 31, 2021: Carrying Value (Dollars in millions) Maturity Principal value at December 31, 2022 December 31, 2022 December 31, 2021 Short-term borrowings: Securities sold under agreements to repurchase (1) $ 525 $ 525 $ 61 Other short-term borrowings (2) 40 40 10 FHLB advances 13,000 13,000 — Total short-term borrowings $ 13,565 $ 71 Long-term debt: 3.50% Senior Notes January 29, 2025 350 349 $ 349 3.125% Senior Notes June 5, 2030 500 496 496 1.800% Senior Notes February 2, 2031 500 495 494 2.100% Senior Notes May 15, 2028 500 497 496 1.800% Senior Notes October 28, 2026 650 646 645 4.345% Senior Fixed Rate/Floating Rate Notes April 29, 2028 350 348 — 4.570% Senior Fixed Rate/Floating Rate Notes April 29, 2033 450 448 — Junior subordinated debentures Various 100 91 90 FHLB advances Various 2,000 2,000 — Total long-term debt $ 5,370 $ 2,570 (1) Securities sold under repurchase agreements are effectively short-term borrowings collateralized by U.S. Treasury securities, U.S. agency securities and foreign government debt securities and contracted on an overnight basis. Our total unused and available borrowing capacity under our master repurchase agreements with various financial institutions totaled $35.0 billion at December 31, 2022. (2) Represents cash collateral received from certain counterparties in excess of net derivative receivables balances.
Aggregate Annual Maturities of Long-Term Debt Obligations	The aggregate annual maturities of long-term debt obligations as of December 31, 2022, are as follows: Year ended December 31, Amount 2023 $ 2,000 2024 — 2025 349 2026 646 2027 — 2028 and thereafter 2,375 Total $ 5,370

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
Derivative Financial Instruments (Tables)	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our consolidated balance sheets as of December 31, 2022, and December 31, 2021: Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets (Dollars in millions) Amortized Cost Basis of the Hedged Assets Active Terminated December 31, 2022 AFS securities $ 563 $ (2) $ (290) December 31, 2021 AFS securities (1) $ 15,260 $ (131) $ 6 (1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million.
Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments	The total notional or contractual amounts and fair value of our derivative financial instruments at December 31, 2022, and December 31, 2021, were as follows: December 31, 2022 December 31, 2021 Notional or Fair Value Notional or Fair Value (Dollars in millions) Derivative Assets (1) Derivative Liabilities (1) Derivative Assets (1) Derivative Liabilities (1) Derivatives designated as hedging instruments: Interest rate risks: Interest rate swaps (2) $ 550 $ — $ — $ 10,700 $ 18 $ — Currency exchange risks: Foreign exchange contracts 778 17 — — — — Foreign exchange contracts 616 — 56 — — — Total derivatives designated as hedging instruments 17 56 18 — Derivatives not designated as hedging instruments: Currency exchange risks: Foreign exchange contracts 1,763 42 — 701 16 — Foreign exchange contracts 2,184 — 29 62 — 2 Other derivative instruments: Equity warrant assets 375 383 — 322 277 — Contingent conversion rights 92 12 — — — — Client foreign exchange contracts 10,145 262 — 8,245 146 — Client foreign exchange contracts 9,960 — 257 7,764 — 126 Total return swaps 119 40 — — — — Client foreign currency options 866 19 — 688 9 — Client foreign currency options 866 — 19 688 — 9 Client interest rate derivatives (2) 2,391 128 — 2,178 99 — Client interest rate derivatives (2) 2,709 — 195 2,315 — 101 Total derivatives not designated as hedging instruments 886 500 547 238 Total gross derivatives 903 556 565 238 Less: netting adjustment (3) (351) (223) (137) (120) Total derivatives $ 552 $ 333 $ 428 $ 118 (1) Derivative assets and liabilities are included in "accrued interest receivable and other assets " and " other liabilities " , respectively, on our consolidated balance sheets. (2) The amount reported reflects reductions of approximately $74 million and $112 million of derivative assets at December 31, 2022, and 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses. (3) For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $31 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at December 31, 2022, and December 31, 2021, respectively.
Summary of Derivative Activity and Related Impact on Consolidated Statements of Income	A summary of our derivative activity and the related impact on our consolidated statements of income for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) Statement of income location 2022 2021 2020 Derivatives designated as hedging instruments: Interest rate risks: Amounts reclassified from AOCI into income Interest income - loans $ 56 $ 63 $ 50 Change in fair value of interest rate swaps hedging investment securities Interest income - investment securities taxable 387 138 — Change in fair value of hedged investment securities Interest income - investment securities taxable (387) (139) — Net gains associated with interest rate risk derivatives $ 56 $ 62 $ 50 Derivatives not designated as hedging instruments: Currency exchange risks: (Losses) gains on revaluations of internal foreign currency instruments, net Other noninterest income $ (42) $ (43) $ 39 Gains (losses) on internal foreign exchange forward contracts, net Other noninterest income 32 43 (40) Net losses associated with internal currency risk $ (10) $ — $ (1) Other derivative instruments: Gains on revaluations of client foreign currency instruments, net Other noninterest income $ 23 $ 17 $ 3 Losses on client foreign exchange forward contracts, net Other noninterest income (10) (17) (3) Net gains associated with client currency risk $ 13 $ — $ — Gains on total return swaps Other noninterest income $ 40 $ — $ — Net gains on equity warrant assets Gains on equity warrant assets, net $ 148 $ 560 $ 237 Net gains on other derivatives Other noninterest income $ 5 $ 2 $ 28
Offsetting Assets	The following table summarizes our assets subject to enforceable master netting arrangements as of December 31, 2022, and December 31, 2021: (Dollars in millions) Gross Amounts of Recognized Assets Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Assets Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount Financial Instruments Cash Collateral Received December 31, 2022: Derivatives $ 382 $ (144) $ (207) $ 31 $ — $ 31 Reverse repurchase, securities borrowing and similar arrangements 722 — — 722 (722) — Total $ 1,104 $ (144) $ (207) $ 753 $ (722) $ 31 December 31, 2021: Derivatives $ 165 $ (87) $ (50) $ 28 $ — $ 28 Reverse repurchase, securities borrowing and similar arrangements 607 — — 607 (607) — Total $ 772 $ (87) $ (50) $ 635 $ (607) $ 28 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.
Offsetting Liabilities	The following table summarizes our liabilities subject to enforceable master netting arrangements as of December 31, 2022, and December 31, 2021: (Dollars in millions) Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Liabilities Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount Financial Instruments Cash Collateral Pledged December 31, 2022: Derivatives $ 234 $ (144) $ (79) $ 11 $ — $ 11 Repurchase, securities lending and similar arrangements 525 — — 525 — 525 Total $ 759 $ (144) $ (79) $ 536 $ — $ 536 December 31, 2021: Derivatives $ 148 $ (87) $ (33) $ 28 $ — $ 28 Repurchase, securities lending and similar arrangements 61 — — 61 — 61 Total $ 209 $ (87) $ (33) $ 89 $ — $ 89 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Noninterest Income (Tables)

Noninterest Income (Tables)	12 Months Ended
Noninterest Income (Tables)	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Summary of Noninterest Income	Included below is a summary of noninterest income for the years ended December 31, 2022, December 31, 2021 and December 31, 2020: Year ended December 31, (Dollars in millions) 2022 2021 2020 Noninterest income: (Losses) gains on investment securities, net $ (285) $ 761 $ 421 Gains on equity warrant assets, net 148 560 237 Client investment fees 386 75 132 Wealth management and trust fees 83 44 — Foreign exchange fees 285 262 179 Credit card fees 150 131 98 Deposit service charges 126 112 90 Lending related fees 94 76 57 Letters of credit and standby letters of credit fees 57 51 47 Investment banking revenue 420 459 414 Commissions 98 79 67 Other 166 128 98 Total noninterest income $ 1,728 $ 2,738 $ 1,840
Summary of Gains and Losses on Investment Securities	The following table presents the net gains and losses on non-marketable and other equity securities in 2022, 2021 and 2020 as recorded in the line item “Gains (losses) on investment securities, net," a component of noninterest income: Year ended December 31, (Dollars in millions) 2022 2021 2020 Net gains (losses) on non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments $ (101) $ 71 $ 32 Unconsolidated venture capital and private equity fund investments (86) 75 60 Other investments without a readily determinable fair value (26) 75 — Other equity securities in public companies (fair value accounting) (52) 23 105 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (49) 474 162 Debt funds (1) 2 — Other investments 9 10 1 Total net gains (losses) on non-marketable and other equity securities $ (306) $ 730 $ 360 Less: realized net gains (losses) on sales of non-marketable and other equity securities (19) 85 24 Net gains (losses) on non-marketable and other equity securities still held $ (287) $ 645 $ 336 Year ended December 31, (Dollars in millions) 2022 2021 2020 Gains (losses) on non-marketable and other equity securities, net $ (306) $ 730 $ 360 Gains (losses) on sales of AFS debt securities, net 21 31 61 Total gains (losses) on investment securities, net $ (285) $ 761 $ 421
Components of Gains on Equity Warrant Assets	A summary of net gains on equity warrant assets for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Equity warrant assets: Gains on exercises, net $ 45 $ 446 $ 179 Terminations (4) (2) (2) Changes in fair value, net 107 116 60 Total net gains on equity warrant assets $ 148 $ 560 $ 237
Components of Client Investment Fees	A summary of client investment fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Client investment fees by type: Sweep money market fees $ 215 $ 43 $ 74 Asset management fees (1) 57 31 43 Repurchase agreement fees 114 1 15 Total client investment fees (2) $ 386 $ 75 $ 132 (1) Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management. (2) Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet.
Components of Wealth Management and Trust Fees	A summary of wealth management and trust fees for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Wealth management and trust fees by type: Wealth management fees $ 75 $ 40 $ — Trust fees 8 4 — Total wealth management and trust fees $ 83 $ 44 $ —
Components of Foreign Exchange Fees	A summary of foreign exchange fee income by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Foreign exchange fees by instrument type: Foreign exchange contract commissions $ 282 $ 260 $ 178 Option premium fees 3 2 1 Total foreign exchange fees $ 285 $ 262 $ 179
Components of Credit Card Fees	A summary of credit card fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Credit card fees by instrument type: Card interchange fees, net $ 117 $ 108 $ 76 Merchant service fees 26 18 18 Card service fees 7 5 4 Total credit card fees $ 150 $ 131 $ 98
Components of Lending Related Fees	A summary of lending related fees by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Lending related fees by instrument type: Unused commitment fees $ 70 $ 59 $ 42 Other 24 17 15 Total lending related fees $ 94 $ 76 $ 57
Schedule of Investment Banking Revenue	A summary of investment banking revenue by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Investment banking revenue: Underwriting fees $ 163 $ 304 $ 353 Advisory fees 214 90 40 Private placements and other 43 65 21 Total investment banking revenue $ 420 $ 459 $ 414
Summary of Other Noninterest Income	A summary of other noninterest income by instrument type for 2022, 2021 and 2020 is as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Other noninterest income by instrument type: Fund management fees $ 59 $ 67 $ 39 Net gains (losses) on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1) 3 — (1) Gains from conversion of convertible debt options — — 30 Gains on total return swaps 40 — — Other service revenue 64 61 30 Total other noninterest income $ 166 $ 128 $ 98 (1) Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.
Disaggregation of Revenue	The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the years ended December 31, 2022, December 31, 2021 and December 31, 2020: Year ended December 31, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 384 $ — $ — $ — $ 2 $ 386 Wealth management and trust fees — 83 — — — 83 Card interchange fees, gross 223 1 — — 3 227 Merchant service fees 25 1 — — — 26 Deposit service charges 124 1 — — 1 126 Investment banking revenue — — — 420 — 420 Commissions — — — 98 — 98 Fund management fees 2 — 52 5 — 59 Other (1) 71 1 6 — — 78 Total revenue from contracts with customers $ 829 $ 87 $ 58 $ 523 $ 6 $ 1,503 Revenues outside the scope of ASC 606 (2) 278 9 (168) (18) 124 225 Total noninterest income $ 1,107 $ 96 $ (110) $ 505 $ 130 $ 1,728 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of NCI. NCI is included within “Other Items." Year ended December 31, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 73 $ 2 $ — $ — $ — $ 75 Wealth management and trust fees — 44 — — — 44 Card interchange fees, gross 198 1 — — 2 201 Merchant service fees 17 1 — — — 18 Deposit service charges 109 1 — — 2 112 Investment banking revenue — — — 459 — 459 Commissions — — — 79 — 79 Fund management fees — — 62 5 — 67 Other (1) 243 2 13 — 1 259 Total revenue from contracts with customers $ 640 $ 51 $ 75 $ 543 $ 5 $ 1,314 Revenues outside the scope of ASC 606 (2) 66 7 412 65 874 1,424 Total noninterest income $ 706 $ 58 $ 487 $ 608 $ 879 $ 2,738 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of NCI. NCI is included within “Other Items." Year ended December 31, 2020 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Securities (3) Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 129 $ 3 $ — $ — $ — $ 132 Card interchange fees, gross 127 1 — — 2 130 Merchant service fees 17 1 — — — 18 Deposit service charges 90 — — — — 90 Investment banking revenue — — — 414 — 414 Commissions — — — 67 — 67 Fund management fees — — 32 7 — 39 Other (1) 162 — 4 — 1 167 Total revenue from contracts with customers $ 525 $ 5 $ 36 $ 488 $ 3 $ 1,057 Revenues outside the scope of ASC 606 (2) 79 — 190 9 505 783 Total noninterest income $ 604 $ 5 $ 226 $ 497 $ 508 $ 1,840 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s and SVB Capital’s components of noninterest income are shown net of NCI. NCI is included within “Other Items."

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Components of Income Before Income Taxes by U.S and Foreign	The components of our income before income taxes by U.S and foreign for 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 U.S $ 1,996 $ 2,624 $ 1,673 Foreign 176 100 69 Income before income tax expense $ 2,172 $ 2,724 $ 1,742
Components of Provision for Income Taxes	The components of our provision for income taxes for 2022, 2021 and 2020 were as follows: Year ended December 31, (Dollars in millions) 2022 2021 2020 Current provision: Federal $ 34 $ 409 $ 282 State (100) 224 141 Foreign 38 26 18 Deferred expense (benefit): Federal 330 5 6 State 254 (11) 2 Foreign 7 (2) (1) Income tax expense $ 563 $ 651 $ 448
Reconciliation between Federal Statutory Income Tax Rate and Effective Income Tax Rate	Our effective tax rate is calculated by dividing income tax expense by the sum of income before income tax expense and the net income attributable to NCI. The reconciliation between the federal statutory income tax rate and our effective income tax rate for 2022, 2021 and 2020 is as follows: December 31, (Dollars in millions) 2022 2021 2020 Federal statutory income tax rate 21.0 % 21.0 % 21.0 % State income taxes, net of the federal tax effect 6.8 7.5 6.8 Share-based compensation expense on incentive stock options and ESPP (0.8) (1.6) (0.3) Qualified affordable housing project tax credits (0.4) (0.2) (0.5) Tax-exempt interest income (1.6) (1.0) (0.8) Other, net 0.2 0.5 0.8 Effective income tax rate 25.2 % 26.2 % 27.0 %
Deferred Tax Assets (Liabilities)	Deferred tax assets and liabilities at December 31, 2022, and December 31, 2021, consisted of the following: December 31, (Dollars in millions) 2022 2021 Deferred tax assets: Allowance for credit losses $ 260 $ 170 Share-based compensation expense 36 26 Accrued compensation 82 77 Loans and debt securities — 113 Lease liability 112 105 Net operating loss carryforwards 1,650 7 Other 205 56 Deferred tax assets 2,345 554 Valuation allowance (6) (7) Net deferred tax assets after valuation allowance 2,339 547 Deferred tax liabilities: Derivative equity warrant assets (80) (82) Net unrealized gains on cash flow hedge derivatives (17) (33) Loans and debt securities (1,773) — Non-marketable and other equity securities (128) (219) Premises and equipment (54) (41) Right-of-use asset and deferred rent assets (89) (81) Goodwill and intangibles (24) (24) Merger-related fair value adjustments (15) (28) Other (6) (15) Deferred tax liabilities (2,186) (523) Net deferred tax assets (liabilities) $ 153 $ 24
Changes in Unrecognized Tax Benefit (Including Interest and Penalties)	A summary of changes in our unrecognized tax benefit (including interest and penalties) for 2022, 2021 and 2020 is as follows: (Dollars in millions) Reconciliation of Unrecognized Tax Benefit Interest and Penalties Total Balance at December 31, 2019 $ 13 $ 1 $ 14 Additions for tax positions for current year 5 — 5 Additions for tax positions for prior years 1 1 2 Reduction for tax positions for prior years (1) — (1) Lapse of the applicable statute of limitations (1) — (1) Reduction as a result of settlement (1) — (1) Balance at December 31, 2020 $ 16 $ 2 $ 18 Additions for tax positions for current year 21 — 21 Additions for tax positions for prior years — 1 1 Reduction for tax positions for prior years — — — Lapse of the applicable statute of limitations — — — Reduction as a result of settlement — — — Balance at December 31, 2021 $ 37 $ 3 $ 40 Additions for tax positions for current year 7 — 7 Additions for tax positions for prior years 1 2 3 Reduction for tax positions for prior years (4) — (4) Lapse of the applicable statute of limitations (2) (1) (3) Reduction as a result of settlement (2) — (2) Balance at December 31, 2022 $ 37 $ 4 $ 41

Off-Balance Sheet Arrangement_2

Off-Balance Sheet Arrangements, Guarantees and Other Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments To Extend Credit	The following table summarizes information related to our commitments to extend credit as of December 31, 2022, and December 31, 2021, respectively: December 31, (Dollars in millions) 2022 2021 Loan commitments (1) $ 58,891 $ 40,327 Standby letters of credit (2) 3,567 3,612 Commercial letters of credit (3) 83 77 Total unfunded credit commitments $ 62,541 $ 44,016 Allowance for unfunded credit commitments (4) 303 171 (1) Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements. (2) See below for additional information on our standby letters of credit. (3) Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature. (4) Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
Summary of Standby Letters of Credit	The table below summarizes our standby letters of credit at December 31, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged. (Dollars in millions) Expires In One Year or Less Expires After One Year Total Amount Outstanding Maximum Amount of Future Payments Financial standby letters of credit $ 3,363 $ 115 $ 3,478 $ 3,478 Performance standby letters of credit 80 9 89 89 Total $ 3,443 $ 124 $ 3,567 $ 3,567
Total Capital Commitments, Unfunded Capital Commitments, and Ownership in Each Fund	The following table details our total capital commitments, unfunded capital commitments and our ownership percentage in each fund at December 31, 2022: (Dollars in millions) SVBFG Capital Commitments SVBFG Unfunded SVBFG Ownership of each Fund Redwood Evergreen Fund, LP $ 250 $ 108 100.0 % CP II, LP (1) 1 — 5.1 Capital Preferred Return Fund, LP 13 — 20.0 Growth Partners, LP 25 1 33.0 Strategic Investors Fund, LP 15 1 12.6 Strategic Investors Fund II, LP 15 1 8.6 Strategic Investors Fund III, LP 15 1 5.9 Strategic Investors Fund IV, LP 12 2 5.0 Strategic Investors Fund V funds 1 — Various Other venture capital and private equity fund investments (equity method accounting) 18 5 Various Debt funds (equity method accounting) 59 — Various Other fund investments (2) 275 45 Various Total $ 699 $ 164 (1) Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP. (2) Represents commitments to 143 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund. At December 31, 2022, we had $3 million of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the NCI).

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
Fair Value of Financial Instruments (Tables)	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) Balance at December 31, 2022 Assets AFS securities: U.S. Treasury securities $ 16,135 $ — $ — $ — $ 16,135 U.S. agency debentures — 101 — — 101 Foreign government debt securities 1,088 — — — 1,088 Residential MBS: Agency-issued MBS — 6,603 — — 6,603 Agency-issued CMO—fixed rate — 678 — — 678 Agency-issued CMBS — 1,464 — — 1,464 Total AFS securities 17,223 8,846 — — 26,069 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 257 Other equity securities in public companies 31 1 — — 32 Total non-marketable and other equity securities (fair value 31 1 — — 289 Other assets: Derivative assets — 508 — (351) 157 Equity warrant assets — 6 377 — 383 Contingent conversion rights — — 12 — 12 Other assets 4 — — — 4 Total assets $ 17,258 $ 9,361 $ 389 $ (351) $ 26,914 Liabilities Derivative liabilities $ — $ 556 $ — $ (223) $ 333 Other liabilities 4 — — — 4 Total liabilities $ 4 $ 556 $ — $ (223) $ 337 (1) Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties. The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments Balance at December 31, 2021 Assets: AFS securities: U.S. Treasury securities $ 15,850 $ — $ — $ — $ 15,850 U.S. agency debentures — 196 — — 196 Foreign government debt securities 61 — — — 61 Residential MBS: Agency-issued MBS — 8,589 — — 8,589 Agency-issued CMO—fixed rate — 982 — — 982 Agency-issued CMBS — 1,543 — — 1,543 Total AFS securities 15,911 11,310 — — 27,221 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 338 Other equity securities in public companies 43 74 — — 117 Total non-marketable and other equity securities (fair value accounting) 43 74 — — 455 Other assets: Derivative assets (2) — 288 — (137) 151 Equity warrant assets — 8 269 — 277 Other assets 8 — — — 8 Total assets $ 15,962 $ 11,680 $ 269 $ (137) $ 28,112 Liabilities: Derivative liabilities (2) $ — $ 238 $ — $ (120) $ 118 Other liabilities 8 — — — 8 Total liabilities $ 8 $ 238 $ — $ (120) $ 126 (1) Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties. (2) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.
Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis	The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for 2022, 2021 and 2020, respectively: (Dollars in millions) Beginning Total Net Gains (Losses) Included in Net Income Sales/Exits Issuances Transfers Out of Level 3 Ending Year ended December 31, 2022: Equity warrant assets (1) $ 269 $ 153 $ (71) $ 30 $ (4) $ 377 Contingent conversion rights (2) — (1) — 13 — 12 Year ended December 31, 2021: Equity warrant assets (1) 192 561 (502) 24 (6) 269 Year ended December 31, 2020: Equity warrant assets (1) 161 229 (215) 19 (2) 192 (1) Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held	The following table presents the amount of net unrealized gains and losses included in earnings (which is inclusive of NCI) attributable to Level 3 assets still held at December 31, 2022, and December 31, 2021, respectively: Year ended December 31, (Dollars in millions) 2022 2021 Other assets: Equity warrant assets (1) $ 111 $ 119 Contingent conversion rights (2) (1) — Total unrealized gains, net $ 110 $ 119 (1) Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs	The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at December 31, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value. (Dollars in millions) Fair Value Valuation Technique Significant Unobservable Inputs Input Range Weighted Average December 31, 2022: Equity warrant assets (private portfolio) $ 377 Black-Scholes option pricing model Volatility 23.2% - 48.7% 41.2 % Risk-Free interest rate 3.4 - 4.8 4.3 Marketability discount (2) 16.5 16.5 Remaining life assumption (3) 40.0 40.0 Contingent conversion rights (private portfolio) 12 Private company equity pricing (4) (4) (4) December 31, 2021: Equity warrant assets (public portfolio) $ 2 Black-Scholes option pricing model Volatility 27.8% - 55.0% 43.7 % Risk-Free interest rate 0.6 - 1.5 1.1 Sales restrictions discount (1) 10.0 - 20.0 10.7 Equity warrant assets (private portfolio) 267 Black-Scholes option pricing model Volatility 24.7 - 55.0 43.0 Risk-Free interest rate 0.06 - 1.4 0.8 Marketability discount (2) 20.1 20.1 Remaining life assumption (3) 40.0 40.0 (1) We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions which typically range from three (2) Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount. (3) We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At December 31, 2022, the weighted average contractual remaining term was 6.1 years, compared to our estimated remaining life of 2.4 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption. (4) In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company, and a weighted average or range of values of the unobservable inputs is not meaningful.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value	The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at December 31, 2022 and December 31, 2021: Estimated Fair Value (Dollars in millions) Carrying Amount Total Level 1 Level 2 Level 3 December 31, 2022: Financial assets: Cash and cash equivalents $ 13,803 $ 13,803 $ 13,803 $ — $ — HTM securities 91,321 76,169 — 76,169 — Non-marketable securities not measured at net asset value 441 441 — — 441 Non-marketable securities measured at net asset value 628 628 — — — Net Loans 73,614 74,602 — — 74,602 FHLB and FRB stock 720 720 — — 720 Financial liabilities: Short-term borrowings 13,565 13,565 — 13,565 — Non-maturity deposits (1) 166,416 166,416 166,416 — — Time deposits 6,693 6,479 — 6,479 — FHLB Advances 2,000 2,000 — 2,000 — 3.50% Senior Notes due 2025 349 337 — 337 — 3.125% Senior Notes due 2030 496 412 — 412 — 1.800% Senior Notes due 2031 495 364 — 364 — 2.100% Senior Notes due 2028 497 417 — 417 — 1.800% Senior Notes due 2026 646 570 — 570 — 4.345% Senior Fixed Rate/Floating Rate Notes due 2028 348 331 — 331 — 4.570% Senior Fixed Rate/Floating Rate Notes due 2033 448 397 — 397 — Junior subordinated debentures 91 96 — 96 — Off-balance sheet financial assets: Commitments to extend credit — 52 — — 52 December 31, 2021: Financial assets: Cash and cash equivalents $ 14,586 $ 14,586 $ 14,586 $ — $ — HTM securities 98,195 97,227 — 97,227 — Non-marketable securities not measured at net asset value 424 424 — — 424 Non-marketable securities measured at net asset value 710 710 — — — Net loans 65,854 67,335 — — 67,335 FHLB and FRB stock 107 107 — — 107 Financial liabilities: Short-term borrowings 71 71 — 71 — Non-maturity deposits (1) 187,464 187,464 187,464 — — Time deposits 1,739 1,728 — 1,728 — 3.50% Senior Notes 349 370 — 370 — 3.125% senior Notes 496 526 — 526 — 1.800% Senior Notes due 2031 494 474 — 474 — 2.100% Senior Notes due 2028 496 501 — 501 — 1.800% Senior Notes due 2026 645 649 — 649 — Junior subordinated debentures 90 92 — 92 — Off-balance sheet financial assets: Commitments to extend credit — 47 — — 47 (1) Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments	The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of December 31, 2022: (Dollars in millions) Carrying Amount Fair Value Unfunded Commitments Non-marketable securities (fair value accounting): Venture capital and private equity fund investments (1) $ 257 $ 257 $ 18 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (2) 605 605 9 Debt funds (2) 5 5 — Other investments (2) 18 18 1 Total $ 885 $ 885 $ 28 (1) Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $40 million and $2 million, respectively, attributable to NCI. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds. (2) Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

Regulatory Matters (Tables)

Regulatory Matters (Tables)	12 Months Ended
Regulatory Matters (Tables)	Dec. 31, 2022
Banking and Thrift, Other Disclosure [Abstract]
Capital Ratios for Company and Bank under Federal Regulatory Guidelines, Compared to Minimum Regulatory Capital Requirements for Adequately Capitalized and Well Capitalized Depository Institution	The following table presents the capital ratios for the Company and the Bank under federal regulatory guidelines, compared to the minimum regulatory capital requirements, as of December 31, 2022, and December 31, 2021: Capital Ratios Capital Amounts (Dollars in millions) Actual Required Minimum (1) Well Capitalized Minimum Actual Required Minimum (1) Well Capitalized Minimum December 31, 2022: CET1 risk-based capital: SVB Financial 12.05 % 7.0 % N/A $ 13,697 $ 7,954 N/A Bank 15.26 7.0 6.5 16,995 7,795 $ 7,238 Tier 1 risk-based capital: SVB Financial 15.40 8.5 6.0 17,504 9,658 6,818 Bank 15.26 8.5 8.0 16,995 9,465 8,908 Total risk-based capital: SVB Financial 16.18 10.5 10.0 18,380 11,931 11,363 Bank 16.05 10.5 10.0 17,871 11,692 11,135 Tier 1 leverage: SVB Financial 8.11 4.0 N/A 17,504 8,630 N/A Bank 7.96 4.0 5.0 16,995 8,537 10,672 December 31, 2021: CET1 risk-based capital: SVB Financial 12.09 % 7.0 % N/A $ 12,186 $ 7,057 N/A Bank 14.89 7.0 6.5 14,622 6,875 $ 6,384 Tier 1 risk-based capital: SVB Financial 16.08 8.5 6.0 16,206 8,569 6,049 Bank 14.89 8.5 8.0 14,622 8,348 7,857 Total risk-based capital: SVB Financial 16.58 10.5 10.0 16,712 10,585 10,081 Bank 15.40 10.5 10.0 15,129 10,313 9,821 Tier 1 leverage: SVB Financial 7.93 4.0 N/A 16,206 8,175 N/A Bank 7.24 4.0 5.0 14,622 8,075 10,094 N/A "Well-Capitalized Minimum" CET1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies. (1) The percentages represent the minimum capital ratios plus, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
Segment Reporting (Tables)	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Reporting	Our segment information for 2022, 2021 and 2020 is as follows: (Dollars in millions) Silicon Valley Bank (1) SVB Private SVB Capital (1) SVB Securities (1) Other Items (2) (3) Total Year ended December 31, 2022 Net interest income $ 4,118 $ 407 $ — $ 3 $ (43) $ 4,485 Provision for credit losses (277) (10) — — (133) (420) Noninterest income 1,107 96 (110) 505 130 1,728 Noninterest expense (4) (1,557) (361) (70) (603) (1,030) (3,621) Income (loss) before income tax expense (5) $ 3,391 $ 132 $ (180) $ (95) $ (1,076) $ 2,172 Total average loans, amortized cost $ 54,647 $ 14,934 $ — $ — $ 708 $ 70,289 Total average assets (6) (7) 175,221 16,637 942 936 22,367 216,103 Total average deposits 172,106 12,884 — — 771 185,761 Year ended December 31, 2021 Net interest income (8) $ 2,914 $ 226 $ — $ 1 $ 38 $ 3,179 Provision for credit losses (55) (14) — — (54) (123) Noninterest income 706 58 487 608 879 2,738 Noninterest expense (4) (8) (1,266) (223) (71) (561) (949) (3,070) Income (loss) before income tax expense (5) (8) $ 2,299 $ 47 $ 416 $ 48 $ (86) $ 2,724 Total average loans, amortized cost (8) $ 43,145 $ 9,986 $ — $ — $ 1,416 $ 54,547 Total average assets (6) (7) (8) 140,362 11,171 700 830 12,948 166,011 Total average deposits (8) 138,057 8,924 — — 966 147,947 Year ended December 31, 2020 Net interest income (8) $ 1,990 $ 112 $ — $ 1 $ 54 $ 2,157 Provision for credit losses (166) (21) — — (33) (220) Noninterest income 604 5 226 497 508 1,840 Noninterest expense (4) (8) (1,011) (55) (51) (379) (539) (2,035) Income (loss) before income tax expense (5) (8) $ 1,417 $ 41 $ 175 $ 119 $ (10) $ 1,742 Total average loans, amortized cost (8) $ 30,116 $ 5,298 $ — $ — $ 1,852 $ 37,266 Total average assets (6) (7) (8) 73,929 5,335 437 557 5,534 85,792 Total average deposits (8) 71,911 2,388 — — 717 75,016 (1) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of NII, noninterest income, noninterest expense and total average assets are shown net of NCI for all periods presented. NCI is included within "Other Items." (2) The "Other Items" column reflects the adjustments necessary to reconcile the results of the operating segments to the consolidated financial statements prepared in conformity with GAAP. NII consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses. (3) Noninterest income included in “Other Items” decreased $749M in 2022. The decrease is driven by lower warrant and investment gains. (4) The Silicon Valley Bank segment includes direct depreciation and amortization of $49 million, $34 million and $25 million for December 31, 2022, December 31, 2021, and December 31, 2020, respectively. (5) The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates. (6) Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders’ equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP. (7) Included in the total average assets is goodwill of $174 million and $138 million for SVB Securities for the year ended December 31, 2022, and December 31, 2021, respectively, and $201 million and $87 million for SVB Private for the years ended December 31, 2022, and December 31, 2021. (8) For the years ended December 31, 2022, December 31, 2021, and December 31, 2020, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

Parent Company Only Condensed_2

Parent Company Only Condensed Financial Information (Tables)	12 Months Ended
	Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]
Condensed Balance Sheets	Condensed Balance Sheets December 31, (Dollars in millions) 2022 2021 Assets: Cash and cash equivalents $ 2,258 $ 2,324 Investment securities 491 731 Loans, amortized cost 1 1 Lease right-of-use assets 102 82 Other assets 475 387 Investment in subsidiaries: Bank subsidiary 15,456 14,795 Nonbank subsidiaries 896 894 Total assets $ 19,679 $ 19,214 Liabilities and SVBFG stockholders’ equity: Long-term debt $ 3,370 $ 2,570 Lease liabilities 135 113 Other liabilities 170 295 Total liabilities $ 3,675 $ 2,978 SVBFG stockholders’ equity 16,004 16,236 Total liabilities and SVBFG stockholders’ equity $ 19,679 $ 19,214
Condensed Statements of Income	Condensed Statements of Income Year ended December 31, (Dollars in millions) 2022 2021 2020 Interest income $ 1 $ 3 $ 3 Interest expense (91) (48) (22) Dividend income from bank subsidiary 294 — 50 Gains on equity warrant assets, net 146 554 227 Gains (losses) on investment securities, net (179) 197 158 Fund management fees and other noninterest income 54 68 62 General and administrative expenses (284) (298) (121) Income tax benefit (expense) 143 (212) (146) Income before net income of subsidiaries 84 264 211 Equity in undistributed net income of bank subsidiary 1,741 1,294 776 Equity in undistributed net income (loss) of nonbank subsidiaries (153) 275 221 Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Preferred stock dividends (163) (63) (17) Net income available to common stockholders $ 1,509 $ 1,770 $ 1,191
Condensed Statements of Comprehensive Income	Condensed Statements of Comprehensive Income Year ended December 31, (Dollars in millions) 2022 2021 2020 Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Other comprehensive income (loss), net of tax: Foreign currency translation gains (losses) (37) (1) 12 Changes in unrealized holding gains (losses) on AFS securities (39) (3) — Changes in fair value on bank cash flow hedges, net of reclassification adjustments in bank net income (6) (46) 131 Equity in other comprehensive income (loss) of bank and nonbank subsidiaries (1,883) (341) 395 Other comprehensive income (loss), net of tax (1,965) (391) 538 Total comprehensive income $ (293) $ 1,442 $ 1,746
Condensed Statements of Cash Flows	Condensed Statements of Cash Flows Year ended December 31, (Dollars in millions) 2022 2021 2020 Cash flows from operating activities: Net income before preferred stock dividend $ 1,672 $ 1,833 $ 1,208 Adjustments to reconcile net income to net cash provided by (used for) operating activities: Gains on equity warrant assets, net (146) (554) (227) Gains (losses) on investment securities, net 179 (197) (158) Gains on derivatives, net — — (30) Distributions of earnings from investment securities 33 60 65 Net income of bank subsidiary (2,035) (1,294) (826) Net income (loss) on nonbank subsidiaries 153 (275) (221) Cash dividends from bank subsidiary 294 — 50 Amortization of share-based compensation 183 136 84 (Increase) decrease in other assets 35 (40) 17 Increase (decrease) in other liabilities (129) 58 99 Other, net 1 2 14 Net cash provided by (used for) operating activities 240 (271) 75 Cash flows from investing activities: Net decrease in investment securities from purchases, sales and maturities 49 533 123 Net decrease in loans — — 15 Increase in investment in bank subsidiary (773) (1,240) (69) Capital infusion in bank subsidiary — (5,750) (700) (Increase) decrease in investment in nonbank subsidiaries (192) 47 4 Business acquisitions — 1,081 (27) Net cash used for investing activities (916) (5,329) (654) Cash flows from financing activities: Proceeds from issuance long-term debt 795 1,636 495 Proceeds from the issuance of common stock, net (22) 2,374 31 Net proceeds from the issuance of preferred stock — 3,306 — Payment of preferred stock dividends (163) (63) (17) Common stock repurchase — — (60) Net cash provided by financing activities 610 7,253 449 Net increase (decrease) in cash and cash equivalents (66) 1,653 (130) Cash and cash equivalents at beginning of period 2,324 671 801 Cash and cash equivalents at end of period $ 2,258 $ 2,324 $ 671

Nature of Business (Details)

Nature of Business (Details)	12 Months Ended
Nature of Business (Details)	Dec. 31, 2022 Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	4

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) class_financing_receivable portfolio_segment	Dec. 31, 2021 USD ($)
Significant Accounting Policies [Line Items]
Interest receivable	$ 402,000,000	$ 171,000,000
Number of portfolio segments \| portfolio_segment	8
Number of classes of financing receivables \| class_financing_receivable	11
Financing receivable, allowance for credit loss, forecast period	3 years
Threshold period past due for nonaccrual loans	90 days
Finance lease obligations	$ 0	0
Commercial loans
Significant Accounting Policies [Line Items]
Threshold period past due, writeoff	180 days
Consumer loans
Significant Accounting Policies [Line Items]
Threshold period past due, writeoff	120 days
Accrued Interest Receivable And Other Assets \| Held-to-maturity securities
Significant Accounting Policies [Line Items]
Interest receivable	$ 211,000,000	$ 225,000,000
Investor dependent
Significant Accounting Policies [Line Items]
Number of classes of financing receivables \| class_financing_receivable	2
Cash flow dependent and innovation C&I
Significant Accounting Policies [Line Items]
Number of classes of financing receivables \| class_financing_receivable	2
Premium wine and other
Significant Accounting Policies [Line Items]
Number of classes of financing receivables \| class_financing_receivable	2
Lower Limit
Significant Accounting Policies [Line Items]
Term of contract on forward contracts	1 year
Lower Limit \| Investor dependent \| Growth stage \| Mid stage
Significant Accounting Policies [Line Items]
Risk-based segments, revenue threshold of subcategories	$ 5,000,000
Lower Limit \| Investor dependent \| Growth stage \| Later stage
Significant Accounting Policies [Line Items]
Risk-based segments, revenue threshold of subcategories	$ 15,000,000
Lower Limit \| Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Significant Accounting Policies [Line Items]
Sponsor equity contribution, percentage of acquisition price	50%
Upper Limit
Significant Accounting Policies [Line Items]
Ownership interest percentage	5%
Term of contract on forward contracts	5 years
Upper Limit \| Investor dependent \| Early stage
Significant Accounting Policies [Line Items]
Risk-based segments, revenue threshold of subcategories	$ 5,000,000
Upper Limit \| Investor dependent \| Growth stage \| Mid stage
Significant Accounting Policies [Line Items]
Risk-based segments, revenue threshold of subcategories	$ 15,000,000
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Upper Limit
Significant Accounting Policies [Line Items]
Sales restriction discounts	0.20
Other equity securities \| Lower Limit
Significant Accounting Policies [Line Items]
Duration of the sale restrictions	3 months
Other equity securities \| Upper Limit
Significant Accounting Policies [Line Items]
Duration of the sale restrictions	6 months
Other equity securities \| Sales restrictions discount \| Lower Limit
Significant Accounting Policies [Line Items]
Sales restriction discounts	0.10
Other equity securities \| Sales restrictions discount \| Upper Limit
Significant Accounting Policies [Line Items]
Sales restriction discounts	0.20
Non-marketable securities \| Fair value accounting \| Venture capital and private equity fund investments measured at net asset value \| Strategic Investors Fund, LP
Significant Accounting Policies [Line Items]
Ownership interest percentage	12.60%	12.60%
Non-marketable securities \| Fair value accounting \| Venture capital and private equity fund investments measured at net asset value \| Capital Preferred Return Fund, LP
Significant Accounting Policies [Line Items]
Ownership interest percentage	20%	20%
Non-marketable securities \| Fair value accounting \| Venture capital and private equity fund investments measured at net asset value \| Growth Partners, LP
Significant Accounting Policies [Line Items]
Ownership interest percentage	33%	33%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Maximum Estimated Useful Lives by Asset Classification (Details)	12 Months Ended
	Dec. 31, 2022
Leasehold Improvements
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	Lesser of lease term or asset life
Furniture and equipment \| Lower Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	3 years
Furniture and equipment \| Upper Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	7 years
Computer software \| Lower Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	3 years
Computer software \| Upper Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	7 years
Computer hardware \| Lower Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	3 years
Computer hardware \| Upper Limit
Property Plant and Equipment Estimated Useful Lives [Line Items]
Premises and equipment, estimated useful life	5 years

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended	12 Months Ended
	Jul. 01, 2021	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2022	Dec. 10, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Goodwill			$ 375	$ 375		$ 143
Boston Private
Business Acquisition [Line Items]
Percentage of voting interests acquired	100%
Consideration transferred in acquisition	$ 1,234
Cash paid for each share of Boston Private common stock	$ 2.10
Number of shares of SIVB common stock that each share of Boston Private common stock was converted (in shares)	0.0228
Shares of common stock issued for acquisition	1,900,000
Additional number of SIVB shares registered issuable upon the exercise, vesting or settlement of converted legacy Boston Private equity awards	99,000
Intangible assets	$ 104
Goodwill	201
Loans	7,217
Purchase price of PCD loans	$ 1,389
Boston Private \| Merger-related charges
Business Acquisition [Line Items]
Direct expenses related to the acquisition			$ 22
Boston Private \| Professional services
Business Acquisition [Line Items]
Direct expenses related to the acquisition		$ 6
MoffettNathanson
Business Acquisition [Line Items]
Percentage of voting interests acquired					100%

Business Combination - Allocati

Business Combination - Allocation of Purchase Price (Details) - USD ($) $ in Millions		12 Months Ended
	Jul. 01, 2021	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 0	$ 232
Boston Private
Business Acquisition [Line Items]
Cash paid	$ 174
Share-based consideration	1,050
Replacement equity awards	10
Total purchase consideration	1,234
Fair value of net assets acquired	1,033
Goodwill	$ 201

Business Combination - Fair Val

Business Combination - Fair Value of Assets Acquired and Liabilities Assumed (Details) - Boston Private $ in Millions	Jul. 01, 2021 USD ($)
Assets acquired:
Cash and cash equivalents	$ 1,290
Investment securities	1,429
Loans	7,217
Premises and equipment	39
Intangible assets	104
Right-of-use assets	107
Other assets	284
Total assets acquired	10,470
Liabilities assumed:
Deposits	8,983
Borrowings	132
Lease liabilities	103
Other liabilities	219
Total liabilities assumed	9,437
Fair value of net assets acquired	$ 1,033

Business Combination - Fair V_2

Business Combination - Fair Value of Other Intangible Assets Acquired and Useful Lives (Details) - Boston Private $ in Millions	Jul. 01, 2021 USD ($)
Other intangible assets:
Estimated Fair Value	$ 104
Customer relationships
Other intangible assets:
Estimated Fair Value	$ 85
Weighted Average Estimated Useful Life - in Years	20 years
Other
Other intangible assets:
Estimated Fair Value	$ 19
Weighted Average Estimated Useful Life - in Years	6 years

Business Combination - Purchase

Business Combination - Purchase Credit Deteriorated Loans (Details) - Boston Private $ in Millions	Jul. 01, 2021 USD ($)
Business Acquisition [Line Items]
Par value of PCD loans	$ 1,368
PCD ACL at acquisition	(22)
Non-credit premium on PCD loans	43
Purchase price of PCD loans	$ 1,389

Stockholders' Equity and EPS -

Stockholders' Equity and EPS - Reclassification of AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Gains (losses) on investment securities, net	$ 285	$ (761)	$ (421)
Income tax expense	563	651	448
Net interest income	(4,485)	(3,179)	(2,157)
Total reclassification adjustment for (gains) losses included in net income, net of tax	(1,509)	(1,770)	(1,191)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total reclassification adjustment for (gains) losses included in net income, net of tax	(55)	(68)	(80)
Accumulated Net Unrealized Investment Gain (Loss) \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Gains (losses) on investment securities, net	(21)	(31)	(61)
Income tax expense	6	9	17
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Income tax expense	16	17	14
Net interest income	$ (56)	$ (63)	$ (50)

Stockholders' Equity and EPS _2

Stockholders' Equity and EPS - Activity Related to Net Gains on Cash Flow Hedges in AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash flow hedge gains expected to reclassified out of AOCI over next 12 months	$ 41
Balance, beginning of period, net of tax	16,609	$ 8,433	$ 6,622
Balance, end of period, net of tax	16,295	16,609	8,433
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period, net of tax	83	130	(2)
Net (decrease) increase in fair value, net of tax	0	(1)	168
Net realized (gain) loss reclassified to net income, net of tax	(40)	(46)	(36)
Balance, end of period, net of tax	$ 43	$ 83	$ 130

Stockholders' Equity and EPS _3

Stockholders' Equity and EPS - Reconciliation of Basic EPS to Diluted EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net income available to common stockholders	$ 1,509	$ 1,770	$ 1,191
Denominator:
Weighted average common shares outstanding-basic (in shares)	58,987	55,763	51,685
Denominator for diluted calculation (in shares)	59,516	56,638	52,084
Earnings per common share:
Basic (usd per share)	$ 25.58	$ 31.74	$ 23.05
Diluted (usd per share)	$ 25.35	$ 31.25	$ 22.87
Stock options and ESPP
Denominator:
Weighted average effect of dilutive securities (in shares)	168	283	151
Restricted stock units
Denominator:
Weighted average effect of dilutive securities (in shares)	361	592	248

Stockholders' Equity and EPS _4

Stockholders' Equity and EPS - Common Shares Excluded from Diluted EPS Calculation (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation (in shares)	507	39	289
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation (in shares)	117	37	279
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation (in shares)	390	2	10

Stockholders' Equity and EPS _5

Stockholders' Equity and EPS - Common Stock (Details) - USD ($) $ / shares in Units, $ in Millions	Aug. 12, 2021	Jul. 01, 2021	Apr. 14, 2021	Mar. 22, 2021	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Common stock, shares, issued					59,171,883	58,748,469
Boston Private
Class of Stock [Line Items]
Number of shares of SIVB common stock that each share of Boston Private common stock was converted (in shares)		0.0228
Common Stock
Class of Stock [Line Items]
Common stock, shares, issued	2,227,000		300,000	2,000,000
Price per share (usd per share)	$ 564			$ 500
Consideration received in sale of stock	$ 1,200		$ 146	$ 972
Common Stock \| Boston Private
Class of Stock [Line Items]
Issuance of common stock in acquisition		1,887,981
Number of shares of SIVB common stock that each share of Boston Private common stock was converted (in shares)		0.0228

Stockholders' Equity and EPS _6

Stockholders' Equity and EPS - Preferred Stock (Details) - $ / shares					12 Months Ended
	Oct. 28, 2021	May 13, 2021	Feb. 02, 2021	Dec. 09, 2019	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock, par value					$ 0.001	$ 0.001
Series A Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate (percent)				5.25%	5.25%
Preferred stock, depositary shares issued				14,000,000
Preferred stock, depositary share ownership interest					2.50%
Preferred stock, par value				$ 0.001	$ 0.001
Preferred stock, liquidation preference (usd per share)				1,000
Preferred stock, liquidation preference per depositary share (usd per share)				$ 25	$ 25
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate (percent)			4.10%		4.10%
Preferred stock, depositary shares issued			750,000
Preferred stock, depositary share ownership interest					1%
Preferred stock, par value			$ 0.001		$ 0.001
Preferred stock, liquidation preference (usd per share)			100,000
Preferred stock, liquidation preference per depositary share (usd per share)			$ 1,000		$ 1,000
Preferred stock, period dividend rate reset using ten-year treasury rate			10 years
Preferred stock, number of business days prior to each reset date dividend rate calculated			3 days
Preferred stock, number of days used for average yields on actively traded US treasury securities			5 days
Preferred stock, margin used for dividend rate at reset			3.064%
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate (percent)		4%			4%
Preferred stock, depositary shares issued		1,000,000
Preferred stock, depositary share ownership interest					1%
Preferred stock, par value		$ 0.001			$ 0.001
Preferred stock, liquidation preference (usd per share)		100,000
Preferred stock, liquidation preference per depositary share (usd per share)		$ 1,000			$ 1,000
Preferred stock, period dividend rate reset using five-year treasury rate		5 years
Preferred stock, number of business days prior to each reset date dividend rate calculated		3 days
Preferred stock, number of days used for average yields on actively traded US treasury securities		5 days
Preferred stock, margin used for dividend rate at reset		3.202%
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate (percent)	4.25%				4.25%
Preferred stock, depositary shares issued	1,000,000
Preferred stock, depositary share ownership interest					1%
Preferred stock, par value	$ 0.001				$ 0.001
Preferred stock, liquidation preference (usd per share)	100,000
Preferred stock, liquidation preference per depositary share (usd per share)	$ 1,000				$ 1,000
Preferred stock, period dividend rate reset using five-year treasury rate	5 years
Preferred stock, number of business days prior to each reset date dividend rate calculated	3 days
Preferred stock, number of days used for average yields on actively traded US treasury securities	5 days
Preferred stock, margin used for dividend rate at reset	3.074%
Series E Preferred Stock
Class of Stock [Line Items]
Preferred stock, dividend rate (percent)	4.70%				4.70%
Preferred stock, depositary shares issued	600,000
Preferred stock, depositary share ownership interest					1%
Preferred stock, par value	$ 0.001				$ 0.001
Preferred stock, liquidation preference (usd per share)	100,000
Preferred stock, liquidation preference per depositary share (usd per share)	$ 1,000				$ 1,000
Preferred stock, period dividend rate reset using ten-year treasury rate	10 years
Preferred stock, number of business days prior to each reset date dividend rate calculated	3 days
Preferred stock, number of days used for average yields on actively traded US treasury securities	5 days
Preferred stock, margin used for dividend rate at reset	3.064%

Stockholders' Equity and EPS _7

Stockholders' Equity and EPS - Preferred Stock Summary Schedule (Details) - USD ($) $ / shares in Units, $ in Millions					12 Months Ended
	Oct. 28, 2021	May 13, 2021	Feb. 02, 2021	Dec. 09, 2019	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Preferred stock, shares issued, value					$ 3,646	$ 3,646
Preferred stock, shares issued					383,500	383,500
Preferred stock, shares outstanding					383,500	383,500
Par Value					$ 0.001	$ 0.001
Series A Preferred Stock
Class of Stock [Line Items]
Amount outstanding					$ 350
Preferred stock, shares issued, value					$ 340
Preferred stock, shares issued					350,000
Preferred stock, shares outstanding					350,000
Par Value				$ 0.001	$ 0.001
Ownership interest per depository share (usd per share)					2.50%
Liquidation preference per depository share (usd per share)				$ 25	$ 25
2022 dividends paid per depository share (usd per share)					$ 1.31
Preferred stock, dividend rate (percent)				5.25%	5.25%
Series B Preferred Stock
Class of Stock [Line Items]
Amount outstanding					$ 750
Preferred stock, shares issued, value					$ 739
Preferred stock, shares issued					7,500
Preferred stock, shares outstanding					7,500
Par Value			$ 0.001		$ 0.001
Ownership interest per depository share (usd per share)					1%
Liquidation preference per depository share (usd per share)			$ 1,000		$ 1,000
2022 dividends paid per depository share (usd per share)					$ 41
Preferred stock, dividend rate (percent)			4.10%		4.10%
Series C Preferred Stock
Class of Stock [Line Items]
Amount outstanding					$ 1,000
Preferred stock, shares issued, value					$ 985
Preferred stock, shares issued					10,000
Preferred stock, shares outstanding					10,000
Par Value		$ 0.001			$ 0.001
Ownership interest per depository share (usd per share)					1%
Liquidation preference per depository share (usd per share)		$ 1,000			$ 1,000
2022 dividends paid per depository share (usd per share)					$ 40
Preferred stock, dividend rate (percent)		4%			4%
Series D Preferred Stock
Class of Stock [Line Items]
Amount outstanding					$ 1,000
Preferred stock, shares issued, value					$ 989
Preferred stock, shares issued					10,000
Preferred stock, shares outstanding					10,000
Par Value	$ 0.001				$ 0.001
Ownership interest per depository share (usd per share)					1%
Liquidation preference per depository share (usd per share)	$ 1,000				$ 1,000
2022 dividends paid per depository share (usd per share)					$ 44.51
Preferred stock, dividend rate (percent)	4.25%				4.25%
Series E Preferred Stock
Class of Stock [Line Items]
Amount outstanding					$ 600
Preferred stock, shares issued, value					$ 593
Preferred stock, shares issued					6,000
Preferred stock, shares outstanding					6,000
Par Value	$ 0.001				$ 0.001
Ownership interest per depository share (usd per share)					1%
Liquidation preference per depository share (usd per share)	$ 1,000				$ 1,000
2022 dividends paid per depository share (usd per share)					$ 49.22
Preferred stock, dividend rate (percent)	4.70%				4.70%

Share-Based Compensation - Shar

Share-Based Compensation - Share Based Compensation and Related Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense	$ 183	$ 136	$ 84
Income tax benefit related to share-based compensation expense	(39)	(35)	(20)
Capitalized compensation costs	$ 3	$ 1	$ 1

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details)	12 Months Ended
Share-Based Compensation - Additional Information (Details)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 shares
Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum aggregate number of shares that may be awarded and sold	12,028,505
Conversion ratio for awards granted	2
Conversion ratio for awards forfeited	2
Number of common stock shares available for future issuance	1,636,040
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum percentage of gross compensation that employees may contribute annually	10%
Maximum amount of gross compensation employees may contribute annually \| $	$ 25,000
Percentage of fair market value of common stock at which employees may purchase shares	85%
Offering period	6 months
Number of hours employed per week to qualify	20 hours
Number of months employed to qualify	5 months
Number of shares issued under ESPP	152,283
Proceeds from issuance of shares under ESPP \| $	$ 44,000,000
Number of common stock shares available for future issuance	907,303
Expected volatility term	5 years
Restricted stock units \| Boston Private
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units assumed in Boston Private acquisition (in units)		67,542
Restricted stock units \| Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock award	4 years
Performance Based Restricted Stock \| Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock award	3 years
Performance Based Restricted Stock \| Equity Incentive Plan \| Lower Limit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock award	1 year
Stock options \| Boston Private
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options assumed in Boston Private acquisition (in shares)		28,724
Stock options \| Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of stock award	4 years
Options granted under the 2006 Incentive Plan, expiration period	7 years

Share-Based Compensation - Unre

Share-Based Compensation - Unrecognized Share-Based Compensation Expense (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Expense	$ 248
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Expense	$ 13
Weighted Average Expected Recognition Period - in Years	2 years 4 months 20 days
Restricted stock awards/units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Expense	$ 235
Weighted Average Expected Recognition Period - in Years	2 years 8 months 4 days

Share-Based Compensation - Weig

Share-Based Compensation - Weighted Average Assumptions and Fair Values Used for Employee Stock Options and Restricted Stock Units (Details) - Equity Incentive Plan - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected volatility of the Company's underlying common stock	46.10%	43.50%	41.90%
Risk-free interest rate	3.06%	0.85%	0.37%
Expected dividend yield	$ 0	$ 0	$ 0
Weighted average grant date fair value - stock options (usd per share)	$ 202.81	$ 224.63	$ 66.44
Weighted average grant date fair value - restricted stock units (usd per share)	$ 463.10	$ 554.32	$ 199.51
Weighted average
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected term of options - in years	4 years 8 months 12 days	4 years 8 months 12 days	4 years 7 months 6 days

Share-Based Compensation - We_2

Share-Based Compensation - Weighted Average Assumptions and Fair Values Used for ESPP (Details) - Employee Stock Purchase Plan - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share based Compensation Arrangement by Share based Payment Award, Fair Value Assumptions, Method Used [Line Items]
Expected term in years	6 months	6 months	6 months
Weighted average expected volatility of the Company's underlying common stock	43.50%	36.20%	51.90%
Risk-free interest rate	1.04%	0.08%	1.12%
Expected dividend yield	$ 0	$ 0	$ 0
Weighted average grant date fair value (usd per share)	$ 156.24	$ 108.83	$ 69.54

Share-Based Compensation - Stoc

Share-Based Compensation - Stock Option Information Related to Equity Incentive Plan (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Options
Outstanding, beginning of period (in shares) \| shares	475,626
Granted (in shares) \| shares	77,888
Exercised (in shares) \| shares	(40,326)
Forfeited (in shares) \| shares	(23,546)
Outstanding, end of period (in shares) \| shares	489,642
Vested and expected to vest (in shares) \| shares	480,972
Exercisable (in shares) \| shares	300,872
Weighted average exercise price
Outstanding, beginning of period (usd per share)	$ 260.77
Granted (usd per share)	477.80
Exercised (usd per share)	184.75
Forfeited (usd per share)	385.40
Outstanding, end of period (usd per share)	295.48
Vested and expected to vest (usd per share)	293.91
Exercisable (usd per share)	$ 238.23
Weighted Average Remaining Contractual Life in Years
Outstanding (in years)	3 years 9 months 18 days
Vested and expected to vest (in years)	3 years 9 months 7 days
Exercisable (in years)	2 years 10 months 2 days
Aggregate Intrinsic Value of In-The-Money Options
Outstanding \| $	$ 11,968,937
Vested and expected to vest \| $	11,851,281
Exercisable \| $	$ 9,528,647
Closing stock price	$ 230.14

Share-Based Compensation - Info

Share-Based Compensation - Information for Restricted Stock Units (Details) - Restricted stock units	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Shares
Nonvested, beginning of period (in shares) \| shares	1,016,146
Granted (in shares) \| shares	548,856
Vested (in shares) \| shares	(390,593)
Forfeited (in shares) \| shares	(91,957)
Nonvested, end of period (in shares) \| shares	1,082,452
Weighted Average Grant Date Fair Value
Nonvested, beginning of period (usd per share) \| $ / shares	$ 328.87
Granted (usd per share) \| $ / shares	463.10
Vested (usd per share) \| $ / shares	279.34
Forfeited (usd per share) \| $ / shares	379.94
Nonvested, end of period (usd per share) \| $ / shares	$ 405.62

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Information Regarding Stock Option and Restricted Stock Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of stock options exercised	$ 14	$ 68	$ 25
Total grant date fair value of stock options vested	14	7	6
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of restricted stock vested	205	164	56
Total grant date fair value of restricted stock vested	$ 126	$ 68	$ 47

Variable Interest Entities - Ca

Variable Interest Entities - Carrying Amounts and Classification of Significant Variable Interests (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 13,803	$ 14,586
Non-marketable and other equity securities	2,664	2,543
Accrued interest receivable and other assets	3,082	1,791
Total assets	211,793	211,308
Other liabilities	3,041	2,467
Long-term debt	5,370	2,570
Total liabilities	195,498	194,699
Investments in Affordable Housing Projects [Abstract]
Investments in qualified affordable housing projects, net	1,306	954
Related other liabilities of unfunded credit commitments	754	482
Consolidated VIEs
Variable Interest Entity [Line Items]
Cash and cash equivalents	20	13
Non-marketable and other equity securities	735	768
Accrued interest receivable and other assets	8	31
Total assets	763	812
Other liabilities	31	18
Long-term debt	0	0
Total liabilities	31	18
Maximum Exposure to Loss in Unconsolidated VIEs	732
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Cash and cash equivalents	0	0
Non-marketable and other equity securities	1,457	1,233
Accrued interest receivable and other assets	6	6
Total assets	1,463	1,239
Other liabilities	759	482
Long-term debt	91	90
Total liabilities	850	572
Maximum Exposure to Loss in Unconsolidated VIEs	1,457	1,233
Non-marketable securities \| Unconsolidated VIEs
Variable Interest Entity [Line Items]
Maximum Exposure to Loss in Unconsolidated VIEs	$ 1,457	$ 1,233

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information (Details) $ in Millions	Dec. 31, 2022 USD ($) entity	Dec. 31, 2021 USD ($)
Investments In Variable Interest Entities [Abstract]
Number of consolidated entities \| entity	4
Consolidated VIEs
Variable Interest Entity [Line Items]
Maximum Exposure to Loss in Unconsolidated VIEs	$ 732
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Maximum Exposure to Loss in Unconsolidated VIEs	$ 1,457	$ 1,233

Reserves on Deposit with the _3

Reserves on Deposit with the Federal Reserve Bank and Federal Bank Stock - Shares Held at Federal Reserve Bank and Federal Home Loan Bank (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Federal Home Loan Bank Stock and Federal Reserve Bank Stock [Abstract]
FHLB stock holdings	$ 418	$ 26
FRB stock holdings	$ 302	$ 81

Cash and Cash Equivalents - Sum

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and due from banks	$ 1,293	$ 2,168
Interest-bearing deposits with the FRB	7,823	5,686
Interest-bearing deposits with other institutions	3,965	5,773
Securities purchased under agreements to resell	722	607
Other short-term investment securities	0	352
Cash and cash equivalents	$ 13,803	$ 14,586

Cash and Cash Equivalents - S_2

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Footnote Information) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Fair value of securities purchased under agreements to resell	$ 734,000,000	$ 620,000,000
Securities received as collateral, amount repledged and sold	$ 0	$ 0

Cash and Cash Equivalents - Sec

Cash and Cash Equivalents - Securities Purchased Under Agreements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Average securities purchased under agreements to resell	$ 290	$ 286
Maximum amount outstanding at any month-end during the year	$ 721	$ 762

Investment Securities - Compone

Investment Securities - Components of Available-for-Sale Investment Securities Portfolio (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Total AFS securities	$ 28,602	$ 27,370
Unrealized Gains	0	164
Unrealized Losses	(2,533)	(313)
Available-for-sale securities	26,069	27,221
U.S. Treasury securities
Investment Holdings [Line Items]
Total AFS securities	17,206	15,799
Unrealized Gains	0	121
Unrealized Losses	(1,071)	(70)
Available-for-sale securities	16,135	15,850
U.S. agency debentures
Investment Holdings [Line Items]
Total AFS securities	120	200
Unrealized Gains	0	0
Unrealized Losses	(19)	(4)
Available-for-sale securities	101	196
Foreign government debt securities
Investment Holdings [Line Items]
Total AFS securities	1,209	61
Unrealized Gains	0	0
Unrealized Losses	(121)	0
Available-for-sale securities	1,088	61
Agency-issued MBS
Investment Holdings [Line Items]
Total AFS securities	7,701	8,786
Unrealized Gains	0	13
Unrealized Losses	(1,098)	(210)
Available-for-sale securities	6,603	8,589
Agency-issued CMO—fixed rate
Investment Holdings [Line Items]
Total AFS securities	762	988
Unrealized Gains	0	3
Unrealized Losses	(84)	(9)
Available-for-sale securities	678	982
Agency-issued CMBS
Investment Holdings [Line Items]
Total AFS securities	1,604	1,536
Unrealized Gains	0	27
Unrealized Losses	(140)	(20)
Available-for-sale securities	$ 1,464	$ 1,543

Investment Securities - Activit

Investment Securities - Activity of Available-for-Sale Securities (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Sales proceeds	$ 9,495	$ 1,591	$ 2,654
Gross realized gains	146	31	61
Gross realized losses	(125)	0	0
Net realized gains (losses)	$ 21	$ 31	$ 61

Investment Securities - Summary

Investment Securities - Summary of Unrealized Losses on Available-for-Sale Securities (Detail)	Dec. 31, 2022 USD ($) Investment	Dec. 31, 2021 USD ($) Investment
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	$ 15,724,000,000	$ 17,596,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(1,109,000,000)	(304,000,000)
Fair Value of Investments, 12 months or longer	10,344,000,000	163,000,000
Unrealized Losses, 12 months or longer	(1,424,000,000)	(9,000,000)
Fair Value of Investments	26,068,000,000	17,759,000,000
Unrealized Losses	$ (2,533,000,000)	$ (313,000,000)
Number of investments in unrealized loss position \| Investment	810	475
Number of investments with unrealized losses greater than 12 months \| Investment	346	4
Investments in our AFS securities portfolio past due	$ 0	$ 0
U.S. Treasury securities
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	11,946,000,000	7,777,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(717,000,000)	(70,000,000)
Fair Value of Investments, 12 months or longer	4,189,000,000	0
Unrealized Losses, 12 months or longer	(354,000,000)	0
Fair Value of Investments	16,135,000,000	7,777,000,000
Unrealized Losses	(1,071,000,000)	(70,000,000)
U.S. agency debentures
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	0	196,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	0	(4,000,000)
Fair Value of Investments, 12 months or longer	101,000,000	0
Unrealized Losses, 12 months or longer	(19,000,000)	0
Fair Value of Investments	101,000,000	196,000,000
Unrealized Losses	(19,000,000)	(4,000,000)
Foreign government debt securities
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	1,088,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(121,000,000)
Fair Value of Investments, 12 months or longer	0
Unrealized Losses, 12 months or longer	0
Fair Value of Investments	1,088,000,000
Unrealized Losses	(121,000,000)
Agency-issued MBS
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	1,744,000,000	8,280,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(203,000,000)	(210,000,000)
Fair Value of Investments, 12 months or longer	4,859,000,000	0
Unrealized Losses, 12 months or longer	(895,000,000)	0
Fair Value of Investments	6,603,000,000	8,280,000,000
Unrealized Losses	(1,098,000,000)	(210,000,000)
Agency-issued CMO—fixed rate
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	136,000,000	740,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(11,000,000)	(9,000,000)
Fair Value of Investments, 12 months or longer	542,000,000	0
Unrealized Losses, 12 months or longer	(73,000,000)	0
Fair Value of Investments	678,000,000	740,000,000
Unrealized Losses	(84,000,000)	(9,000,000)
Agency-issued CMBS
Investments, Unrealized Loss Position [Line Items]
Fair Value of Investments, Less than 12 months	810,000,000	603,000,000
Unrealized Losses, Less than 12 months (less than $1 million at December 31, 2020 for U.S. Treasury AFS)	(57,000,000)	(11,000,000)
Fair Value of Investments, 12 months or longer	653,000,000	163,000,000
Unrealized Losses, 12 months or longer	(83,000,000)	(9,000,000)
Fair Value of Investments	1,463,000,000	766,000,000
Unrealized Losses	$ (140,000,000)	$ (20,000,000)

Investment Securities - Summa_2

Investment Securities - Summary of Remaining Contractual Principal Maturities for Available-for-Sale Securities (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	$ 26,069	$ 27,221
One Year or Less	1,084
After One Year to Five Years	14,784
After Five Years to Ten Years	2,963
After Ten Years	7,238
U.S. Treasury securities
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	16,135	15,850
One Year or Less	983
After One Year to Five Years	14,373
After Five Years to Ten Years	779
After Ten Years	0
U.S. agency debentures
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	101	196
One Year or Less	0
After One Year to Five Years	33
After Five Years to Ten Years	68
After Ten Years	0
Foreign government debt securities
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	1,088	61
One Year or Less	101
After One Year to Five Years	52
After Five Years to Ten Years	935
After Ten Years	0
Agency-issued MBS
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	6,603	8,589
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	43
After Ten Years	6,560
Agency-issued CMO—fixed rate
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	678	982
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	0
After Ten Years	678
Agency-issued CMBS
Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	1,464	$ 1,543
One Year or Less	0
After One Year to Five Years	326
After Five Years to Ten Years	1,138
After Ten Years	$ 0
Lower Limit \| Available-for-sale Securities
Investments Classified By Contractual Maturity Date [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Upper Limit \| Available-for-sale Securities
Investments Classified By Contractual Maturity Date [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

Investment Securities - Compo_2

Investment Securities - Components and Unrealized Losses on Held-to-Maturity Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]
AFS securities transferred to HTM securities	$ 8,800
AFS securities transferred to HTM securities, unrealized gains (losses)	132
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	98,202	$ 91,327
Unrealized Gains	368	2
Unrealized Losses	(1,343)	(15,160)
Fair Value	97,227	76,169
Allowance for credit losses	7	6	$ 1
Net Carry Value	98,195	91,321
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	609	486
Unrealized Gains	8	0
Unrealized Losses	(2)	(52)
Fair Value	615	434
Allowance for credit losses	0	0
Net Carry Value	609	486
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	64,439	57,705
Unrealized Gains	124	0
Unrealized Losses	(887)	(9,349)
Fair Value	63,676	48,356
Allowance for credit losses	0	0
Net Carry Value	64,439	57,705
Agency-issued CMO \| Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	10,226	10,461
Unrealized Gains	9	0
Unrealized Losses	(145)	(1,885)
Fair Value	10,090	8,576
Allowance for credit losses	0	0
Net Carry Value	10,226	10,461
Agency-issued CMO \| Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	100	79
Unrealized Gains	1	0
Unrealized Losses	0	(2)
Fair Value	101	77
Allowance for credit losses	0	0
Net Carry Value	100	79
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	14,959	14,471
Unrealized Gains	39	0
Unrealized Losses	(277)	(2,494)
Fair Value	14,721	11,977
Allowance for credit losses	0	0
Net Carry Value	14,959	14,471
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	7,157	7,417
Unrealized Gains	185	2
Unrealized Losses	(27)	(1,269)
Fair Value	7,315	6,150
Allowance for credit losses	1	1
Net Carry Value	7,156	7,416
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	712	708
Unrealized Gains	2	0
Unrealized Losses	(5)	(109)
Fair Value	709	599
Allowance for credit losses	6	5
Net Carry Value	$ 706	$ 703

Investment Securities - Allowan

Investment Securities - Allowance for Credit Losses for HTM Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss [Abstract]
Beginning balance, ACL	$ 7	$ 1
Allowance for credit losses for HTM securities	1	(7)
Ending balance, ACL	$ 6	$ 7

Investment Securities - Credit

Investment Securities - Credit Quality Indicators (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	$ 91,327	$ 98,202
Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	7,417	7,157
Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	708	712
Aaa \| Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	4,263	3,774
Aaa \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	39	39
Aa1 \| Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	1,843	2,031
Aa2 \| Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	1,113	1,154
Aa2 \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	42	42
Aa3 \| Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	171	172
Aa3 \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	127	105
A1 \| Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	27	26
A1 \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	280	251
A2 \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	209	264
A3 \| Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity debt securities, at amortized cost	$ 11	$ 11

Investment Securities - Summa_3

Investment Securities - Summary of Remaining Contractual Principal Maturities for Held-to-Maturity Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	$ 91,321
Fair Value	76,169	$ 97,227
One Year or Less - Amortized Cost	69
One Year or Less - Fair Value	68
After One Year to Five Years - Amortized Cost	736
After One Year to Five Years - Fair Value	689
After Five Years to Ten Years - Amortized Cost	4,478
After Five Years to Ten Years - Fair Value	3,986
After Ten Years - Amortized Cost	86,038
After Ten Years - Fair Value	71,426
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	486
Fair Value	434	615
One Year or Less - Amortized Cost	1
One Year or Less - Fair Value	1
After One Year to Five Years - Amortized Cost	118
After One Year to Five Years - Fair Value	111
After Five Years to Ten Years - Amortized Cost	367
After Five Years to Ten Years - Fair Value	322
After Ten Years - Amortized Cost	0
After Ten Years - Fair Value	0
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	57,705
Fair Value	48,356	63,676
One Year or Less - Amortized Cost	0
One Year or Less - Fair Value	0
After One Year to Five Years - Amortized Cost	25
After One Year to Five Years - Fair Value	24
After Five Years to Ten Years - Amortized Cost	1,066
After Five Years to Ten Years - Fair Value	994
After Ten Years - Amortized Cost	56,614
After Ten Years - Fair Value	47,338
Agency-issued CMO \| Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	10,461
Fair Value	8,576	10,090
One Year or Less - Amortized Cost	0
One Year or Less - Fair Value	0
After One Year to Five Years - Amortized Cost	90
After One Year to Five Years - Fair Value	86
After Five Years to Ten Years - Amortized Cost	129
After Five Years to Ten Years - Fair Value	120
After Ten Years - Amortized Cost	10,242
After Ten Years - Fair Value	8,370
Agency-issued CMO \| Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	79
Fair Value	77	101
One Year or Less - Amortized Cost	0
One Year or Less - Fair Value	0
After One Year to Five Years - Amortized Cost	0
After One Year to Five Years - Fair Value	0
After Five Years to Ten Years - Amortized Cost	0
After Five Years to Ten Years - Fair Value	0
After Ten Years - Amortized Cost	79
After Ten Years - Fair Value	77
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	14,471
Fair Value	11,977	14,721
One Year or Less - Amortized Cost	39
One Year or Less - Fair Value	38
After One Year to Five Years - Amortized Cost	153
After One Year to Five Years - Fair Value	141
After Five Years to Ten Years - Amortized Cost	966
After Five Years to Ten Years - Fair Value	810
After Ten Years - Amortized Cost	13,313
After Ten Years - Fair Value	10,988
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	7,416
Fair Value	6,150	7,315
One Year or Less - Amortized Cost	29
One Year or Less - Fair Value	29
After One Year to Five Years - Amortized Cost	235
After One Year to Five Years - Fair Value	224
After Five Years to Ten Years - Amortized Cost	1,362
After Five Years to Ten Years - Fair Value	1,244
After Ten Years - Amortized Cost	5,790
After Ten Years - Fair Value	4,653
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	703
Fair Value	599	$ 709
One Year or Less - Amortized Cost	0
One Year or Less - Fair Value	0
After One Year to Five Years - Amortized Cost	115
After One Year to Five Years - Fair Value	103
After Five Years to Ten Years - Amortized Cost	588
After Five Years to Ten Years - Fair Value	496
After Ten Years - Amortized Cost	0
After Ten Years - Fair Value	$ 0
Lower Limit \| Held-to-maturity securities
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Upper Limit \| Held-to-maturity securities
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

Investment Securities - Compo_3

Investment Securities - Components of Non-marketable and Other Securities (Detail) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Investments in qualified affordable housing projects, net	$ 1,306	$ 954
Non-marketable and other equity securities	2,664	2,543
Venture capital and private equity fund investments measured at net asset value \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	147	130
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	605	671
Unconsolidated venture capital and private equity fund investments \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	110	208
Unconsolidated venture capital and private equity fund investments \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	605	671
Other investments \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	183	164
Other investments \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	276	294
Equity securities \| Fair value accounting
Investment Holdings [Line Items]
Other equity securities	32	117
Debt funds \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	$ 5	$ 5

Investment Securities - Summa_4

Investment Securities - Summary of Venture Capital and Private Equity Fund Investments Held by Consolidated Funds and Percentage Ownership (Details) - Venture capital and private equity fund investments measured at net asset value - Fair value accounting - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Nonmarketable securities	$ 147	$ 130
Strategic Investors Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 2	$ 2
Strategic Investors Fund, LP \| Non-marketable securities
Investment Holdings [Line Items]
Ownership interest percentage	12.60%	12.60%
Capital Preferred Return Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 28	$ 61
Capital Preferred Return Fund, LP \| Non-marketable securities
Investment Holdings [Line Items]
Ownership interest percentage	20%	20%
Growth Partners, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 24	$ 67
Growth Partners, LP \| Non-marketable securities
Investment Holdings [Line Items]
Ownership interest percentage	33%	33%
Redwood Evergreen Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 93	$ 0
Redwood Evergreen Fund, LP \| Non-marketable securities
Investment Holdings [Line Items]
Ownership interest percentage	100%	0%

Investment Securities - Other I

Investment Securities - Other Investments Without a Readily Determinable Fair Value (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Investments, Debt and Equity Securities [Abstract]
Carrying value at December 31, 2022	$ 183
Year end Adjustments
Impairment	(23)
Upward changes for observable prices	0
Downward changes for observable prices	(6)
Cumulative Adjustments
Impairment	(24)
Upward changes for observable prices	52
Downward changes for observable prices	$ 11

Investment Securities - Unconso

Investment Securities - Unconsolidated Venture Capital and Private Equity Fund Investments (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) Investment	Dec. 31, 2021 USD ($) Investment
Upper Limit
Investment Holdings [Line Items]
Ownership interest percentage	5%
Unconsolidated venture capital and private equity fund investments \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities \| $	$ 110	$ 208
Non-marketable securities \| Unconsolidated venture capital and private equity fund investments \| Fair value accounting
Investment Holdings [Line Items]
Number of investments \| Investment	136	150

Investment Securities - Nonmark

Investment Securities - Nonmarketable Securities Under Equity Method Accounting (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	$ 605	$ 671
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Nonmarketable securities	2	3
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Nonmarketable securities	12	25
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Nonmarketable securities	21	36
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund V funds
Investment Holdings [Line Items]
Nonmarketable securities	58	87
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| CP II, LP
Investment Holdings [Line Items]
Nonmarketable securities	1	2
Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Other venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	511	518
Debt funds \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	5	5
Debt funds \| Equity method accounting \| Gold Hill Capital 2008, LP (ii)
Investment Holdings [Line Items]
Nonmarketable securities	4	4
Debt funds \| Equity method accounting \| Other debt funds
Investment Holdings [Line Items]
Nonmarketable securities	1	1
Other investments \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	276	294
Other investments \| Equity method accounting \| SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Nonmarketable securities	146	154
Other investments \| Equity method accounting \| Other investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 130	$ 140
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| CP II, LP \| Direct ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	1.30%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| CP II, LP \| Indirect ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	3.80%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Ownership interest percentage	8.60%	8.60%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Ownership interest percentage	5.90%	5.90%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Ownership interest percentage	5%	5%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| CP II, LP
Investment Holdings [Line Items]
Ownership interest percentage	5.10%	5.10%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| CP II, LP \| Direct ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	1.30%
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting \| CP II, LP \| Indirect ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	3.80%
Non-marketable securities \| Debt funds \| Equity method accounting \| Direct ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	11.50%
Non-marketable securities \| Debt funds \| Equity method accounting \| Indirect ownership interest
Investment Holdings [Line Items]
Ownership interest percentage	4%
Non-marketable securities \| Debt funds \| Equity method accounting \| Gold Hill Capital 2008, LP (ii)
Investment Holdings [Line Items]
Ownership interest percentage	15.50%	15.50%
Non-marketable securities \| Other investments \| Equity method accounting \| SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Ownership interest percentage	50%	50%

Investment Securities - Qualifi

Investment Securities - Qualified Affordable Housing Projects (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Investments in Affordable Housing Projects [Abstract]
Investments in qualified affordable housing projects, net	$ 1,306	$ 954
Other liabilities	754	482
Tax credits and other tax benefits recognized	99	77	$ 57
Amortization expense included in provision for income taxes	$ 80	$ 64	$ 44

Investment Securities - Compo_4

Investment Securities - Components of Gains and Losses (Realized and Unrealized) on Investment Securities (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	$ (306)	$ 730	$ 360
Non-marketable securities
Gain (Loss) on Securities [Line Items]
Less: Realized net losses on the sales and OTTI of non-marketable and other equity securities	19	(85)	(24)
Net gains (losses) on non-marketable and other equity securities still held	(287)	645	336
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Fair value accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	(101)	71	32
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	(49)	474	162
Non-marketable securities \| Unconsolidated venture capital and private equity fund investments \| Fair value accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	(86)	75	60
Non-marketable securities \| Other investments \| Fair value accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	(26)	75	0
Non-marketable securities \| Other investments \| Equity method accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	9	10	1
Non-marketable securities \| Debt funds \| Equity method accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	(1)	2	0
Other equity securities \| Fair value accounting
Gain (Loss) on Securities [Line Items]
Gains (losses) on non-marketable and other equity securities, net	$ (52)	$ 23	$ 105

Loans and Allowance for Credi_3

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 74,250	$ 66,276
Allowance for credit losses: loans	(636)	(422)	$ (448)	$ (305)
Net loans	73,614	65,854
Unearned income on loans	283	250
Credit card receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	555	583
Construction loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	539	367
Global fund banking
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	41,269	37,958
Allowance for credit losses: loans	(110)	(67)	(46)	(107)
Investor dependent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	6,713	5,544
Allowance for credit losses: loans	(273)	(146)	(213)	(82)
Investor dependent \| Early stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,950	1,593
Investor dependent \| Growth stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	4,763	3,951
Cash flow dependent and innovation C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses: loans	(155)	(118)	(125)	(81)
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,966	1,798
Cash flow dependent and innovation C&I \| Innovation C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	8,609	6,673
Private Bank
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	10,477	8,743
Allowance for credit losses: loans	(50)	(33)	(53)	(22)
CRE
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	2,583	2,670
Allowance for credit losses: loans	(25)	(36)	0
Premium wine and other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for credit losses: loans	(10)	(8)	(9)	(13)
Premium wine and other \| Premium wine
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,158	985
Premium wine and other \| Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	433	317
Other C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,019	1,257
Allowance for credit losses: loans	(13)	(14)	0
PPP
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 23	331
Allowance for credit losses: loans		$ 0	$ (2)	$ 0

Loans and Allowance for Credi_4

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Credit Quality Indicators, Broken out by Class of Financing Receivables and Vintage Year (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	$ 11,486	$ 11,032
Year Two	7,876	5,880
Year Three	3,687	3,045
Year Four	1,951	1,279
Year Five	766	1,006
Prior	2,452	2,462
Revolving Loans	46,036	41,516
Revolving Loans Converted to Term Loans	71	77
Unallocated	(75)	(21)
Loans, amortized cost	74,250	66,276
Global fund banking
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	543	814
Year Two	90	133
Year Three	55	36
Year Four	29	6
Year Five	1	8
Prior	5	5
Revolving Loans	40,543	36,956
Revolving Loans Converted to Term Loans	3	0
Unallocated	0	0
Loans, amortized cost	41,269	37,958
Global fund banking \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Global fund banking \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	543	764
Year Two	90	115
Year Three	55	36
Year Four	29	6
Year Five	1	8
Prior	5	4
Revolving Loans	40,539	36,955
Revolving Loans Converted to Term Loans	3	0
Unallocated	0	0
Loans, amortized cost	41,265	37,888
Global fund banking \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	50
Year Two	0	18
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	1
Revolving Loans	4	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	4	70
Investor dependent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	3,609	3,053
Year Two	2,046	1,374
Year Three	427	448
Year Four	58	117
Year Five	12	23
Prior	5	2
Revolving Loans	551	522
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	6,713	5,544
Investor dependent \| Early stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	1,045	820
Year Two	607	379
Year Three	63	155
Year Four	19	31
Year Five	1	6
Prior	0	1
Revolving Loans	215	201
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,950	1,593
Investor dependent \| Early stage \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	5	2
Year Two	7	5
Year Three	1	3
Year Four	2	0
Year Five	0	0
Prior	0	0
Revolving Loans	2	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	17	11
Investor dependent \| Early stage \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	910	754
Year Two	480	287
Year Three	44	122
Year Four	12	26
Year Five	1	6
Prior	0	1
Revolving Loans	182	171
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,629	1,367
Investor dependent \| Early stage \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	130	64
Year Two	120	87
Year Three	18	30
Year Four	5	5
Year Five	0	0
Prior	0	0
Revolving Loans	31	29
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	304	215
Investor dependent \| Growth stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,564	2,233
Year Two	1,439	995
Year Three	364	293
Year Four	39	86
Year Five	11	17
Prior	5	1
Revolving Loans	336	321
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	4,763	3,951
Investor dependent \| Growth stage \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	20	2
Year Two	31	0
Year Three	0	1
Year Four	0	2
Year Five	0	0
Prior	0	0
Revolving Loans	4	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	55	6
Investor dependent \| Growth stage \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,358	2,072
Year Two	1,175	910
Year Three	283	265
Year Four	34	78
Year Five	8	14
Prior	2	1
Revolving Loans	300	286
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	4,165	3,631
Investor dependent \| Growth stage \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	186	159
Year Two	233	85
Year Three	81	27
Year Four	5	6
Year Five	3	3
Prior	3	0
Revolving Loans	32	34
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	543	314
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	947	875
Year Two	584	384
Year Three	185	284
Year Four	162	107
Year Five	16	83
Prior	30	15
Revolving Loans	42	50
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,966	1,798
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	12
Year Four	0	10
Year Five	0	7
Prior	0	0
Revolving Loans	0	5
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	34
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	930	875
Year Two	550	384
Year Three	169	252
Year Four	162	72
Year Five	14	76
Prior	19	2
Revolving Loans	37	35
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,881	1,696
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	17	0
Year Two	34	0
Year Three	16	20
Year Four	0	25
Year Five	2	0
Prior	11	13
Revolving Loans	5	10
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	85	68
Cash flow dependent and innovation C&I \| Innovation C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,626	2,294
Year Two	1,533	1,188
Year Three	663	350
Year Four	190	135
Year Five	16	58
Prior	35	0
Revolving Loans	3,546	2,648
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	8,609	6,673
Cash flow dependent and innovation C&I \| Innovation C&I \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	7	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	21	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	28	1
Cash flow dependent and innovation C&I \| Innovation C&I \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,554	2,230
Year Two	1,309	1,058
Year Three	495	288
Year Four	157	123
Year Five	5	58
Prior	35	0
Revolving Loans	3,152	2,411
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	7,707	6,168
Cash flow dependent and innovation C&I \| Innovation C&I \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	65	64
Year Two	224	130
Year Three	168	62
Year Four	33	12
Year Five	11	0
Prior	0	0
Revolving Loans	373	236
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	874	504
Private Bank
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,782	2,952
Year Two	2,770	2,015
Year Three	1,719	1,126
Year Four	916	529
Year Five	429	434
Prior	1,012	969
Revolving Loans	837	710
Revolving Loans Converted to Term Loans	12	8
Unallocated	0	0
Loans, amortized cost	10,477	8,743
Private Bank \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	2
Year Four	2	9
Year Five	1	0
Prior	20	8
Revolving Loans	1	2
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	25	21
Private Bank \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2,782	2,952
Year Two	2,754	2,015
Year Three	1,718	1,122
Year Four	912	520
Year Five	427	432
Prior	978	952
Revolving Loans	832	705
Revolving Loans Converted to Term Loans	12	8
Unallocated	0	0
Loans, amortized cost	10,415	8,706
Private Bank \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	16	0
Year Three	0	2
Year Four	2	0
Year Five	1	2
Prior	14	9
Revolving Loans	4	3
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	37	16
CRE
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	519	329
Year Two	287	254
Year Three	232	463
Year Four	349	192
Year Five	158	283
Prior	914	1,007
Revolving Loans	119	128
Revolving Loans Converted to Term Loans	5	14
Unallocated	0	0
Loans, amortized cost	2,583	2,670
CRE \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	5
Year Four	5	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	5	5
CRE \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	519	326
Year Two	276	215
Year Three	193	344
Year Four	211	155
Year Five	144	236
Prior	802	868
Revolving Loans	102	110
Revolving Loans Converted to Term Loans	5	2
Unallocated	0	0
Loans, amortized cost	2,252	2,256
CRE \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	3
Year Two	11	39
Year Three	39	114
Year Four	133	37
Year Five	14	47
Prior	112	139
Revolving Loans	17	18
Revolving Loans Converted to Term Loans	0	12
Unallocated	0	0
Loans, amortized cost	326	409
Premium wine and other \| Premium wine
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	310	218
Year Two	214	119
Year Three	90	167
Year Four	142	78
Year Five	52	71
Prior	144	162
Revolving Loans	173	136
Revolving Loans Converted to Term Loans	33	34
Unallocated	0	0
Loans, amortized cost	1,158	985
Premium wine and other \| Premium wine \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	309	217
Year Two	209	112
Year Three	90	156
Year Four	135	69
Year Five	43	71
Prior	135	162
Revolving Loans	163	125
Revolving Loans Converted to Term Loans	33	34
Unallocated	0	0
Loans, amortized cost	1,117	946
Premium wine and other \| Premium wine \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	1	1
Year Two	5	7
Year Three	0	11
Year Four	7	9
Year Five	9	0
Prior	9	0
Revolving Loans	10	11
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	41	39
Premium wine and other \| Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	114	61
Year Two	196	151
Year Three	150	83
Year Four	37	20
Year Five	0	16
Prior	0	0
Revolving Loans	9	7
Revolving Loans Converted to Term Loans	2	0
Unallocated	(75)	(21)
Loans, amortized cost	433	317
Premium wine and other \| Other \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other \| Other \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	114	61
Year Two	189	144
Year Three	148	82
Year Four	29	20
Year Five	0	14
Prior	0	0
Revolving Loans	9	7
Revolving Loans Converted to Term Loans	2	0
Unallocated	(75)	(21)
Loans, amortized cost	416	307
Premium wine and other \| Other \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	7	7
Year Three	2	1
Year Four	8	0
Year Five	0	2
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	17	10
Other C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	36	186
Year Two	141	181
Year Three	158	88
Year Four	68	95
Year Five	82	30
Prior	307	302
Revolving Loans	216	359
Revolving Loans Converted to Term Loans	11	16
Unallocated	0	0
Loans, amortized cost	1,019	1,257
Other C&I \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	0
Year Four	0	2
Year Five	0	0
Prior	1	1
Revolving Loans	0	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	2	4
Other C&I \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	34	181
Year Two	141	175
Year Three	156	82
Year Four	64	86
Year Five	81	28
Prior	284	301
Revolving Loans	207	350
Revolving Loans Converted to Term Loans	10	11
Unallocated	0	0
Loans, amortized cost	977	1,214
Other C&I \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	2	5
Year Two	0	6
Year Three	1	6
Year Four	4	7
Year Five	1	2
Prior	22	0
Revolving Loans	9	8
Revolving Loans Converted to Term Loans	1	5
Unallocated	0	0
Loans, amortized cost	40	39
PPP
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	250
Year Two	15	81
Year Three	8	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	23	331
PPP \| Nonperforming
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	2
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	2
PPP \| Pass
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	226
Year Two	12	72
Year Three	3	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	15	298
PPP \| Criticized
Accounts, Notes, Loans and Financing Receivable [Line Items]
Year One	0	22
Year Two	3	9
Year Three	5	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	$ 8	$ 31

Loans and Allowance for Credi_5

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Activity Relating to our Allowance for Credit Losses for Loans (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Increase (decrease) in allowance for credit loss	$ 214,000
Interest receivable	402,000	$ 171,000
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	422,000	448,000	$ 305,000
Charge-offs	(103,000)	(138,000)	(103,000)
Recoveries	32,000	24,000	29,000
Provision (Reduction) for Loans	288,000	66,000	189,000
Foreign Currency Translation Adjustments	(3,000)		3,000
Allowance for credit loss, ending balance	636,000	422,000	448,000
Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			25,000
Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		22,000
Allowance for credit loss, ending balance			22,000
Global fund banking
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	67,000	46,000	107,000
Charge-offs	0	(80,000)	0
Recoveries	7,000	0	0
Provision (Reduction) for Loans	36,000	101,000	9,000
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	110,000	67,000	46,000
Global fund banking \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			(70,000)
Global fund banking \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		0
Allowance for credit loss, ending balance			0
Investor dependent
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	146,000	213,000	82,000
Charge-offs	(79,000)	(46,000)	(89,000)
Recoveries	20,000	18,000	25,000
Provision (Reduction) for Loans	184,000	(39,000)	125,000
Foreign Currency Translation Adjustments	2,000		(2,000)
Allowance for credit loss, ending balance	273,000	146,000	213,000
Investor dependent \| Non-PCD loan
Financing Receivable, Impaired [Line Items]
Provision (Reduction) for Loans		44,000
Investor dependent \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			72,000
Investor dependent \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		0
Allowance for credit loss, ending balance			0
Cash flow dependent and innovation C&I
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	118,000	125,000	81,000
Charge-offs	(19,000)	(8,000)	(11,000)
Recoveries	1,000	6,000	3,000
Provision (Reduction) for Loans	55,000	(5,000)	53,000
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	155,000	118,000	125,000
Cash flow dependent and innovation C&I \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			(1,000)
Cash flow dependent and innovation C&I \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		0
Allowance for credit loss, ending balance			0
Private Bank
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	33,000	53,000	22,000
Charge-offs	0	(3,000)	(2,000)
Recoveries	2,000	0	0
Provision (Reduction) for Loans	15,000	(18,000)	21,000
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	50,000	33,000	53,000
Private Bank \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			12,000
Private Bank \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		1,000
Allowance for credit loss, ending balance			1,000
CRE
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	36,000	0
Charge-offs	0	0
Recoveries	0	0
Provision (Reduction) for Loans	(11,000)	19,000
Foreign Currency Translation Adjustments	0
Allowance for credit loss, ending balance	25,000	36,000	0
CRE \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		17,000
Allowance for credit loss, ending balance			17,000
Other C&I
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	14,000	0
Charge-offs	(4,000)	0
Recoveries	1,000	0
Provision (Reduction) for Loans	2,000	10,000
Foreign Currency Translation Adjustments	0
Allowance for credit loss, ending balance	13,000	14,000	0
Other C&I \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		4,000
Allowance for credit loss, ending balance			4,000
Premium wine and other
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	8,000	9,000	13,000
Charge-offs	(1,000)	(1,000)	(1,000)
Recoveries	1,000	0	1,000
Provision (Reduction) for Loans	7,000	0	(21,000)
Foreign Currency Translation Adjustments	(5,000)		5,000
Allowance for credit loss, ending balance	10,000	8,000	9,000
Premium wine and other \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			12,000
Premium wine and other \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		0
Allowance for credit loss, ending balance			0
PPP
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance	$ 0	2,000	0
Charge-offs		0	0
Recoveries		0	0
Provision (Reduction) for Loans		(2,000)	2,000
Foreign Currency Translation Adjustments			0
Allowance for credit loss, ending balance		0	2,000
PPP \| Impact of Adopting ASC 326
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance			0
PPP \| Initial Allowance on PCD Loans
Financing Receivable, Impaired [Line Items]
Allowance for credit loss, beginning balance		$ 0
Allowance for credit loss, ending balance			$ 0

Loans and Allowance for Credi_6

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of the Aging of Loans Broken out by Risk-based Segments (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	$ 74,250	$ 66,276
Loans Past Due 90 Days or More Still Accruing Interest	5	7
30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	96	63
60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	17	8
90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	29	20
Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	142	91
Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	74,108	66,185
Global fund banking
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	41,269	37,958
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Global fund banking \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	20	0
Global fund banking \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Global fund banking \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Global fund banking \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	20	0
Global fund banking \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	41,249	37,958
Investor dependent
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	6,713	5,544
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	37	22
Investor dependent \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	13	5
Investor dependent \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	5	0
Investor dependent \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	55	27
Investor dependent \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	6,658	5,517
Investor dependent \| Early stage
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,950	1,593
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| Early stage \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	11	6
Investor dependent \| Early stage \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	13	5
Investor dependent \| Early stage \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2	0
Investor dependent \| Early stage \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	26	11
Investor dependent \| Early stage \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,924	1,582
Investor dependent \| Growth stage
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	4,763	3,951
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| Growth stage \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	26	16
Investor dependent \| Growth stage \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Investor dependent \| Growth stage \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	3	0
Investor dependent \| Growth stage \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	29	16
Investor dependent \| Growth stage \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	4,734	3,935
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,966	1,798
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,966	1,798
Cash flow dependent and innovation C&I \| Innovation C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	8,609	6,673
Loans Past Due 90 Days or More Still Accruing Interest	0	7
Cash flow dependent and innovation C&I \| Innovation C&I \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2	7
Cash flow dependent and innovation C&I \| Innovation C&I \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1	0
Cash flow dependent and innovation C&I \| Innovation C&I \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	7
Cash flow dependent and innovation C&I \| Innovation C&I \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	3	14
Cash flow dependent and innovation C&I \| Innovation C&I \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	8,606	6,659
Private Bank
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	10,477	8,743
Loans Past Due 90 Days or More Still Accruing Interest	1	0
Private Bank \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	22	28
Private Bank \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2	1
Private Bank \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	17	12
Private Bank \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	41	41
Private Bank \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	10,436	8,702
CRE
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2,583	2,670
Loans Past Due 90 Days or More Still Accruing Interest	0	0
CRE \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	10	1
CRE \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1	0
CRE \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
CRE \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	11	1
CRE \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2,572	2,669
Premium wine and other \| Premium wine
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,158	985
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other \| Premium wine \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	3	3
Premium wine and other \| Premium wine \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	3	3
Premium wine and other \| Premium wine \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,155	982
Premium wine and other \| Other
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	433	317
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other \| Other \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	433	317
Other C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,019	1,257
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Other C&I \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2	1
Other C&I \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	2
Other C&I \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	2	1
Other C&I \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	4	4
Other C&I \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	1,015	1,253
PPP
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	23	331
Loans Past Due 90 Days or More Still Accruing Interest	4	0
PPP \| 30 - 59 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	1
PPP \| 60 - 89 Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	0	0
PPP \| 90 or More Days Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	5	0
PPP \| Total Past Due
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	5	1
PPP \| Current
Financing Receivable, Allowance for Credit Loss [Line Items]
Loans, amortized cost	$ 18	$ 330

Loans and Allowance for Credi_7

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Nonaccrual Loans with No Allowance for Credit Loss (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	$ 132,000	$ 84,000
Nonaccrual Loans with no ACL	11,000	9,000
Investor dependent
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	72,000	17,000
Nonaccrual Loans with no ACL	3,000	0
Investor dependent \| Early stage
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	17,000	11,000
Nonaccrual Loans with no ACL	0	0
Investor dependent \| Growth stage
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	55,000	6,000
Nonaccrual Loans with no ACL	3,000	0
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	0	34,000
Nonaccrual Loans with no ACL	0	0
Cash flow dependent and innovation C&I \| Innovation C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	28,000	1,000
Nonaccrual Loans with no ACL	0	1,000
Private Bank
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	25,000	21,000
Nonaccrual Loans with no ACL	7,000	8,000
CRE
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	5,000	5,000
Nonaccrual Loans with no ACL	0	0
Other C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	2,000	4,000
Nonaccrual Loans with no ACL	1,000	0
PPP
Financing Receivable, Allowance for Credit Loss [Line Items]
Nonaccrual Loans	0	2,000
Nonaccrual Loans with no ACL	$ 0	$ 0

Loans and Allowance for Credi_8

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of Loans Modified in Troubled Debt Restructurings (TDRs) (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) troubled_debt_restructuring	Dec. 31, 2021 USD ($) troubled_debt_restructuring
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of TDRs \| troubled_debt_restructuring	36	62
Loans modified in TDRs	$ 90,000,000	$ 96,000,000
Unfunded commitments available for funding	0	0
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	31,000,000	15,000,000
Investor dependent \| Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1,000,000	12,000,000
Investor dependent \| Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	30,000,000	3,000,000
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	0	34,000,000
Cash flow dependent and innovation C&I \| Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1,000,000	0
Private Bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	24,000,000	12,000,000
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	33,000,000	33,000,000
Other C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	$ 1,000,000	$ 2,000,000

Loans and Allowance for Credi_9

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 53,000	$ 57,000	$ 56,000
Partial charge-offs on loans classified as TDRs	110,000	6,000	31,000
Payment deferrals
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	52,000	31,000	55,000
Partial forgiveness of principal
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		2,000	1,000
Interest rate reductions
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	2,000
Combination Of TDR Modifications
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		22,000
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	30,000	12,000	32,000
Investor dependent \| Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	12,000	6,000
Investor dependent \| Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	30,000	0	26,000
Cash flow dependent and innovation C&I \| Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	12,000	22,000
Cash flow dependent and innovation C&I \| Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	0	1,000
Private Bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	17,000	4,000	0
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	5,000	29,000	0
Premium wine and other \| Premium wine
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 0	$ 0	$ 1,000

Loans and Allowance for Cred_10

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs within Previous 12 months Subsequently Defaulted (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Troubled Debt Restructuring [Line Items]
TDRs modified within the previous 12 months that defaulted in the period		$ 0
Investor dependent \| Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
TDRs modified within the previous 12 months that defaulted in the period	$ 1
Premium wine and other \| Premium wine
Financing Receivable, Troubled Debt Restructuring [Line Items]
TDRs modified within the previous 12 months that defaulted in the period			$ 1
Cash flow dependent and innovation C&I \| Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
TDRs modified within the previous 12 months that defaulted in the period	$ 1

Loans and Allowance for Cred_11

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Activity in Allowance for Unfunded Commitments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Increase in ACL for unfunded commitments	$ (214,000)
Allowance for credit loss, beginning balance	422,000	$ 448,000	$ 305,000
Provision for credit losses	288,000	66,000	189,000
Foreign currency translation adjustments	(3,000)		3,000
Allowance for credit loss, ending balance	636,000	422,000	448,000
Impact of Adopting ASC 326
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance			25,000
Unfunded credit commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Increase in ACL for unfunded commitments	132,000
Allowance for credit loss, beginning balance	171,000	121,000	68,000
Provision for credit losses	133,000	50,000	30,000
Foreign currency translation adjustments	(1,000)	0	0
Allowance for credit loss, ending balance	303,000	171,000	121,000
Unfunded credit commitments \| Impact of Adopting ASC 326
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	$ 0	0	23,000
Allowance for credit loss, ending balance		$ 0	$ 0

Premises and Equipment - Summar

Premises and Equipment - Summary of Premises and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Computer software	$ 581	$ 408
Computer hardware	116	102
Leasehold improvements	164	149
Furniture and equipment	59	53
Building	3	3
Total	923	715
Accumulated depreciation and amortization	(529)	(445)
Premises and equipment, net	$ 394	$ 270

Premises and Equipment - Additi

Premises and Equipment - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 91	$ 64	$ 53

Leases - Lease Assets and Liabi

Leases - Lease Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Lease right-of-use assets	$ 335	$ 313
Lease liabilities	$ 413	$ 388

Leases - Lease Expense Componen

Leases - Lease Expense Components (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease cost	$ 68	$ 90	$ 69
Short-term lease cost	0	0	1
Variable lease cost	6	4	4
Less: sublease income	(3)	(4)	(2)
Total lease expense, net	71	90	72
Cash paid for operating leases	81	66	50
Lease obligations in exchange for obtaining right-of-use assets, operating leases	$ 88	$ 187	$ 75
Weighted-average remaining term (in years) - operating leases	7 years 8 months 12 days	7 years 3 months 14 days
Weighted-average discount rate - operating leases	2.25%	1.83%

Leases - Schedule of Future Lea

Leases - Schedule of Future Lease Payments (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2023	$ 85
2024	76
2025	64
2026	49
2027	39
2028 and thereafter	146
Total lease payments	459
Less: imputed interest	(46)
Total lease liabilities	$ 413	$ 388

Leases - Lease Exits (Details)

Leases - Lease Exits (Details) - USD ($) $ in Millions	12 Months Ended
Leases - Lease Exits (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Impairment charges on right-of-use asset	$ 3	$ 39

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 375,000,000	$ 375,000,000	$ 143,000,000
Impairment	0
Amortization expense	$ 24,000,000	$ 15,000,000	$ 5,000,000

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning balance	$ 375,000,000	$ 143,000,000
Acquisitions	0	232,000,000
Impairment	0
Ending balance	$ 375,000,000	$ 375,000,000

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other intangible assets:
Gross Amount	$ 192	$ 192
Accumulated Amortization	56	32
Net Carrying Amount	136	160
Customer relationships
Other intangible assets:
Gross Amount	135	135
Accumulated Amortization	30	16
Net Carrying Amount	105	119
Other
Other intangible assets:
Gross Amount	57	57
Accumulated Amortization	26	16
Net Carrying Amount	$ 31	$ 41

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 22,000
2024	20,000
2025	17,000
2026	15,000
2027	12,000
2028 and thereafter	50,000
Net Carrying Amount	$ 136,000	$ 160,000

Deposits - Composition of Depos

Deposits - Composition of Deposits (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deposits [Abstract]
Noninterest-bearing demand deposits	$ 80,753	$ 125,851
Interest bearing checking and savings	32,916	5,106
Money market	52,032	54,842
Money market deposits in foreign offices	51	696
Sweep deposits in foreign offices	664	969
Time	6,693	1,739
Total deposits	$ 173,109	$ 189,203

Deposits - Additional Informati

Deposits - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deposits [Abstract]
Time deposits equal to or greater than $250,000	$ 6,600	$ 1,600
Time deposits equal to or greater than $250,000 maturing within one year	$ 6,600

Short-Term Borrowings and Lon_3

Short-Term Borrowings and Long-Term Debt - Outstanding Short Term Borrowings and Long Term Debt (Details) - USD ($)	Dec. 31, 2022	Apr. 29, 2022	Dec. 31, 2021	Oct. 28, 2021	May 13, 2021	Feb. 02, 2021	Jun. 05, 2020	Jan. 31, 2015
Debt Outstanding [Line Items]
Short-term borrowings	$ 13,565,000,000		$ 71,000,000
Total long-term debt	$ 5,370,000,000		2,570,000,000
3.50% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	3.50%
3.125% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	3.125%
1.800% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	1.80%
2.100% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	2.10%
1.800% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	1.80%
4.345% Senior Fixed Rate/Floating Rate Notes
Debt Outstanding [Line Items]
Stated interest rate	4.345%
4.570% Senior Fixed Rate/Floating Rate Notes
Debt Outstanding [Line Items]
Stated interest rate	4.57%
Senior Notes \| 3.50% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate								3.50%
Principal value	$ 350,000,000							$ 350,000,000
Total long-term debt	349,000,000		349,000,000
Senior Notes \| 3.125% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate							3.125%
Principal value	500,000,000						$ 500,000,000
Total long-term debt	$ 496,000,000		496,000,000
Senior Notes \| 1.800% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	1.80%					1.80%
Principal value	$ 500,000,000					$ 500,000,000
Total long-term debt	$ 495,000,000		494,000,000
Senior Notes \| 2.100% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	2.10%				2.10%
Principal value	$ 500,000,000				$ 500,000,000
Total long-term debt	$ 497,000,000		496,000,000
Senior Notes \| 1.800% Senior Notes
Debt Outstanding [Line Items]
Stated interest rate	1.80%			1.80%
Principal value	$ 650,000,000			$ 650,000,000
Total long-term debt	646,000,000		645,000,000
Senior Notes \| 4.345% Senior Fixed Rate/Floating Rate Notes
Debt Outstanding [Line Items]
Stated interest rate		4.435%
Principal value	350,000,000	$ 350,000,000
Total long-term debt	348,000,000		0
Senior Notes \| 4.570% Senior Fixed Rate/Floating Rate Notes
Debt Outstanding [Line Items]
Stated interest rate		4.57%
Principal value	450,000,000	$ 450,000,000
Total long-term debt	448,000,000		0
Junior subordinated debentures
Debt Outstanding [Line Items]
Principal value	100,000,000
Total long-term debt	91,000,000		90,000,000
FHLB advances
Debt Outstanding [Line Items]
Principal value	2,000,000,000
Total long-term debt	2,000,000,000		0
Securities sold under agreements to repurchase
Debt Outstanding [Line Items]
Principal value	525,000,000
Short-term borrowings	525,000,000		61,000,000
Line of credit, remaining borrowing capacity	35,000,000,000
Other short-term borrowings
Debt Outstanding [Line Items]
Principal value	40,000,000
Short-term borrowings	40,000,000		10,000,000
FHLB advances
Debt Outstanding [Line Items]
Principal value	13,000,000,000
Short-term borrowings	$ 13,000,000,000		$ 0

Short-Term Borrowings and Lon_4

Short-Term Borrowings and Long-Term Debt - Aggregate Annual Maturities of Long-Term Debt Obligations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Long-term Debt, Fiscal Year Maturity [Abstract]
2023	$ 2,000
2024	0
2025	349
2026	646
2027	0
2028 and thereafter	2,375
Total	5,370	$ 2,570
Interest expense on debt	$ 326	$ 48	$ 25
Weighted average interest rate on short-term borrowings	290%	0.20%

Short-Term Borrowings and Lon_5

Short-Term Borrowings and Long-Term Debt - Short-term and Long-term Credit Facilities (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) borrowings	Dec. 31, 2021 USD ($)
Short-term Debt [Line Items]
Short-term advances	$ 13,565	$ 71
Long-term debt	$ 5,370	2,570
Number of borrowings \| borrowings	2
FHLB net weighted average fixed rate	4.69%
FHLB advances
Short-term Debt [Line Items]
Long-term debt	$ 2,000	0
FHLB advances
Short-term Debt [Line Items]
Short-term advances	13,000	0
FHLB advances	44,900	7,300
Amount of unused FHLB credit facility	25,900	$ 6,300
FRB advances
Short-term Debt [Line Items]
Line of credit, remaining borrowing capacity	5,300
Uncommitted federal funds lines
Short-term Debt [Line Items]
Line of credit, remaining borrowing capacity	$ 3,200

Short-Term Borrowings and Lon_6

Short-Term Borrowings and Long-Term Debt - Long-term Debt (Details)						1 Months Ended	12 Months Ended
	Apr. 29, 2022 USD ($)	Oct. 28, 2021 USD ($)	May 13, 2021 USD ($)	Feb. 02, 2021 USD ($)	Jun. 05, 2020 USD ($)	Jan. 31, 2015 USD ($)	Dec. 31, 2022 USD ($) quarterly_interest_payments	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Long-term debt							$ 5,370,000,000	$ 2,570,000,000
3.50% Senior Notes
Debt Instrument [Line Items]
Stated interest rate							3.50%
3.125% Senior Notes
Debt Instrument [Line Items]
Stated interest rate							3.125%
1.800% Senior Notes
Debt Instrument [Line Items]
Stated interest rate							1.80%
2.100% Senior Notes
Debt Instrument [Line Items]
Stated interest rate							2.10%
1.800% Senior Notes
Debt Instrument [Line Items]
Stated interest rate							1.80%
4.345% Senior Fixed Rate/Floating Rate Notes
Debt Instrument [Line Items]
Stated interest rate							4.345%
4.570% Senior Fixed Rate/Floating Rate Notes
Debt Instrument [Line Items]
Stated interest rate							4.57%
Senior Notes \| 3.50% Senior Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")						$ 350,000,000	$ 350,000,000
Stated interest rate						3.50%
Proceeds from issuance of senior notes, net of discount and issuance cost						$ 346,000,000
Long-term debt							349,000,000	349,000,000
Debt issuance costs							1,000,000
Discount on debt (less than $1 million for all but 1.800% Senior Notes due 2026 and 2031)							1,000,000
Senior Notes \| 3.125% Senior Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")					$ 500,000,000		500,000,000
Stated interest rate					3.125%
Proceeds from issuance of senior notes, net of discount and issuance cost					$ 496,000,000
Long-term debt							496,000,000	496,000,000
Debt issuance costs							4,000,000
Discount on debt (less than $1 million for all but 1.800% Senior Notes due 2026 and 2031)							1,000,000
Senior Notes \| 1.800% Senior Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")				$ 500,000,000			$ 500,000,000
Stated interest rate				1.80%			1.80%
Proceeds from issuance of senior notes, net of discount and issuance cost				$ 494,000,000
Long-term debt							$ 495,000,000	494,000,000
Debt issuance costs							4,000,000
Discount on debt (less than $1 million for all but 1.800% Senior Notes due 2026 and 2031)							1,000,000
Senior Notes \| 2.100% Senior Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")			$ 500,000,000				$ 500,000,000
Stated interest rate			2.10%				2.10%
Proceeds from issuance of senior notes, net of discount and issuance cost			$ 496,000,000
Long-term debt							$ 497,000,000	496,000,000
Debt issuance costs							3,000,000
Discount on debt (less than $1 million for all but 1.800% Senior Notes due 2026 and 2031)							1,000,000
Senior Notes \| 1.800% Senior Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")		$ 650,000,000					$ 650,000,000
Stated interest rate		1.80%					1.80%
Proceeds from issuance of senior notes, net of discount and issuance cost		$ 644,000,000
Long-term debt							$ 646,000,000	645,000,000
Debt issuance costs							3,000,000
Discount on debt (less than $1 million for all but 1.800% Senior Notes due 2026 and 2031)							1,000,000
Senior Notes \| 4.345% Senior Fixed Rate/Floating Rate Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")	$ 350,000,000						350,000,000
Stated interest rate	4.435%
Proceeds from issuance of senior notes, net of discount and issuance cost	$ 348,000,000
Long-term debt							348,000,000	0
Debt issuance costs							2,000,000
Senior Notes \| 4.570% Senior Fixed Rate/Floating Rate Notes
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")	$ 450,000,000						450,000,000
Stated interest rate	4.57%
Proceeds from issuance of senior notes, net of discount and issuance cost	$ 447,000,000
Long-term debt							448,000,000	0
Debt issuance costs							2,000,000
Junior subordinated debentures
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")							100,000,000
Long-term debt							91,000,000	$ 90,000,000
Junior subordinated debentures \| Boston Private Capital Trust II Junior Subordinated Debentures (Trust II)
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")							$ 100,000,000
Basis spread on variable rate							1.68%
Number of quarterly interest payments allowed to defer \| quarterly_interest_payments							20
Effective percentage on debt							2.676%
Investment in trust, carrying value							$ 3,000,000
Junior subordinated debentures \| Boston Private Capital Trust I Junior Subordinated Debenture (Trust I)
Debt Instrument [Line Items]
Principal value (less than $1 million for "Trust I")							$ 1,000,000
Stated interest rate		4.875%
Effective percentage on debt							4.875%
Investment in trust, carrying value							$ 3,000,000

Derivative Financial Instrume_3

Derivative Financial Instruments - Fair Value Hedges (Details) - Other assets - Interest rate swaps - Derivatives designated as hedging instruments - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Amortized Cost Basis of the Hedged Assets	$ 563	$ 15,260
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Active	(2)	(131)
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Terminated	$ (290)	6
Amortized cost of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		11,200
Amount of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		6,700
Cumulative adjustments of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		$ 83

Derivative Financial Instrume_4

Derivative Financial Instruments - Cash Flow Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2020
Derivative [Line Items]
Unrealized gains on terminated cash flow hedges remaining in AOCI, before tax	$ 60
Changes in fair value on bank cash flow hedges, net of reclassification adjustments in bank net income	$ 43
Remaining term over which unrealized gains will be reclassified into earnings	2 years
Interest rate swaps \| Derivatives designated as hedging instruments
Derivative [Line Items]
Notional balances		$ 5,000
Net asset fair value		$ 228

Derivative Financial Instrume_5

Derivative Financial Instruments - Currency Exchange Risk (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Net investment pretax gains (losses) recognized in AOCI	$ (18)

Derivative Financial Instrume_6

Derivative Financial Instruments - Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Fair Value, Derivative Assets	$ 382	$ 165
Fair Value, Derivative Liabilities	234	148
Derivative Assets, Total Gross Derivatives	903	565
Derivative Liabilities, Total Gross Derivatives	556	238
Less: netting adjustment (Derivative Assets)	(351)	(137)
Less: netting adjustment (Derivative Liabilities)	(223)	(120)
Derivative Assets, Total derivatives	552	428
Derivative Liabilities, Total derivatives	333	118
Cash collateral in excess of net derivative receivables	(31)
Cash collateral in excess of net derivative payables		1
Derivatives designated as hedging instruments
Derivative [Line Items]
Fair Value, Derivative Assets	17	18
Fair Value, Derivative Liabilities	56
Derivatives designated as hedging instruments \| Interest rate swaps \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	550	10,700
Fair Value, Derivative Assets	0	18
Approximate reduction amounts of derivative assets reflecting variation margin treated as settlement of the related derivative fair values	(74)
Derivatives designated as hedging instruments \| Foreign exchange contracts \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	778
Fair Value, Derivative Assets	17
Derivatives designated as hedging instruments \| Foreign exchange contracts \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	616
Fair Value, Derivative Liabilities	56
Derivatives not designated as hedging instruments
Derivative [Line Items]
Fair Value, Derivative Assets	886	547
Fair Value, Derivative Liabilities	500	238
Derivatives not designated as hedging instruments \| Foreign exchange contracts \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	1,763	701
Fair Value, Derivative Assets	42	16
Derivatives not designated as hedging instruments \| Foreign exchange contracts \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	2,184	62
Fair Value, Derivative Liabilities	29	2
Derivatives not designated as hedging instruments \| Equity warrant assets \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	375	322
Fair Value, Derivative Assets	383	277
Derivatives not designated as hedging instruments \| Contingent conversion rights \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	92
Fair Value, Derivative Assets	12
Derivatives not designated as hedging instruments \| Client foreign exchange forwards \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	10,145	8,245
Fair Value, Derivative Assets	262	146
Derivatives not designated as hedging instruments \| Client foreign exchange forwards \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	9,960	7,764
Fair Value, Derivative Liabilities	257	126
Derivatives not designated as hedging instruments \| Total Return Swap \| Other assets
Derivative [Line Items]
Fair Value, Derivative Assets	40	0
Derivatives not designated as hedging instruments \| Total Return Swap \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	119	0
Derivatives not designated as hedging instruments \| Client foreign currency options \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	866	688
Fair Value, Derivative Assets	19	9
Derivatives not designated as hedging instruments \| Client foreign currency options \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	866	688
Fair Value, Derivative Liabilities	19	9
Derivatives not designated as hedging instruments \| Client interest rate derivatives \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	2,391	2,178
Fair Value, Derivative Assets	128	99
Derivatives not designated as hedging instruments \| Client interest rate derivatives \| Other liability
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	2,709	2,315
Fair Value, Derivative Liabilities	$ 195	101
Approximate reduction amounts of derivative assets reflecting variation margin treated as settlement of the related derivative fair values		$ (112)

Derivative Financial Instrume_7

Derivative Financial Instruments - Summary of Derivative Activity and Related Impact on Consolidated Statements of Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ (193)	$ (52)	$ 82
Interest rate risks \| Derivatives designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	56	62	50
Interest rate risks \| Derivatives designated as hedging instruments \| Amounts reclassified from AOCI into income \| Interest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	56	63	50
Interest rate risks \| Derivatives designated as hedging instruments \| Change in fair value of interest rate swaps hedging investment securities \| Interest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	387	138	0
Interest rate risks \| Derivatives designated as hedging instruments \| Change in fair value of hedged investment securities \| Interest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(387)	(139)	0
Currency exchange risks \| Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(10)	0	(1)
Currency exchange risks \| Derivatives not designated as hedging instruments \| Gains (losses) on revaluations of internal foreign currency instruments, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(42)	(43)	39
Currency exchange risks \| Derivatives not designated as hedging instruments \| Gains (losses) on client foreign exchange forward contracts, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	32	43	(40)
Other derivative instruments \| Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	13	0	0
Other derivative instruments \| Derivatives not designated as hedging instruments \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	5	2	28
Other derivative instruments \| Derivatives not designated as hedging instruments \| Gains (losses) on revaluations of internal foreign currency instruments, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	23	17	3
Other derivative instruments \| Derivatives not designated as hedging instruments \| Gains (losses) on client foreign exchange forward contracts, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(10)	(17)	(3)
Total return swaps \| Derivatives not designated as hedging instruments \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	40	0	0
Equity warrant assets \| Derivatives not designated as hedging instruments \| Gains on equity warrant assets, net
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ 148	$ 560	$ 237

Derivative Financial Instrume_8

Derivative Financial Instruments - Balance Sheet Offsetting, Assets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative Assets
Gross Amounts of Recognized Assets	$ 382	$ 165
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(144)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Received	(207)	(50)
Net Amounts of Assets Presented in the Statement of Financial Position	31	28
Net Amount	31	28
Reverse repurchase, securities borrowing, and similar arrangements
Gross Amounts of Recognized Assets	722	607
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Assets Presented in the Statement of Financial Position	722	607
Gross Amounts Not Offset in the Statement of Financial Position	(722)	(607)
Net Amount	0	0
Total
Gross Amounts of Recognized Assets	1,104	772
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(144)	(87)
Net Amounts of Assets Presented in the Statement of Financial Position	753	635
Gross Amounts Not Offset in the Statement of Financial Position	(722)	(607)
Net Amount	$ 31	$ 28
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Accrued interest receivable and other assets	Accrued interest receivable and other assets

Derivative Financial Instrume_9

Derivative Financial Instruments - Balance Sheet Offsetting, Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative Liabilities
Gross Amounts of Recognized Liabilities	$ 234	$ 148
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(144)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Pledged	(79)	(33)
Net Amounts of Liabilities Presented in the Statement of Financial Position	11	28
Net Amount	11	28
Repurchase, securities lending, and similar arrangements
Gross Amounts of Recognized Liabilities	525	61
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Liabilities Presented in the Statement of Financial Position	525	61
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	525	61
Total
Gross Amounts of Recognized Liabilities	759	209
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(144)	(87)
Net Amounts of Liabilities Presented in the Statement of Financial Position	536	89
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	$ 536	$ 89
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other liabilities	Other liabilities

Noninterest Income - Summary of

Noninterest Income - Summary of Noninterest Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Gains (losses) on investment securities, net	$ (285)	$ 761	$ 421
Gains on equity warrant assets, net	148	560	237
Client investment fees	386	75	132
Wealth management and trust fees	83	44	0
Foreign exchange fees	285	262	179
Credit card fees	150	131	98
Deposit service charges	126	112	90
Lending related fees	94	76	57
Letters of credit and standby letters of credit fees	57	51	47
Investment banking revenue	420	459	414
Commissions	98	79	67
Other	166	128	98
Total noninterest income	$ 1,728	$ 2,738	$ 1,840

Noninterest Income - Gains on I

Noninterest Income - Gains on Investment Securities, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Gains (losses) on non-marketable and other equity securities, net	$ (306)	$ 730	$ 360
Gains (losses) on sales of AFS debt securities, net	21	31	61
Total gains (losses) on investment securities, net	$ (285)	$ 761	$ 421

Noninterest Income - Gains on E

Noninterest Income - Gains on Equity Warrant Assets, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Gains on exercises, net	$ 45	$ 446	$ 179
Terminations	(4)	(2)	(2)
Changes in fair value, net	107	116	60
Gains on equity warrant assets, net	$ 148	$ 560	$ 237

Noninterest Income - Client Inv

Noninterest Income - Client Investment Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Sweep money market fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	215	43	74
Asset management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	57	31	43
Repurchase agreement fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	114	1	15
Client investment fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 386	$ 75	$ 132

Noninterest Income - Wealth Man

Noninterest Income - Wealth Management and Trust Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Wealth management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	75	40	0
Trust fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	8	4	0
Wealth management and trust fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 83	$ 44	$ 0

Noninterest Income - Foreign Ex

Noninterest Income - Foreign Exchange Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue not from contracts with customer	$ 225	$ 1,424	$ 783
Foreign exchange fees	285	262	179
Foreign exchange contract commissions
Disaggregation of Revenue [Line Items]
Revenue not from contracts with customer	282	260	178
Option premium fees
Disaggregation of Revenue [Line Items]
Revenue not from contracts with customer	$ 3	$ 2	$ 1

Noninterest Income - Credit Car

Noninterest Income - Credit Card Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Revenue not from contracts with customer	225	1,424	783
Total credit card fees	150	131	98
Credit interchange fees, net
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	117	108	76
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	26	18	18
Card service fees
Disaggregation of Revenue [Line Items]
Revenue not from contracts with customer	$ 7	$ 5	$ 4

Noninterest Income - Lending Re

Noninterest Income - Lending Related Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Lending related fees	$ 94	$ 76	$ 57
Unused commitment fees
Disaggregation of Revenue [Line Items]
Lending related fees	70	59	42
Other
Disaggregation of Revenue [Line Items]
Lending related fees	$ 24	$ 17	$ 15

Noninterest Income - Investment

Noninterest Income - Investment Banking Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Underwriting fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	163	304	353
Advisory fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	214	90	40
Private placements and other
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 43	$ 65	$ 21

Noninterest Income - Summary _2

Noninterest Income - Summary of Other Noninterest Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Net gains (losses) on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)	3	0	(1)
Gains from conversion of convertible debt options	0	0	30
Gains on total return swaps	40	0	0
Other service revenue	64	61	30
Total other noninterest income	166	128	98
Fund management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 59	$ 67	$ 39

Noninterest Income - Disaggrega

Noninterest Income - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 1,503	$ 1,314	$ 1,057
Revenue not from contracts with customer	225	1,424	783
Noninterest income	1,728	2,738	1,840
Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	6	5	3
Revenue not from contracts with customer	124	874	505
Noninterest income	130	879	508
Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	829	640	525
Revenue not from contracts with customer	278	66	79
Noninterest income	1,107	706	604
SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	87	51	5
Revenue not from contracts with customer	9	7	0
Noninterest income	96	58	5
SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	58	75	36
Revenue not from contracts with customer	(168)	412	190
Noninterest income	(110)	487	226
SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	523	543	488
Revenue not from contracts with customer	(18)	65	9
Noninterest income	505	608	497
Client investment fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	386	75	132
Client investment fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	0	0
Client investment fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	384	73	129
Client investment fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	2	3
Client investment fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Client investment fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Wealth management and trust fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	83	44	0
Wealth management and trust fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0
Wealth management and trust fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0
Wealth management and trust fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	83	44
Wealth management and trust fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0
Wealth management and trust fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0
Card interchange fees, gross
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	227	201	130
Card interchange fees, gross \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	3	2	2
Card interchange fees, gross \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	223	198	127
Card interchange fees, gross \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	1	1
Card interchange fees, gross \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Card interchange fees, gross \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	26	18	18
Merchant service fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Merchant service fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	25	17	17
Merchant service fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	1	1
Merchant service fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Merchant service fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Deposit service charges
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	126	112	90
Deposit service charges \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	2	0
Deposit service charges \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	124	109	90
Deposit service charges \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	1	0
Deposit service charges \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Deposit service charges \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Investment banking revenue
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	420	459	414
Investment banking revenue \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Investment banking revenue \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Investment banking revenue \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Investment banking revenue \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Investment banking revenue \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	420	459	414
Commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	98	79	67
Commissions \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Commissions \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Commissions \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Commissions \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Commissions \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	98	79	67
Fund management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	59	67	39
Fund management fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Fund management fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	0	0
Fund management fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0
Fund management fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	52	62	32
Fund management fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	5	5	7
Other
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	78	259	167
Other \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	1
Other \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	71	243	162
Other \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	2	0
Other \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	6	13	4
Other \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 0	$ 0	$ 0

Income Taxes - Components of In

Income Taxes - Components of Income Before Income Taxes by Domestic and Foreign (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Components of income before income taxes by U.S and foreign
U.S.	$ 1,996	$ 2,624	$ 1,673
Foreign	176	100	69
Income before income tax expense	$ 2,172	$ 2,724	$ 1,742

Income Taxes - Components of Pr

Income Taxes - Components of Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current provision:
Federal	$ 34	$ 409	$ 282
State	(100)	224	141
Foreign	38	26	18
Deferred expense (benefit):
Federal	330	5	6
State	254	(11)	2
Foreign	7	(2)	(1)
Income tax expense	$ 563	$ 651	$ 448

Income Taxes - Reconciliation b

Income Taxes - Reconciliation between Federal Statutory Income Tax Rate and Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21%	21%	21%
State income taxes, net of the federal tax effect	6.80%	7.50%	6.80%
Share-based compensation expense on incentive stock options and ESPP	(0.80%)	(1.60%)	(0.30%)
Qualified affordable housing project tax credits	(0.40%)	(0.20%)	(0.50%)
Tax-exempt interest income	(1.60%)	(1.00%)	(0.80%)
Other, net	0.20%	0.50%	0.80%
Effective income tax rate	25.20%	26.20%	27%

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Allowance for credit losses	$ 260	$ 170
Share-based compensation expense	36	26
Accrued compensation	82	77
Loans and debt securities	0	113
Lease liability	112	105
Net operating loss carryforwards	1,650	7
Other	205	56
Deferred tax assets	2,345	554
Valuation allowance	(6)	(7)
Net deferred tax assets after valuation allowance	2,339	547
Deferred tax liabilities:
Derivative equity warrant assets	(80)	(82)
Net unrealized gains on cash flow hedge derivatives	(17)	(33)
Loans and debt securities	(1,773)	0
Non-marketable and other equity securities	(128)	(219)
Premises and equipment	(54)	(41)
Right-of-use asset and deferred rent assets	(89)	(81)
Goodwill and intangibles	(24)	(24)
Merger-related fair value adjustments	(15)	(28)
Other	(6)	(15)
Deferred tax liabilities	(2,186)	(523)
Net deferred tax assets (liabilities)	$ 153	$ 24

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S. federal net operating loss carryforwards	$ 6,400
State net operating loss carryforwards	4,500
Foreign net operating loss carryforwards	22
Foreign tax credit carryforward	43
State general business tax credit carryforwards	16
Unrecognized tax benefit	37	$ 37	$ 16	$ 13
Unrecognized tax benefits that if recognized would reduce income tax expense	29
Operating Loss Carryforwards [Line Items]
Deferred tax assets, valuation allowance	6	$ 7
Canadian net operating loss carryforwards
Operating Loss Carryforwards [Line Items]
Deferred tax assets, valuation allowance	$ 6

Income Taxes - Changes in Unrec

Income Taxes - Changes in Unrecognized Tax Benefit (Including Interest and Penalties) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Beginning Balance	$ 37	$ 16	$ 13
Additions for tax positions for current year	7	21	5
Additions for tax positions for prior years	1	0	1
Reduction for tax positions for prior years	(4)	0	(1)
Lapse of the applicable statute of limitations	(2)	0	(1)
Reduction as a result of settlement	(2)	0	(1)
Ending Balance	37	37	16
Interest and Penalties
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Beginning Balance	3	2	1
Additions for tax positions for current year	0	0	0
Additions for tax positions for prior years	2	1	1
Reduction for tax positions for prior years	0	0	0
Lapse of the applicable statute of limitations	(1)	0	0
Reduction as a result of settlement	0	0	0
Ending Balance	4	3	2
Total
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Beginning Balance	40	18	14
Additions for tax positions for current year	7	21	5
Additions for tax positions for prior years	3	1	2
Reduction for tax positions for prior years	(4)	0	(1)
Lapse of the applicable statute of limitations	(3)	0	(1)
Reduction as a result of settlement	(2)	0	(1)
Ending Balance	$ 41	$ 40	$ 18

Employee Benefit Plans - Deferr

Employee Benefit Plans - Deferred Compensation Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Compensation Related Costs [Abstract]
Maximum percentage of base salary that may be deferred under the DC Plan	50%
Maximum percentage of eligible bonus payment that may be deferred under the DC Plan	100%
Deferrals under the DC Plan	$ 13	$ 8	$ 6
DC Plan investment gains (losses)	$ (9)	$ (7)	$ 8

Employee Benefit Plans - 401(k)

Employee Benefit Plans - 401(k) and ESOP (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Employee Benefits Disclosure [Line Items]
Number of shares allocated to participants in ESOP	12,449	6,100	12,094
Employee Stock Ownership Plan (ESOP), Plan
Employee Benefits Disclosure [Line Items]
Maximum percentage of employee's eligible pay earned in the fiscal year contributed by the company in cash or common stock towards ESOP	10%
ESOP contributions vesting period	5 years
Employee Stock Ownership Plan (ESOP), Plan \| Defined Contribution Plan, The 401(k) Plan
Employee Benefits Disclosure [Line Items]
Expenses incurred related to employee benefit plan	$ 74	$ 54	$ 36

Off-Balance Sheet Arrangement_3

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Extend Credit (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Commitments [Line Items]
Commitments to extend credit	$ 62,541	$ 44,016
Allowance for unfunded credit commitments	636	422	$ 448	$ 305
Unfunded credit commitments
Other Commitments [Line Items]
Allowance for unfunded credit commitments	303	171	$ 121	$ 68
Loan commitments
Other Commitments [Line Items]
Commitments to extend credit	58,891	40,327
Standby letters of credit
Other Commitments [Line Items]
Commitments to extend credit	3,567	3,612
Commercial letters of credit
Other Commitments [Line Items]
Commitments to extend credit	$ 83	$ 77

Off-Balance Sheet Arrangement_4

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Standby Letters of Credit (Details) $ in Millions	Dec. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Expires In One Year or Less	$ 3,443
Expires After One Year	124
Total Amount Outstanding	3,567
Maximum Amount of Future Payments	3,567
Financial standby letters of credit
Loss Contingencies [Line Items]
Expires In One Year or Less	3,363
Expires After One Year	115
Total Amount Outstanding	3,478
Maximum Amount of Future Payments	3,478
Performance standby letters of credit
Loss Contingencies [Line Items]
Expires In One Year or Less	80
Expires After One Year	9
Total Amount Outstanding	89
Maximum Amount of Future Payments	$ 89

Off-Balance Sheet Arrangement_5

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Standby letters of credit
Commitments and Contingencies Disclosure [Line Items]
Deferred fees	$ 20	$ 20

Off-Balance Sheet Arrangement_6

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Total Capital Commitments, Unfunded Capital Commitments, and Our Ownership in Each Fund (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) Investment
Venture capital and private equity fund investments measured at net asset value
Other Commitments [Line Items]
Commitments expiration period	10 years
SVBFG Unfunded Commitments	$ 3
Venture capital and private equity fund investments measured at net asset value \| CP II, LP \| Non-marketable securities \| Direct ownership interest
Other Commitments [Line Items]
SVBFG Ownership interest percentage	1.30%
Venture capital and private equity fund investments measured at net asset value \| CP II, LP \| Non-marketable securities \| Indirect ownership interest
Other Commitments [Line Items]
SVBFG Ownership interest percentage	3.80%
Venture capital and private equity fund investments measured at net asset value \| Other fund investments \| Non-marketable securities
Other Commitments [Line Items]
Number of other funds with investment commitments \| Investment	143
Upper Limit
Other Commitments [Line Items]
SVBFG Ownership interest percentage	5%
Upper Limit \| Venture capital and private equity fund investments measured at net asset value
Other Commitments [Line Items]
Fund commitments investment cycle	7 years
Upper Limit \| Venture capital and private equity fund investments measured at net asset value \| Other fund investments \| Non-marketable securities
Other Commitments [Line Items]
SVBFG Ownership interest percentage	5%
Lower Limit \| Venture capital and private equity fund investments measured at net asset value
Other Commitments [Line Items]
Fund commitments investment cycle	5 years
Parent Company
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 699
SVBFG Unfunded Commitments	164
Parent Company \| CP II, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	1
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership interest percentage	5.10%
Parent Company \| Strategic Investors Fund II, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership interest percentage	8.60%
Parent Company \| Strategic Investors Fund III, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership interest percentage	5.90%
Parent Company \| Strategic Investors Fund IV, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 12
SVBFG Unfunded Commitments	$ 2
SVBFG Ownership interest percentage	5%
Parent Company \| Strategic Investors Fund V funds
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 1
SVBFG Unfunded Commitments	0
Parent Company \| Other venture capital and private equity fund investments
Other Commitments [Line Items]
SVBFG Capital Commitments	18
SVBFG Unfunded Commitments	5
Parent Company \| Debt funds (equity method accounting)
Other Commitments [Line Items]
SVBFG Capital Commitments	59
SVBFG Unfunded Commitments	0
Parent Company \| Other fund investments
Other Commitments [Line Items]
SVBFG Capital Commitments	275
SVBFG Unfunded Commitments	45
Parent Company \| Redwood Evergreen Fund, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	250
SVBFG Unfunded Commitments	$ 108
SVBFG Ownership interest percentage	100%
Parent Company \| Capital Preferred Return Fund, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 13
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership interest percentage	20%
Parent Company \| Growth Partners, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 25
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership interest percentage	33%
Parent Company \| Strategic Investors Fund, LP
Other Commitments [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership interest percentage	12.60%

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	$ 26,069	$ 27,221
Fair Value, Derivative Assets	382	165
Fair Value, Derivative Liabilities	234	148
Less: netting adjustment (Derivative Assets)	(351)	(137)
Less: netting adjustment (Derivative Liabilities)	(223)	(120)
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	16,135	15,850
U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	101	196
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,088	61
Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	6,603	8,589
Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	678	982
Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,464	1,543
Derivative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Less: netting adjustment (Derivative Assets)	(351)	(137)
Less: netting adjustment (Derivative Liabilities)	(223)	(120)
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	26,069	27,221
Total assets	26,914	28,112
Total liabilities	337	126
Recurring \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	4
Other assets		8
Recurring \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	4
Other liabilities		8
Recurring \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	383	277
Recurring \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	12
Recurring \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	289	455
Recurring \| U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	16,135	15,850
Recurring \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	101	196
Recurring \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,088	61
Recurring \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	6,603	8,589
Recurring \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	678	982
Recurring \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,464	1,543
Recurring \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	32	117
Recurring \| Derivative \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	157	151
Recurring \| Derivative \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	333	118
Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	17,223	15,911
Total assets	17,258	15,962
Total liabilities	4	8
Recurring \| Level 1 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	4
Other assets		8
Recurring \| Level 1 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	4
Other liabilities		8
Recurring \| Level 1 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0	0
Recurring \| Level 1 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0
Recurring \| Level 1 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	31	43
Recurring \| Level 1 \| U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	16,135	15,850
Recurring \| Level 1 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 1 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,088	61
Recurring \| Level 1 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 1 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 1 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 1 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	31	43
Recurring \| Level 1 \| Derivative \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0	0
Recurring \| Level 1 \| Derivative \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	0	0
Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	8,846	11,310
Total assets	9,361	11,680
Total liabilities	556	238
Recurring \| Level 2 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0
Other assets		0
Recurring \| Level 2 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	0
Other liabilities		0
Recurring \| Level 2 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	6	8
Recurring \| Level 2 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0
Recurring \| Level 2 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	1	74
Recurring \| Level 2 \| U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 2 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	101	196
Recurring \| Level 2 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 2 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	6,603	8,589
Recurring \| Level 2 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	678	982
Recurring \| Level 2 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	1,464	1,543
Recurring \| Level 2 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	1	74
Recurring \| Level 2 \| Derivative \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	508	288
Recurring \| Level 2 \| Derivative \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	556	238
Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Total assets	389	269
Total liabilities	0	0
Recurring \| Level 3 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0
Other assets		0
Recurring \| Level 3 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	0
Other liabilities		0
Recurring \| Level 3 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	377	269
Recurring \| Level 3 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	12
Recurring \| Level 3 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	0	0
Recurring \| Level 3 \| U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Recurring \| Level 3 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	0	0
Recurring \| Level 3 \| Derivative \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Assets	0	0
Recurring \| Level 3 \| Derivative \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Derivative Liabilities	0	0
Recurring \| Measured at net asset value \| Venture capital and private equity fund investments measured at net asset value \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Nonmarketable securities	$ 257	$ 338

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity warrant assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	$ 269	$ 192	$ 161
Total Net Gains (Losses) Included in Net Income	153	561	229
Sales/Exits	(71)	(502)	(215)
Issuances	30	24	19
Transfers Out of Level 3	(4)	(6)	(2)
Ending Balance	377	269	$ 192
Contingent conversion rights
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	0
Total Net Gains (Losses) Included in Net Income	(1)
Sales/Exits	0
Issuances	13
Transfers Out of Level 3	0
Ending Balance	$ 12	$ 0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total unrealized gains, net	$ 110	$ 119
Equity warrant assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	111	119
Contingent conversion rights
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	$ (1)	$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Details) $ in Millions	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Equity warrant assets (public portfolio) \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value		$ 2
Equity warrant assets (public portfolio) \| Volatility \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.278
Equity warrant assets (public portfolio) \| Volatility \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.550
Equity warrant assets (public portfolio) \| Volatility \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.437
Equity warrant assets (public portfolio) \| Risk-Free Interest Rate \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.006
Equity warrant assets (public portfolio) \| Risk-Free Interest Rate \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.015
Equity warrant assets (public portfolio) \| Risk-Free Interest Rate \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.011
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.10	0.100
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Upper Limit
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.20
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.20	0.200
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average		0.107
Equity warrant assets (private portfolio) \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 377	$ 267
Equity warrant assets (private portfolio) \| Volatility \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.232	0.247
Equity warrant assets (private portfolio) \| Volatility \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.487	0.550
Equity warrant assets (private portfolio) \| Volatility \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.412	0.430
Equity warrant assets (private portfolio) \| Risk-Free Interest Rate \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.034	0.0006
Equity warrant assets (private portfolio) \| Risk-Free Interest Rate \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.048	0.014
Equity warrant assets (private portfolio) \| Risk-Free Interest Rate \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.043	0.008
Equity warrant assets (private portfolio) \| Marketability discount \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.165	20.1
Equity warrant assets (private portfolio) \| Marketability discount \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.165	0.201
Equity warrant assets (private portfolio) \| Remaining life assumption \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.400	40
Equity warrant assets (private portfolio) \| Remaining life assumption \| Weighted average \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.400	0.400
Contingent conversion rights \| Private Portfolio \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 12

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Footnote Information) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Lower Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.10	0.100
Duration of the sale restrictions	3 months
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Upper Limit
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.20
Equity warrant assets (public portfolio) \| Sales restrictions discount \| Upper Limit \| Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted Average	0.20	0.200
Duration of the sale restrictions	6 months
Equity warrant assets (private portfolio)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Weighted average contractual remaining term	6 years 1 month 6 days
Estimated remaining life	2 years 4 months 24 days

Fair Value of Financial Instr_8

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Financial Instruments not Carried at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Held-to-maturities, fair value	$ 76,169	$ 97,227
Net loans	73,614	65,854
Time deposits	6,693	1,739
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,803	14,586
Held-to-maturities, fair value	91,321	98,195
Non-marketable securities not measured at net asset value	441	424
Non-marketable securities measured at net asset value	628	710
Net loans	73,614	65,854
FHLB and FRB stock	720	107
Non-maturity deposits	166,416	187,464
Time deposits	6,693	1,739
FHLB Advances	2,000
Junior subordinated debentures	91	90
Commitments to extend credit	0	0
Carrying Amount \| Other short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,565	71
Carrying Amount \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	349	349
Carrying Amount \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	496	496
Carrying Amount \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	495	494
Carrying Amount \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	497	496
Carrying Amount \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	646	645
Carrying Amount \| 4.345% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	348
Carrying Amount \| 4.570% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	448
Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,803	14,586
Held-to-maturities, fair value	76,169	97,227
Non-marketable securities not measured at net asset value	441	424
Non-marketable securities measured at net asset value	628	710
Net loans	74,602	67,335
FHLB and FRB stock	720	107
Non-maturity deposits	166,416	187,464
Time deposits	6,479	1,728
FHLB Advances	2,000
Junior subordinated debentures	96	92
Commitments to extend credit	52	47
Estimated Fair Value \| Other short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,565	71
Estimated Fair Value \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	337	370
Estimated Fair Value \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	412	526
Estimated Fair Value \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	364	474
Estimated Fair Value \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	417	501
Estimated Fair Value \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	570	649
Estimated Fair Value \| 4.345% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	331
Estimated Fair Value \| 4.570% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	397
Estimated Fair Value \| Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,803	14,586
Held-to-maturities, fair value	0	0
Non-marketable securities not measured at net asset value	0	0
Net loans	0	0
FHLB and FRB stock	0	0
Non-maturity deposits	166,416	187,464
Time deposits	0	0
FHLB Advances	0
Junior subordinated debentures	0	0
Commitments to extend credit	0	0
Estimated Fair Value \| Level 1 \| Other short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimated Fair Value \| Level 1 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 1 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 1 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 1 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 1 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 1 \| 4.345% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0
Estimated Fair Value \| Level 1 \| 4.570% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0
Estimated Fair Value \| Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Held-to-maturities, fair value	76,169	97,227
Non-marketable securities not measured at net asset value	0	0
Net loans	0	0
FHLB and FRB stock	0	0
Non-maturity deposits	0	0
Time deposits	6,479	1,728
FHLB Advances	2,000
Junior subordinated debentures	96	92
Commitments to extend credit	0	0
Estimated Fair Value \| Level 2 \| Other short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,565	71
Estimated Fair Value \| Level 2 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	337	370
Estimated Fair Value \| Level 2 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	412	526
Estimated Fair Value \| Level 2 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	364	474
Estimated Fair Value \| Level 2 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	417	501
Estimated Fair Value \| Level 2 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	570	649
Estimated Fair Value \| Level 2 \| 4.345% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	331
Estimated Fair Value \| Level 2 \| 4.570% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	397
Estimated Fair Value \| Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Held-to-maturities, fair value	0	0
Non-marketable securities not measured at net asset value	441	424
Net loans	74,602	67,335
FHLB and FRB stock	720	107
Non-maturity deposits	0	0
Time deposits	0	0
FHLB Advances	0
Junior subordinated debentures	0	0
Commitments to extend credit	52	47
Estimated Fair Value \| Level 3 \| Other short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimated Fair Value \| Level 3 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 3 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 3 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 3 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	0
Estimated Fair Value \| Level 3 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0	$ 0
Estimated Fair Value \| Level 3 \| 4.345% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	0
Estimated Fair Value \| Level 3 \| 4.570% Senior Fixed Rate/Floating Rate Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior Notes	$ 0

Fair Value of Financial Instr_9

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Details) $ in Millions	Dec. 31, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	$ 885
Fair Value	885
Unfunded Commitments	28
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	257
Fair Value	257
Unfunded Commitments	18
Non-marketable securities \| Venture capital and private equity fund investments measured at net asset value \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	605
Fair Value	605
Unfunded Commitments	9
Non-marketable securities \| Debt funds \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	5
Fair Value	5
Unfunded Commitments	0
Non-marketable securities \| Other investments \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	18
Fair Value	18
Unfunded Commitments	$ 1

Fair Value of Financial Inst_10

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Footnote Information) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 885
Unfunded commitments	28
Non-marketable securities \| Fair value accounting \| Venture capital and private equity fund investments measured at net asset value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	257
Unfunded commitments	18
Non-marketable securities \| Fair value accounting \| Noncontrolling Interests \| Venture capital and private equity fund investments measured at net asset value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	40
Unfunded commitments	$ 2
Non-marketable securities \| Fair value accounting \| Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Estimated future period of distributions from the fund investments	10 years
Non-marketable securities \| Fair value accounting \| Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Estimated future period of distributions from the fund investments	13 years
Non-marketable securities \| Equity method accounting \| Venture capital and private equity fund investments measured at net asset value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 605
Unfunded commitments	9
Non-marketable securities \| Equity method accounting \| Other investments
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	18
Unfunded commitments	$ 1
Non-marketable securities \| Equity method accounting \| Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Estimated future period of distributions from the fund investments	5 years
Non-marketable securities \| Equity method accounting \| Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Estimated future period of distributions from the fund investments	8 years

Regulatory Matters - Capital Ra

Regulatory Matters - Capital Ratios for Company and Bank under Federal Regulatory Guidelines (Details) $ in Millions	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
SVB Financial Group
CET 1 risk-based capital, Actual Capital Ratios	0.1205	0.1209
CET 1 risk-based capital, Required Capital Ratios	7%	7%
CET 1 risk-based capital, Actual Capital Amounts	$ 13,697	$ 12,186
CET 1 risk-based capital, Required Capital Amounts	$ 7,954	$ 7,057
Tier 1 risk-based capital, Actual Capital Ratios	0.1540	0.1608
Tier 1 risk-based capital, Required Capital Ratios	0.085	0.085
Tier 1 risk-based capital, Well Capitalized Capital Ratios	0.060	0.060
Tier 1 risk-based capital, Actual Capital Amounts	$ 17,504	$ 16,206
Tier 1 risk-based capital, Required Capital Amounts	9,658	8,569
Tier 1 risk-based capital, Well Capitalized Capital Amounts	$ 6,818	$ 6,049
Total risk-based capital, Actual Capital Ratios	0.1618	0.1658
Total risk-based capital, Required Capital Ratios	0.105	0.105
Total risk-based capital, Well Capitalized Capital Ratios	0.100	0.100
Total risk-based capital, Actual Capital Amounts	$ 18,380	$ 16,712
Total risk-based capital, Required Capital Amounts	11,931	10,585
Total risk-based capital, Well Capitalized Capital Amounts	$ 11,363	$ 10,081
Tier 1 leverage, Actual Capital Ratios	0.0811	0.0793
Tier 1 leverage, Required Capital Ratios	0.040	0.040
Tier 1 leverage, Actual Capital Amounts	$ 17,504	$ 16,206
Tier 1 leverage, Required Capital Amounts	$ 8,630	$ 8,175
Silicon Valley Bank
CET 1 risk-based capital, Actual Capital Ratios	0.1526	0.1489
CET 1 risk-based capital, Required Capital Ratios	7%	7%
CET 1 risk-based capital, Well Capitalized Capital Ratios	6.50%	6.50%
CET 1 risk-based capital, Actual Capital Amounts	$ 16,995	$ 14,622
CET 1 risk-based capital, Required Capital Amounts	7,795	6,875
CET 1 risk-based capital, Well Capitalized Capital Amounts	$ 7,238	$ 6,384
Tier 1 risk-based capital, Actual Capital Ratios	0.1526	0.1489
Tier 1 risk-based capital, Required Capital Ratios	0.085	0.085
Tier 1 risk-based capital, Well Capitalized Capital Ratios	0.080	0.080
Tier 1 risk-based capital, Actual Capital Amounts	$ 16,995	$ 14,622
Tier 1 risk-based capital, Required Capital Amounts	9,465	8,348
Tier 1 risk-based capital, Well Capitalized Capital Amounts	$ 8,908	$ 7,857
Total risk-based capital, Actual Capital Ratios	0.1605	0.1540
Total risk-based capital, Required Capital Ratios	0.105	0.105
Total risk-based capital, Well Capitalized Capital Ratios	0.100	0.100
Total risk-based capital, Actual Capital Amounts	$ 17,871	$ 15,129
Total risk-based capital, Required Capital Amounts	11,692	10,313
Total risk-based capital, Well Capitalized Capital Amounts	$ 11,135	$ 9,821
Tier 1 leverage, Actual Capital Ratios	0.0796	0.0724
Tier 1 leverage, Required Capital Ratios	0.040	0.040
Tier 1 leverage, Well Capitalized Capital Ratios	0.050	0.050
Tier 1 leverage, Actual Capital Amounts	$ 16,995	$ 14,622
Tier 1 leverage, Required Capital Amounts	8,537	8,075
Tier 1 leverage, Well Capitalized Capital Amounts	$ 10,672	$ 10,094

Segment Reporting - Additional

Segment Reporting - Additional Information (Details)	12 Months Ended
Segment Reporting - Additional Information (Details)	Dec. 31, 2022 Segment
Segment Reporting [Abstract]
Number of reportable segments	4

Segment Reporting - Segment Inf

Segment Reporting - Segment Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Net interest income	$ 4,485	$ 3,179	$ 2,157
Provision for credit losses	(420)	(123)	(220)
Noninterest income	1,728	2,738	1,840
Noninterest expense	(3,621)	(3,070)	(2,035)
Income before income tax expense	2,172	2,724	1,742
Total average loans, net of unearned income	70,289	54,547	37,266
Total average assets	216,103	166,011	85,792
Total average deposits	185,761	147,947	75,016
Silicon Valley Bank
Segment Reporting Information [Line Items]
Income before income tax expense	3,391	2,299
SVB Private Bank
Segment Reporting Information [Line Items]
Income before income tax expense	132	47
SVB Capital
Segment Reporting Information [Line Items]
Noninterest income	(110)	487	226
Income before income tax expense	(180)	416
SVB Securities
Segment Reporting Information [Line Items]
Income before income tax expense	(95)	48
Operating segments \| Silicon Valley Bank
Segment Reporting Information [Line Items]
Net interest income	4,118	2,914	1,990
Provision for credit losses	(277)	(55)	(166)
Noninterest income	1,107	706	604
Noninterest expense	(1,557)	(1,266)	(1,011)
Income before income tax expense			1,417
Total average loans, net of unearned income	54,647	43,145	30,116
Total average assets	175,221	140,362	73,929
Total average deposits	172,106	138,057	71,911
Operating segments \| SVB Private Bank
Segment Reporting Information [Line Items]
Net interest income	407	226	112
Provision for credit losses	(10)	(14)	(21)
Noninterest income	96	58	5
Noninterest expense	(361)	(223)	(55)
Income before income tax expense			41
Total average loans, net of unearned income	14,934	9,986	5,298
Total average assets	16,637	11,171	5,335
Total average deposits	12,884	8,924	2,388
Operating segments \| SVB Capital
Segment Reporting Information [Line Items]
Net interest income	0	0	0
Provision for credit losses	0	0	0
Noninterest income	(110)	487	226
Noninterest expense	(70)	(71)	(51)
Income before income tax expense			175
Total average loans, net of unearned income	0	0	0
Total average assets	942	700	437
Total average deposits	0	0	0
Operating segments \| SVB Securities
Segment Reporting Information [Line Items]
Net interest income	3	1	1
Provision for credit losses	0	0	0
Noninterest income	505	608	497
Noninterest expense	(603)	(561)	(379)
Income before income tax expense			119
Total average loans, net of unearned income	0	0	0
Total average assets	936	830	557
Total average deposits	0	0	0
Other Items
Segment Reporting Information [Line Items]
Net interest income	(43)	38	54
Provision for credit losses	(133)	(54)	(33)
Noninterest income	130	879	508
Noninterest expense	(1,030)	(949)	(539)
Income before income tax expense	(1,076)	(86)	(10)
Total average loans, net of unearned income	708	1,416	1,852
Total average assets	22,367	12,948	5,534
Total average deposits	$ 771	$ 966	$ 717

Segment Reporting - Segment I_2

Segment Reporting - Segment Information (Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Goodwill	$ 375	$ 375	$ 143
Operating segments \| Silicon Valley Bank
Segment Reporting Information [Line Items]
Depreciation and amortization	49	34	$ 25
Operating segments \| SVB Securities
Segment Reporting Information [Line Items]
Goodwill	174	138
Operating segments \| SVB Private Bank
Segment Reporting Information [Line Items]
Goodwill	$ 201	$ 87

Parent Company Only Condensed_3

Parent Company Only Condensed Financial Information - Condensed Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets:
Cash and cash equivalents	$ 13,803	$ 14,586
Investment securities	120,054	127,959
Loans, amortized cost	74,250	66,276
Lease right-of-use assets	335	313
Other assets	3,082	1,791
Total assets	211,793	211,308
Liabilities and total equity
Long-term debt	5,370	2,570
Lease liabilities	413	388
Other liabilities	3,041	2,467
Total liabilities	195,498	194,699
SVBFG stockholders' equity	16,004	16,236
Total liabilities and total equity	211,793	211,308
Parent Company
Assets:
Cash and cash equivalents	2,258	2,324
Investment securities	491	731
Loans, amortized cost	1	1
Lease right-of-use assets	102	82
Other assets	475	387
Total assets	19,679	19,214
Liabilities and total equity
Long-term debt	3,370	2,570
Lease liabilities	135	113
Other liabilities	170	295
Total liabilities	3,675	2,978
SVBFG stockholders' equity	16,004	16,236
Total liabilities and total equity	19,679	19,214
Parent Company \| Bank Subsidiary
Assets:
Investment in subsidiaries	15,456	14,795
Parent Company \| Nonbank Subsidiaries
Assets:
Investment in subsidiaries	$ 896	$ 894

Parent Company Only Condensed_4

Parent Company Only Condensed Financial Information - Condensed Statements of Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Condensed Income Statements, Captions [Line Items]
Interest income	$ 5,673	$ 3,289	$ 2,242
Interest expense	(1,188)	(110)	(85)
Gains on equity warrant assets, net	148	560	237
Gains (losses) on investment securities, net	(285)	761	421
Income tax expense	(563)	(651)	(448)
Preferred stock dividends	(163)	(63)	(17)
Net income available to common stockholders	1,509	1,770	1,191
Parent Company
Condensed Income Statements, Captions [Line Items]
Interest income	1	3	3
Interest expense	(91)	(48)	(22)
Dividend income from bank subsidiary	294	0	50
Gains on equity warrant assets, net	146	554	227
Gains (losses) on investment securities, net	(179)	197	158
Fund management fees and other noninterest income	54	68	62
General and administrative expenses	(284)	(298)	(121)
Income tax expense	143	(212)	(146)
Income before net income of subsidiaries	84	264	211
Net income before preferred stock dividend	1,672	1,833	1,208
Preferred stock dividends	(163)	(63)	(17)
Net income available to common stockholders	1,509	1,770	1,191
Parent Company \| Bank Subsidiary
Condensed Income Statements, Captions [Line Items]
Income before net income of subsidiaries	2,035	1,294	826
Equity in undistributed net income of subsidiaries	1,741	1,294	776
Parent Company \| Nonbank Subsidiaries
Condensed Income Statements, Captions [Line Items]
Income before net income of subsidiaries	(153)	275	221
Equity in undistributed net income of subsidiaries	$ (153)	$ 275	$ 221

Parent Company Only Condensed_5

Parent Company Only Condensed Financial Information - Condensed Statements of Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Condensed Statement of Income Captions [Line Items]
Changes in fair value on bank cash flow hedges, net of reclassification adjustments in bank net income	$ 43
Other comprehensive income (loss), net of tax	(1,902)	$ (632)	$ 538
Comprehensive income attributable to SVBFG	(230)	1,201	1,746
Parent Company
Condensed Statement of Income Captions [Line Items]
Net income before preferred stock dividend	1,672	1,833	1,208
Foreign currency translation gains (losses)	(37)	(1)	12
Changes in unrealized holding gains (losses) on AFS securities	(39)	(3)	0
Changes in fair value on bank cash flow hedges, net of reclassification adjustments in bank net income	(6)	(46)	131
Equity in other comprehensive income (loss) of bank and nonbank subsidiaries	(1,883)	(341)	395
Other comprehensive income (loss), net of tax	(1,965)	(391)	538
Comprehensive income attributable to SVBFG	$ (293)	$ 1,442	$ 1,746

Parent Company Only Condensed_6

Parent Company Only Condensed Financial Information - Condensed Statements of Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Adjustments to reconcile net income to net cash used for operating activities:
Gains on equity warrant assets, net	$ (148)	$ (560)	$ (237)
Gains (losses) on investment securities, net	285	(761)	(421)
Amortization of share-based compensation	183	136	84
Other, net	(483)	(296)	(310)
Net cash provided by operating activities	2,864	1,868	1,412
Cash flows from investing activities:
Net decrease in loans	(7,879)	(13,726)	(11,927)
Business acquisitions, net	0	1,081	(27)
Net cash used for investing activities	(3,638)	(90,336)	(31,206)
Cash flows from financing activities:
Proceeds from issuance of common stock, net	(22)	2,374	31
Net proceeds from the issuance of preferred stock	0	3,306	0
Payment of preferred stock dividends	(163)	(63)	(17)
Common stock repurchase	0	0	(60)
Net cash provided (used for) by financing activities	(9)	85,432	40,656
Net increase (decrease) in cash and cash equivalents	(783)	(3,036)	10,862
Cash and cash equivalents at beginning of period	14,586	17,622	6,760
Cash and cash equivalents at end of period	13,803	14,586	17,622
Parent Company
Condensed Cash Flow Statements, Captions [Line Items]
Net income before preferred stock dividend	1,672	1,833	1,208
Adjustments to reconcile net income to net cash used for operating activities:
Gains on equity warrant assets, net	(146)	(554)	(227)
Gains (losses) on investment securities, net	179	(197)	(158)
Gains on derivatives, net	0	0	(30)
Distributions of earnings from investment securities	33	60	65
Net income of subsidiaries	(84)	(264)	(211)
Cash dividends from bank subsidiary	294	0	50
Amortization of share-based compensation	183	136	84
(Increase) decrease in other assets	35	(40)	17
Increase (decrease) in other liabilities	(129)	58	99
Other, net	1	2	14
Net cash provided by operating activities	240	(271)	75
Cash flows from investing activities:
Net decrease in investment securities from purchases, sales and maturities	49	533	123
Net decrease in loans	0	0	15
Net cash used for investing activities	(916)	(5,329)	(654)
Cash flows from financing activities:
Proceeds from issuance long-term debt	795	1,636	495
Proceeds from issuance of common stock, net	(22)	2,374	31
Net proceeds from the issuance of preferred stock	0	3,306	0
Payment of preferred stock dividends		(63)	(17)
Common stock repurchase	0	0	(60)
Net cash provided (used for) by financing activities	610	7,253	449
Net increase (decrease) in cash and cash equivalents	(66)	1,653	(130)
Cash and cash equivalents at beginning of period	2,324	671	801
Cash and cash equivalents at end of period	2,258	2,324	671
Bank Subsidiary \| Parent Company
Adjustments to reconcile net income to net cash used for operating activities:
Net income of subsidiaries	(2,035)	(1,294)	(826)
Cash flows from investing activities:
Increase (decrease) in investment in subsidiaries	(773)	(1,240)	(69)
Capital Infusion In Bank Subsidiary	0	(5,750)	(700)
Nonbank Subsidiaries \| Parent Company
Adjustments to reconcile net income to net cash used for operating activities:
Net income of subsidiaries	153	(275)	(221)
Cash flows from investing activities:
Increase (decrease) in investment in subsidiaries	(192)	47	4
Business acquisitions, net	$ 0	$ 1,081	$ (27)